var title_f20_62_21472="Path of papillary fibroelastoma";
var content_f20_62_21472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76001&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Papillary fibroelastoma of mitral valve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 335px; height: 215px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gross and microscopic pathology of a papillary fibroelastoma of the mitral valve. The gross specimen (left) reveals multiple frond-like structures when photographed underwater. Low (right, top) and high power (right, bottom) microscopic features include dense elastin (black) at the core of each frond coated with collagen (red pink) and lined by flat endocardial cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted from Journal of the American College of Cardiology, volume 30, Klarich, KW, Enriquez-Sarano, M, Gura, GM, et al. Papillary fibroelastoma: Echocardiographic characteristics for diagnosis and pathogenesis correlation, p.784, Copyright 1997, with permission from the American College of Cardiology.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.elsevier.com/locate/jacc\">",
"      file://www.elsevier.com/locate/jacc",
"     </a>",
"     <br/>",
"     <a href=\" file://www.sciencedirect.com\">",
"      file://www.sciencedirect.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21472=[""].join("\n");
var outline_f20_62_21472=null;
var title_f20_62_21473="Onychomatricoma";
var content_f20_62_21473=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Onychomatricoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 477px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHdAhwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzae4x1rNuLjJ68+1Q3M+D97NUJZ8H2rihT01PUqVbD55+vP8A9eqMkmfrTpG3H0NR7NxxXVCBwTqXI2O6pI4yKkSEnjkirMcXPIrdLuc8mJaRnIPNdBpsfKk9ao2kGccD6Gt+wtsbeOKxrSsjejG7NmxTIAxzW5brtUHHvWdYxYCnt6VqoOmK8etLmeh6sFoWEziplwRUKdamXOaw9C9h4GfwpwFIBUg6UMVxMZ/GlB7UpBoxjFDAcDTs0gHelAovoDHY+Wl255po9RT6dwGbM+tG2pAPXNKME+1UCZGBxS49KmCjuKUx5FFguQ9OtJnHWptnGRTWTI4pgR0hAA96cR7UY4wadrCISOKTpU+z8qjMfNO3YLjM5ppz9aeUOaQgin6idiFs9Kjc4FTvx71Vmbtnik5WBK40sfwoB6Uirk5qVE6ZrJybNVGwqIcU7HFTxoOPzpxUUrFFbyyx6cVNFEaeAKnjwKFFFDQpHahk96kLYHFMYk+1DCxAwwfenAEYpcHdQwrNjSAc96eAcZxxQgAGSakV1bgVajpcT0IDk0YIp5xu9qXaOtJoroIpPpTlHIpQR1o3daGugWHEHNIetJkmhVyeaLCsLipVXAzgZoRMnmpgvt+NKxLICppMVM4ABFRsadmFiMg0o5ApCeadTXYdgUZPpSlecU1Tg07JODSFYYyDpTGh+XjrU+B3/SngcUXYikkRwcUx0INXsZOB0pCgP0ouO5USMsOTxS+Wy9D0qx04HSm5I60X6BdkcTlDzVhZeOajADCoyvtRvsG5863M3zZqoWJNLc5JOMZpkQPccelfQwj0PCqTbHhc9BVqJPXp7U6GMHnHNWhF8vHSuhRsc7Y1EXirMcOSMCo0XawB6e1XbPBbnoO9GwLctWcByOBXQWUe0KAKoWaAkGtq1QcECvOxMj0cPA0LZcAcVdT61XhXGM5qyBxXmN3bO9bEidTUygEVGtSgcDFLfUCVAMYzTxwKjB7VKBxxSsSOGKMZPtSHinClYY9RS4pAeakGBjrTQnoNC9sUoFPA3cGkOce9Uu4Ae1IOeaCcCii4DhTwc45qNfenr+lFgY/2o70n9aXt15qrkjSPamlQSeOak4NMNPzAZtwee9BHtTs4FJxRdiYwjrULsB1qSaTaDWfNNubANDlYaVwnlOcDp3qBVLHnpUqx5wTU6IB2rN6m8VYYkeBjFSKOacB+tPCetFitBF5NSAUYCikLccUWQ7CEZ4/KnA4GKaW96j3ZOKlstIkBz1NPB9aizT06ULQbHIhY8dKkMAAyT0oVygGKhklklBVaaWpDv0K0s5eTy4+ccGrUWI4+epqtaW3llmbk561O/PXmqasPfQXPP1p65qNAalBxUXKYpGfpSBc96dkUm/n2pJWZI5QNuTzSA46UnbinAHvTaAkQ1IJMHOahyB24oUkmlYGiR2zzUJyTT+vHIpQOnH41SQJDFXnnpUnGKb34ppySarlAU9acvrimjpz0pwYEY7VLQg5Jpy896ahxTuc57VmyRcUEDNHJp23uaXqK4wADFNdM896lHXkUoAx70xXIFAUZPemO3PAqZkOOlMMfNFugaHzOyZY96lii7cCnpFk8DnNTxrgCvqYo+ckxQrZGPyqUMRwOaFGfenFB+NXYlkke3rjFXrWPkelU41yc8Vp2StnmoqStuXSV2atmnC4rctE/Os60jGF9a2Ldf0rxsRLU9ihHQsxjCjmp1qNBxzUyVydTosOTrxUq57mmrkntT196LCHqO/pUg6VED2709T09KbCxJjj1pV60gpeg6UrASKKkzioh+lPX60CsSA8dKTnrQDQOvSqfkSJn8qP0FLgHrS4GRSGN6mnDpQAaUA85NNAOFOXrn9Kb0oziqQtx3bpTf50Fu1B59qBWG+9QzSBRmieYRr1rJuJy7HBolLl0HGNx9xOXOAaSGPPU81Em0+tTq4HSsr3ZslbYnGB0pck1GGzn0NOBI6UX7lJE8fHWnA1XBY1KOnPamkUojmO7imFsCmSSYOBUJbOeaNtC0iRnJalzyCKiXJPtUo461LVhseBzU6gKMtxxVcEKfalMnmOFGcd6qKJs2W1XdEzE9KiiYAMQOaY8jldi/dpoO1ffvT1QWLA5FNwOMgVF5oAwDRuyalvqCViUH0pAcUzOaeAcUJXAdmkXjFGKUDpTSSEx4PanA8d6QCpEUnjFFmK5HUiLShctUyLxTtqO5EB+dOI470uMGnqhNOwrkO3vSMoqcoajKGmMj28U3YQamIxSZ4PrmpENGOppfYUhBJFO24FQ0hNCqfmqUkbfrUca5NTEYHFZvch6ETD0pwHahjlgKeME4pWEKwAXgc1Aw56VYKnHWmbM00yb2Pm+NRnPvUoXqMYpuB0pyk9Pzr6xI+cbAKQQKlRM9RxRHgjpzVlIt2Md6tRE2PtkyeMYrZtIRkAcn1qjbwMvTpWxaKVGK5cRJrc6sPBt6F21jClfp1rUhGBVK3UE5q/EMdq8SpK7PYgrInXtUq4PFRqOalGc1nvsaXJB3p2euKapGAaeOvvTuIB1qRfrTM/hThn0ouBIowetSY79aYnXGak/WkIUe9O7U0daeOKOghRmnD0pAe1KOuaZIqjPengdu1NBp4FADlUd6AlKB608c80ySIoRTCvtVg9OlMcZyapILkB4qCaXYCc0+dtnJrHu7jJwDkVLdioq4lzcGRsZ4qAduaYMmn446dKhu+pulYeCe1Lk7hTenenL1pFWsWEbKjFSRnLc1EnTpQCd2Aaa2GkXVxkU+UfLxUMK+pp0gbBA5FWthdSrJ3xUag1Z8vLDIp5jOelKzNFLoQDC1IDgZ71JDD5j4x0qeS1YDJGKdtBOaRTjUsSTViBFBLGmlGAIHOKgJfBHbvS1WwXuWGlUscdKru25uOlCodvvUvlccj3pNhdIiCk8nNSKOKftIWnohI9qEkO90NRc1OnP0FLEnBJ7UoGFxVW7EsTO5vanAcZpgBLeoqdQCcU0A+FdzgYq2YtqnFQQL83FWu5UU0QyGOPg8U6NM8DJqwRtXHeiLA4qmrCuRGHHamkc4FW5Pu8d6iEZUe9Jq2wXGKnHFMZKuKBt6Co2j96nVBcrSRDFRrH1NXdmRz0qPG3g0rDuVdvNGwk81ZCZJoK47VNguRomBQ43H0qUdKRlx9alozZXxhqbyrU+Q4NNJBHvUNFIkV8jmkLYpicUjuM1JPKfOyDcenFTCMY4PNOWM8Y7U9FK8mvsE9bHzL0FjhIxVuFWGMiiCrsK7iBVSJTbZYgGQBjFaUMfT1qtDHnGB7VoQIMCvJxU7Jo9fDwLUC4HvVyNe3aoYVwB6VZUdsV5R6CJFXmpR71GvXpUg6U15DuOHtTu9N6H1oHWhiJPrTweaiBJJp9JO+gEgPNSA1CDg9acD6UBYmB460qnniowaXPtTE0S5py/lUecnipFHFGqJY9c1Mo4x3qNR0qRB+dFiWxw6UvrSdPrSg0xC5qKZ9qkmnM2OaydRusAgGquCV2Vr65LMQp/Ks9jk5zQSS2TTSeKydzpirDgemKeh596gQln6VbiiOeaa1LAKc1KkZPtU0UQ64qzHH6jFCQnNLQhETEYFT29oztnFXLVEJ+atFRHEuRiq0MZVXsjPW024zUqwo1Pkk3nFKuB3zRchyb3H29irHd2qSezjUYA5NaunQhk55ou7UB9xPSqV7GftHcradpUcY3setN1OJQMKKuG4wAo6VFM6NzgE+9O9gTk3dmGYPlyajNsmCcVryjenGKrPbsO/FZtmqkygLcbhxTzbk9uK0LeElxnBqzcKkcfIxSTBzaZgPCc9KkSLC4xzWikSlSx6U+2tg+5gOKFuae27mS6FUApp9q0bm1YtwKrCEqxBHAqrlqaZAV2/jT4lPfinyICOOlSJH8vsKq5d9CW3IQc08vtOR+VRKDSEgkc8U9ibakySZHPU1I/ygAdTUcKA0+RDkfpTtdCaJXYBRzTgflyaqMWGM9KsphgKL6gSH7uaarbuBT8ZXApyoFYYpMWg0ocf0qOVQVBq0BxzzUDg0mhEYPAo25BpxXsKa3C4qEhERPOBSFuOaZ/EetRuT0FSx7iTEY+tQL97rxUkg460xUzipZaFDHJ54qMt7ilYEdM1AeppWDc8OjPAGatQqPQkj1qNIwOvFWol5GOa+vV0fJt3Y6KIHkce4q5bR4wB2NQxt83y8VehCr6Gs60rI0ormZcgwoyeDV+AZwcVThAIBFaNuuAOleFiZuTsz3KMbK5YjXip1HemIOmKnUeprlWpvccBwKAfWjjsKbnjFPUasSLS1HnJxSj8aSsIkzTgaZ9aUHmjyGSDpipBiox6U9aAHU5elNpcc8UWZJIvQVPGDgZ61Ch4qZOCPSmrEslAxT8dKYD+VKWp2IY4sOlNZsU1mx0qKWTapJodraCsQ3lyEQjisKdzI5J5qe8mMjkA8VV9hUm8FYaxppG48f/AK6njiZiPSrcFoS4GKVmy+ZIhs4MdRWnDblzwKtxWYRBkc1dtoDjpWiVzGVTmKsdsIx81NZC3CitZLXd1qZLdQRxzTUbkKRjR2z7uOKtrbO5G4/hWqsI9KkWIdsUOKQOZlfZTjjrTxZksM8VqeXj6UhWiyW4uYlsgIFBJHSq15JLKxAPFSkc80uzJ6VLktiV3M0RSFsliDUgg/vVoCIL161G0bOwC1ncvmIobYHpVgwgIQQKtwReWnIpzR5U00yHK5kNHtfI4qrcsS3tWx9mZzwKhlsGJGVpWbLUl1MOWR2O1MirUNz9nRQe9Wns9vOOao3cBY+mKTuitHsX7SVJskn2pl3bBuUxWdCXjwF4FXre5wcSU1Imzi7oo+SwJyKmSLETNmrm0FMgcZzSDb5YB9a0T6mqqNoobSE6UFMdefcVK5BbpwKRjlgMVV7miZKiFYwcc08c9aYrZ6c4ppcq4BrRD3Yk4AFRrJggU6ZizdOKqzHGGFKSLSNJJV4HFTBhnOayrcO7c9KvFGJ9hWbfQhq2hZBDDnpUMjBiAvWotzA4HSnRdScUhWtqSgbVHc1Xlzmp1bJ5ocDk0+hOzM8IxJz1pXUYGKnIyKjKHIqbWKTK79McUj8LmpdnPSoZTg4z1qSrjSpKk1ERipQ42YqE+9AzxKHgZIznrVpOcY4FTQwgjDcn2qQxd1HHtX1yXY+PYxEzVyJMYzzUEQKmrkBzzXJiZ6HfhY31L1sOAK0oQBjrVO2HFX4hgda+fm/ebPZjoiZBzU4PHFQL+tSA/LyKhXQ7Dzz7U3oeOlKG4pM5ql5jQuOakUZ5pmMnk08ZHSkMUDilHfIxSZ7U4c9aTBD1/Wnr+Gaav1py9KYMeOadnGKZSimIkWpQ3IquDg07d7UbEvcshhRuquGp2/16VS1IaJGfjrWdfzHG0ZzVl2J4XvU9ppbSndIKXkF1HU50IzMe5zVqC23EZFb8ulrGw+X9KbNaiNaEuhXtb7GfFEqngc1pWlt8wY0ltbjOTzWnEgAAxVaENjVjz1FWI1AAxxTlXjFTKntTJsIF4p4Xj3pwWnAdKV9RCAelPAxgmgUh5GKVwFPIph64FKAamSPpUOXYY1I88mpUXsOac0ZEZIpbVCqZbOTUNsV0IseWqTAjXIHPtRuy+B0FTLFyM1PoS2RopIyads4qwE4pduBVWIuNgCgYNTMENRY9KB15q1KwrXKs8Qas65txtJxz2rZcZqGSMEHAqtC4yaOc8j5uRzTZIGzkDHrW59m+bpSTRKFORSsbe0M+Bcwbc89MVGyYb6VZXCSZFOEfmZB6mhLuPbUprBujc1H5BODjpV1SIVcHoTTBIBExIrSJSkU412LuNRMSST61Nu3gDHFKISD81Na7G8dCvglTUBUs4FXmXBbFIsXG6m0XzDEjx8qjirP3eKSNSDkngVMVDLmkokMYig57VEMKD6U5iU4qpKzHjpU3Ek2S+d82BQsmTgiktosHJ61IyBTnPNS7sHZDwuFGajIGTRJKT8q0xWAyMkmldCsxjcMaquhParJ6k1G3INJoorKnJB4FNKgkmp5FAxioyMd6lgeSLEQevB9KnQFTjipImVjxj6elTeWu8dM/Svr3oj5Jash8sYJPOamhjA6HFKVwQBwKmQc15OKnoevhYFuBexq4g/Cq0PBqyteS9T0iQe3an9utMHWnipsApPFJmg/WkI5609wJFPXNSD9ahB4GamT9aLgKB61IAc01R+VSKM0txXFAp2KUDHfIop2bC4AU6kH40Hk01oO4U3NO7c03Hel6CuGTQ77RnvSN8tQkmQkKDVITLun4eQMxroLWZVkUADFYOmQMrfN0q9K+1vl60NNGE1zOyNLUbhFxtxmswyGTrSYaTlualVKq5rCnYWI4GKtRPzUCrx0qSNTnigbSLsR46VZQcVXhHrVhWA6UmZMf3pQO5pqtzTialuxIjHmlRc0KMtViFfzrO42xqRDjip1T8qeq45NOx6Ur3IuwONuKQjoBSHNG7L7RSYh8UYU571OBSKMCnZxVIlsXoPek/lRTS1O4gY4qNzSk5pwXNO49iMZxShfWpgmBzUcrBelNIe+wxyFBNUp2yamdi2fSoWSrSNYq25QcneM9M0+OUiVucg1JNH8vHWqDsVVh3pSWhsrSLlwolOB0qn5ZeQxjoK0IMvahhycc0xUENs8x+8eBVxXMiFK2hctbGMQLwCagmtx5rHsKfaSOIhkn1FMkmzHjuTz9K1TSQ1zJkbW22Iu3U9KrLtOfarVzN5pCLwMVQJwx7Ch23ZrC/UmbG3+VR+ZgHFRh2LH2phbanzdc1DZokOdtxNMwBg+tAYU7BNZtsNiQMFQVBJuduOlHzbhnH0qTcBnjmp3WohAmxTnriqmT5nJ4qeR2c8cCo5V4GOtD2sNDiflwOtQudgqXIEROBnpVdzvHNIBu75eevamNyabI+3AHpSZNTyhY8qibZirUMvOeaoI47mrELBxx0r62roj5Sjqy+G3YqaLr04qtCMDjmrkKnA9TXg4qd3Y93DxsizH1qdTxUK1KvQGuI6yVTx0qUGoR6Cn0akj80h9KTjFGOaVxjh1FTJxUC9anTp7UlohMlU1ID2qMCndqCR+fzpQc0wH86F60yh47elLnPWm5zSdKdwJCeOaB+tMDUySTH1qriEmYngVoWVuBGGfrVOFAx3Eda0owSoA6VS0Id5DkbAwgqRIu560+OPHOKmUY4xSb7FJKIwJjpTsYp4X604Kc8YpWHcaq5NWETGDREnfFSN0oJbuGcU4H9aYvXJpx/nSJsSKx6mnB89KhANTwxk8kVDYrE0WTjNXIVwvNMt4hgs2cVOR0GKVjOT6DgMg+1IOaf0XFIB6UMi40j071JDDjnqaVVGfepM4GBStYTYMcAYpuaDxzUTseaYrDmfjimljnFMGe1PVc0D2HIM1OuAOaauAKYz8807WFuSO3FVHQsakL00sKpMqOmxFJheKgY56U+Zs1AW4NO5qh8eGk2n0rKvCFdh6VrWa75cjoKwtUk/fShegNOXw3NKesrGhpMhMATByzH8hWnFCLmLy8Z2motMtwtnbNj5gmfxNT6W3l+c/bcRWlJWijGo7t2CSMRDYMfKMVlznk+vatK8Y5OB171lSviTJ6Vs9DakhgLKfeq7/f5q2/zAN2qhcOFb1NZyOmKuyTzFTJPOarsWmk46U2NS7ZbOBVmPCqfU1GpTXKLsCrk05fu5PSmsSwxQ+SvynpS2ZIxiC3FAQFj1ppU4GOpqVQB35pMCOTC9MVEzEsM1LLgRZNVw3TJpNDSFdudvpVaRsH2NSMwMo5wKJAoXnrQ/Idisy5OTSbscCnOSQDTQvr1pPRBc8dVXLZI4z2q9ESOBxUETZOAOKuxRgnI696+kxMrI+awsbstwdB6mr0Q4zVOAev51djAyK+fqy5pHuU42ROtSDoCajB6U5fU1g3qXYlXH+FPHOBiol5608c00tBDwKcBzTVPtTxg0WQDlA3VKlRjj2qVOfpUsJMlC9KXGDQMYHNSAD8aZFyMgg0DpUm3jg0mMfShKwcwmOaDilx160jVaHzETNgU2ONpXB5xUgjMje1attbbV5HNOw1qMtoMAZq/HHjtSom2pe/WjcBAvHWnqo5PQdqVRT1GT0pEtjQpNTRx4pUT1qQcUXsJsbjgikC1IFzzRjk4FJvQVyPac04JuPHSnBdxwOlTKnFRdhcbHHkirttFk5PQU2CLOKtrgLgULzM5SAZHHan45owAB60Lyfam2ZhjPNPAp4AwBS49OtIVwUcdKMd6fjAxUUr9loJIpHJOBTACTigDJ96sRJhcmi/Yp6CKgVcnvTtu1M07GcHPFNkYY4prQnchLcHNRu1JIfeoWamWkSO3HvUTNwSKY7/AC1EXyPSixaQ52+WoS3GKRmJOBTXO33NUkzRIvaeTslI7Cufuk/fFW5JNbdvMsNozNwSetZqx+fK8p5jjIyfc02vdsODs2zeiIjtYVGScYFV7BgBgk43EmrLJtETkcKDj8qbpNsZE3Du+c+1bLRJGN1qx9ypWAnHU4FZn2fOWkAABre1TYqpzwKwbuYFgg6E1cka0W2tCC+nULsTtVCONpFLNV6a1xInJ5GTSFQAFFZs64NJaFPYQOKI1yMk8ZqdxlsCgIUWk1cq4BcYxS8AY70M200xPmy2fpU3JGltoJFQeYQ3NEuQaiYGRht6VLGkSPKSpHWqpJbNT4IRsDgVBFxmh7DI+sgA6CpH75qFnxLhetLjcTnmhDuO/hB9KhLZJp7H5DUJIJPNFhHmSxkLwKtQL6ipIgoXB5NOYAEYr2cZNJM8PCwJYVIbiragVWiBwM1OOleLe+p6yJwfypwI7VEDx1p46jk0vQRIDxnrThTM80vXvUvQCVWz0qRahBHSpVP5UN6ASqcmpFPGKiXNSL0680XuImU4qRG5FQKTTt2OBijfYgnzRwah3c8+tKG9aa8xEmaFQue5pYk34x0rStbcLjNV5jiriWtvtGT1q+iYXmkVcc08DvnigvYMcZpyrnntSKM9Klx0xQK4Y44qaJPmzTUXNWANoo8yWxMClVc9aTq1SZAFIQ1sgdKaxwPenE0KhPPvUthsOgUkA1ajTc3So4xtAxwavQoEi3Hqam5En1AKEXFIM5Gad1zS4x+NBBInPJp+Mc0kY45qQDNMh6CKD1p4GOTQBSynanPWnuIinfaMDrVfqfelYknJ6mnRJ3NJjWg+GPqTU0aEgk9PSiIZyOgqVjhcDtVR2uS2QyEKKrO3y+9STNz1quxwp9aQ0hgPrVaRsGlkk9DVaV+TzQaxQM1R5JOBTQxdsDFPI2/WmkXsO4Q89etQBwznPAFNnl6k1RlnYA471rsUlcW+vtsTLn5a0rKJk0OyRv8AXXtwG/AdBXKXzFmWNTyxwPqa9Ctrffd6f8uEtojj69Ka3HVXJFGhqMW23RF6qpqK0xaWcC5G7blqk1a5WG2c8GQjAFYTXrS7V7hefatX0OanFyRPqU5cEnjHIrIjcyTAntVmdiyZY8GoYoxGufXmpkzvppRViV5GLbqjJwuRTjhlzR1X2FSWhiDBJPWlQGVz2AphaljcKhxU2BjZVy20Y5OKe6hF2jGajjJLbvSkuX+cAdTyaaXULDXjDKxHbioIsfMO49KthgsYHfrUFryZGpWC+gx1HlY5BNUipQGrZbJppTJOQMUNdgvYoIhMntSyfKD6mrDEAHb1NVZs88VKKTuIQTEB3NRbccU8cICaaCXyRjGaoDhHhKtnnGaD1qeV1Y8YqsCN9duLnfQ8rCxsWY+g+lSA1GhFO6cV5tle7O+w/cfWpFYVXzg04HHei4mWM9zT1OcVWDdM1NGQe9FgJ1qRO4qJD+VTLmnYVyVfTtUg6DrUS/Wng4qbXJuPzzQSOxppP4U3v7U15giQnng1LCpdhUUSF2AFa9pAExkVVh2JbWAKM1dVe/pUQHQVOBR5jbFHPFL1zikwBTkUdT1pkj1GB71IoyRQqjHNTRL3xSsA5FxzTielB6UqDPWpZO4qrgUuM05sU08YpNiDHzVKq8io0BLVZjTpUXEPiTncasZ3EDtSYAAApUHNMhseRyBSohZulORdzVOi7RTSuQ3YaFxwKeq+lIAQOe9TBeKa3IZHwDk9BVaSTex9BT55OcCq+CTgUm7DSHRruPNWQvQUyMbeKnXpzRFX1BscmF6VDI2KVzzgVE3J57VTEkQPySxqtO+Bjip5GyeKoXDc4pGkYkbt83aqxcvJtHSpcb+BSxwiMbu5pb7G10hiKI+T1qOaXAJp87Y71QuG7VqtNBxVyC5lJOBzmpruIRWaMeuM1VztJZjzUV3dtJHt7Cne7NVEr6egl1e2DD5Q+4/hXeXmpR2UO8notczbWfky2+PvFd7cetRajKb6++zRnIA+bFVHuKcVUaXY1/Pku4ftM3CkfKKktYsW7M2MkYqxNZE/Z7ZRtVEAxTL9/LPloPlq+hMddIlSdsoo9KarZ5P0xSgDaM9qZjJ9qXkdCQu8u+0DinlTjGaWABST3NSSEAGklcLleTCrVchgcA8GrON3PpUZxvwKTHccV2Bcd6rT7t2T0qy7AsM0TpujGKdkTezK4UtGSDUUBwWHrxVpfljKioCFQcc0mtAuV5mxJj0qcrttyT1NQAbpcmpLl/3eAcUK1xMqbgJOaglfLtgcVKBnJNRSLSLViF87c077gABHSmsSSfQVEzEHFIZwpbHc59aI+GNM5OAuTmp414BravLmZxUI2RNGQABUvB7CoQCBn0p6E85rl8jcdj0pD7UpPamn2oAM9aljbkcc1D+NODY/GhoC9GwNTg8YFUVfGCasRv6/lRqS0Wh1HSnetQhqcDxS6aEseTiliUuwAGTTcE4GK1NPtv4mqkikrk9lb7RkitAYB4qJeOlSJyeabYMlU45xUin24NRr8x9qeDuIAoEPQZP0qTqRQBt7c09UIx60hDkH5VYXhaaiYFOPTFHkJgOeKlAwKaoA+tSqMLzSJbG4x1pAMnJpXJPFPRSeah9gQ+Ne/SrUQwuTTY4w2PapAM8UtiJMUDJqRAN3egLipYELODTIbJokwKUDJzT24O0U3HOBVMzFRepPSmyvsU1ITtHPSqU8m9jzxRsgSuyI8n3qWNMcmmRDc2T0q1Gm4ioV2ymwSPNPYbeDVlECjJqrOeTiteUi92MPJqGcgKcU9jtFVZXyCTQWkQu2NxqhcnrirDNuJwKEh3EZFQ30NlpqMtYsRgn0ouHAHFTynYpAqjMepP4VcY23BasqyEAkk5qpI4bNTTPwc1Tkb0q7m8EVZ2Jb2qrICxAz1IFWZeuKfbW7EiRuinikbXsjT1C6FtatKeGxtHtjirPhHTW8p765XDOQVB9Kx1hbWNVhtRkRA5Y+w6128s8UQ8mMgKp7VaXQwm3GNluyC+vFgc4++w61nM29Ac8mm3f7y4LdR29qjRgm4557VTeuhUIJIcwDHHYUg9BSDOM9zUyKFjycA0JGuwxVIPNEh3nANBJPJ6dqZGfmyaNtAsPkASEY6moyu1cnvTywYgelRXTgkJ70MRGMtk+vAqwSEjwetRnClB+lMLebOR0UUr21YmMkyEye9VxlpBmrN0w37V6AVUB+8R0FISZGzfOfc066YbAMc1BDzMKfcH94QOtIelyAtgc1C7A4yDUhI3E5qJjls0FJjFO59oFMdQWNORgA5/KqxkyTzSSsho42FQT/AEq0qACmW65xVxE9BRJ3MIqyK7A4A7U3oattHwfeoylRa+xXoVycHn86A1PdODmonX/9VMESA84xQOc1CW2kc8CpAw7UkFmTLUsbHPWq6nIqZCcf1peomiwjelTqT6VWX261ctITIwzwKcVqLcuWEG9tzDitdQFUAY4qKBRGgA61IOefWqfYolBPapAPSokz1NTIOKTEyQHA471LEAOTUark1MTgAd6TJZLH8zirAGWqvGDxVmMetCJY/p0oUZb1pvU81MgwKRLY4ADHrTZG7A5pGbJNM+83epbBIkjGatRL0qKJauQjHJqSW7EwUJGB3NKFxg+tIp3HJ6VIeWBFNqxkKqknGKtRAIme9NjTHUU7qT6CqirakMcvCknrSqNq5PU0wNlvamTy4FO4htzJ/COpqm5HSnOx5OeTSRoWYVnJ30NErFi3jLVoxxbRSW0O2MZHap5DhMd62hGyMm7leZ+wquwA5NTlctk1Uu32kgVcnZDRBdP2rPkYsalmk496iVcmsWbRVhIky1WDhRSxrtXmoZmzVRiDd2QykEFj0rPmlzmp7qXjaKzpG681TZtCNxkrcVWbvUrHrUb8D3oRutCAoWPAyc4AHetG7AtbRoxy2OtQaf8APeKxXKRnJqeYC68yQcKzlfwHWmhN3aRe8NW32O2a6cZllXjPvTd7u74OWJyTVuaZVs4SOm3gVVgcKpLfePSqWxMbttis2OvUimwpuOW6UY3ZY8nNSL8qA0JGuyHSADFMkbcmKdzIcUirgH2qm76CGSH5ABTHUqmanWPd8x/KoLpgzhF6DrQkNMhVioy1Mj+eUs3QUl42AAew7UwNtiz/AHqRVtCxK4U5/CkhbEbP61UZjK+BViVgsIVam9zN6EO/KsSeSajZtsB96jQ5k25pty/IUdBQ9wCD7+e9QySEyMaerYVj+FV3b5SaEPdgAWRm6CoC3ynNP83EO31qFSD8nc0dCgkBWME9DVUtzVu6fdhQeFqmRzx/Ki40YduoFW0XjgdKghxjpk1bUDFRcxDbuNIY8nipV61IB0pBYpPCcVXkjwM9q1SmRUMkXHSi2ojHdCBURBHPbNaUsfpVdk9qCkyFSR9KsI44x1qIp609EJIC96E2w3LkC7zxW3ZxCNQe9ULKIKoJHNasfAqrWKtYsA5+lSKPyqFOtWFGOKGiR6DOB2qwBngVHGMc96sRKSanQljkG0dOaevJzijGWwKkQcigkkROKmUHpTlXCfWmFsHFSRe47vnrSmkAoJ4z6UrgIzY4FOTtnrUQ5IJqeIZIJqdwbLIO0CrCt8oqk5ywUVajzgY6VKepDRYTnirEK5OahhFXIl2irSMpEhwAPU0h4GO9JnJPPAoBySTWlyBrfKtVXJdutTTvhcVWJwpx1NZvUpITG9gK0bSDcfaqttHkjitu3iCR4qqcLu4pSFxtTFV3bt61YkwAc1VHOSe1dFrakISY7Ix61k3cm5vSrl5NzgVj3Em4471lKRrBXIycsfSrMK5wTVaMZNXV+VazSuay0I5n2jFU7mQKv1qW4bALE8VlXMpY8VtYcI3IpnyxNV3PBpWPPWoi3y1J1JJEkQBkGenerK24nXCjnPUVnNJt4GR9K1tEl2QMzjgEkZql3ZM7pXKsyraW8m3AbNWbG1I0uND95zkk+/NUZpDc3IU8jdk1svcKAqKOgoWrFrbzKd1kgIPurwKeq5Ge1NxukJ7Cn5yPpVJGq2HY+UAUvOMU1DkY75qZVAOW/KqSBjmARR64qNuWCj8ae+XPHQUxOSSTimSOkO2PAA9qoynaBnqTViSTdIQOwqlduMZ7ikUitMfMf0HpTpTghQeBUa/cLtUTydxzUstluFljB/vVG0hEYz1JqHftCk9Saimk+Y45x0pJ2M2rksbDzarzNuckGlDbYy3c1Cp3OB+dK4EkpwgHrUBOcDvRcvmTjt0qMSANupsYspA4qJPmJPOBTJGyM04vtXBpMNhrtjPrURY560m6mb8d6NAMS3kGBV6N88dqw4pdvXpV2KbntUJEWNZW6c1Ipyaoxyg9TVhX7UwLQ5HvTW5601XHTNKxyOKauKxBIvPI4qBl6jtVlx71E3tSd76CK5T8KmtosknFAG44796tRrtAx0qkhotQjp+tW07CqsYwPrVmHrTew3qWYxn6VZjGccVWj7gVai6DrUiZMoxViE7VyetQDHAqUelSyG7kyHjJ61YjHTNV0HIqypxSsS+w93IHFMTluaa2SaeoxQwtYkz0pOppOtLjAqdBMCOgqdRgD1qOMVZhTceelRJifcbBGxJYjrV2FKWNRtwBT1GBQo2Rk5E0WAelThuOOtVSSi/WpogdoJrRIhkjcYHrQ3yikXliT0FQ3MmFIoYt9CKVtzfSmoNx5qPJxVi3GSKhq+xexes1CsCa0fMAUVSiXpViuiGisjFivl8iq8rBVIBqbzNoNZdzL1wacmNK5BcPndWaxyx9asTyEA1DGpbmsZHRFWRNbp61JIcnHaheOAOtQXEvlqfWrjHS7J3ZVvpeqisqVxnGeamuZSSTzWfI+TTZ104WQryc1EW7UjnFRO3J4yKTZukSR5muI0XJywB+lat3KtvGUTsMfWqejxjc078KvSmSSi5vtufkXLH3pXM5e9KxbtofKsw7n5z8xpsTMzFyTUbys8ajGPUVOi7Ihk8mrRaViXJCnjBNS5+XHeoQeCx6dqdH8wGasB8WQ3HWpmbeRiod2HOaQyYGaewrFnzVQFR1xVd22xlj36VAjFmJPeop5i7iMfdHFIFEcJMBm71Smbe4HapbhwBharQ8yDd9aHoWtNR07FRtHQCq5OMZ61JO4Z/aoMhiTUvQOg+Rscnr2qDdnJPc0XT5fAxio0+/7CkxWJZnwoGeKjQ7ULHvTHbpSSv8wUHgCmSJI2DyagfhR6mldtx46VFK+cH0oGBPI5pjPnqaUkLFk/eNQnnqaQXFLdeabuJ6YprHAxURc56D8qLPoQ2c+Vx9e1KrkZ5OatyRCqc4I7/jU26k3LMU+D14q9DPlev41hAkdKsQysvH86SYzfSUcc81KJMrWPHP3zVqObI5NNsGi6W6VG/XHrUaycZpIiXkHHJoimS3YsWydyD7VaUY60kagL7U4nH8q0Q1sTL+QFWYz0xVRDwMmrMfY1I1oXIzVhWxiq8WMVMmSQOtAmWYjnmpo+vNRDhQKmToP1qCb2J4xgZp5OBTVPFH40iGOXk1MOlRx9Kd070hdBw5NOzyKjDYFPj+Y5P50m+otidBxjuatp+7TFRWqAvk9BUr8samxEnrYsQHINSjGcVXTgelTRnmrSM2PYZYZqfouKh6kU7d3oJbJSQq1Qmbc5qeV8KTVV2wvuallRQqDc1XrdCKq2q5xmtKFQAM0RWopyJ4+lOzlsUZUUkbcFjiuhbGZHOdqnJrGupetXb2bg81hTyF261Ema043AncfUVbhUBQTVWFSatP8qYFZpXZrJ9ALjdk9qy72bczDPFTXc+xcDqetZcknUmtSoRIpG5PrVdmzn2okfLcdaiZsZzSvY64oHOe1FqnmO/XgUgBbAAq0FW1tmc/ebgVLbYN2ViO5mMNv5Mf3iMGktLcxxhm+8/JJo0yL7VcZkPygZNXLo75sJ90cCqSLXu+6SGMbVwKGPAB/Kp9uIgT1qADIJ71okyUGDjAPFSKcLkjpTIyC34UXMgSPA6mn0G+w0uWcYPWiZ9owCabFgEMR0FQSsZGJHAFLzGPaXaOD7VHkAE559agZizACiWTbx6UA0PlOemCar+Zhjg9KRpAq7u5qIf6vPcmkMJHOBSA449OaY554pHbauMctRuSyORupJ5oBKJlurUwYLc9BTZZctjt0ouhPsLu5z2AqJn4J70kkgzgHpUJbJxR0Cw/f8vuahdsnjpQ7cZ7dqYT8ucc0vIQSP8ANjsKiZyM45zSFvzqKRsZJ64pO9yWxZJOMCoi471GzcE1A0uTwKbQmWmGfeq0sWT7VZU9gKXbn/Cp3FYzGgJJwKaISDitYRAjpzSNBkU7CbsZe3bjmnLIwP8AWrjwce9VmiIPShrsPmLVsTJxWjaxjcSfpVGwTJGBz2rZaPywoq0rbGV7yFPHemE8j0pM5oXlvam+xoidOQMdatx+9VYjzk4qzFyR3qSi2pwKsxcnPtVTPuKuW4wvNSRLYtRIWPrip9uPc06FQkIHrSMfm68UrXM73YucDmkBy2BTS3BzToxxmkMmU9qGNNQ880jUgY4nJ46VZhGBVeMEmrIOCBU77EsuxHZHnPJoVueageT5QKWM5xnpSM7dS3nipI+BVdOTzVlacVYhkucJ70bsLTCckCmyPgU2xEc75OO1Q53MKazknNSQKTyetTa+hexdth8tXFbFVohtWpC+BVLQyerHvIScDmnSSbUxmoYiM5qtdzckCruFuhWvJs5FUByTTrh/moiU/jUs3S5UWYRg5pk0mAcmnudkfuazdQm2RnB604oSV2Ury43SYz0qo8hIqNmyck1XlfPSmdcY2JN2c0igs2ccUwc8CtKyt9xUEcmk3YtuwkMPlxmR/TvVaXfdyJGoyOmKt6nKDJ5UZ+VeOKuaXAkNuZ3HOeKcV1FF2XMyMwi0XYg+bHOKIIuNx6052M0uetSxq2D6dK0SHfS7Ef5kxTCvb0FOYjzNozTmXAJ9KphciUAAmqjZkl56Cp2cgHnrUZwpx+NTfoWmOmbbFjIqnvARjSzyb8DsKgmbaoAFA0ETbdxPWoZn3SYGaaz5UYqEPgljQ7FLuOnfLbR2pGl+UDjioN2WJpjnilcGS7gDyfemySEkntUJY9zSqQVyTwKSbIYrMVj5+8ahDAgnnio5nyck0wvtUigXQUvyQKYzYznrTFbDZJqKSTLHFArkucn2ps78YXpTCdqc9ahZiec0LUm4OfzFQyPSO2KgkfjrmnYVxJJTg4PSoCxzx+lIzdelR7j2NXZktmoGqRWA71UDc1Ir89awv2NLF5Wp4fPFUQ9SK/PFUmS4logFRVS7XYB3zVhGJ9Kq3jEyKKszlsX9JjBkyewrRuxgioNITbb7/U1Pej5QRnFBkmVQ3yjJpykZ9qjHSnj0HSk72sbRLMeMVbj+7kVSiPOKtg/KB3oKbLEQ3MKvQ8yBewqpAdq7jVi0bL5qX2IexrSN+7FQqcmo2k4xmhHwp5qbWWhnEkPXFSjhagjJLZqdj2A5pjY7I20gOSDUbt+dOT61LEyzHxUqepqBTkgDvVmQhQFHWlYlsbjLD0qx07VCo71NGpZuaQmyzagkZNWl68UyFAop45NPzMm7ic5NVrhuKsscdKqS/M9LcEMjXe444rQhQADPaoII9rDNWzgELQkEpXH4yKYx5AqVOFNRFctmqRmgkbatZty+MkmtCYZWqNxCXXGKdmXFoz4wZZOc4zWjBF3IpsMAjGB2q0wwmO5pIuUrsp3JGT6Vz+oPuYgVt3rbFI7mudu25PrTNKW5UkbAxmq/3m606RsmnwR7iKd7anVeyuWrODLZPSr7yi3hZ++MCi2j2x1R1V84jU1EVzMzXvysV4WMsxY885NdApD2aKD8o5rCsU2qR3xitO3DGEqK303NqiLdoVDHOKsSMMHaBiqCwug6mnSv5cJP8VVbUhxuxAcOSeabPNiJh3NJGwYcmqly/wC8wDxSbuWtWPVieo4FRXD8HHFI7YTjqarSElgKlliu2I8HrVaRix47U+ZjnAqKRgkWT1PFIa0I5XCjHaoHPAA70Plj7ChSN2T0FO/YpuyEk+UYHT1pidCTzSuRkAetRO3YE9aRFxCc8HH1pGbAwOBTS/tzUcjZNMhsbJ03VCz560TSAggdPSq7v6duKPQLj5JMDsKjD8gnpUJOXGR0pGYE+mKOUHsTM5ao3fGAKYWwOvNQySAknNIzvqLI+Ac1Wkf5en4UksmahdupxVqOoMV34qJnOaR3yRjNOWFiBmto03LoZVKkY/EXA3QdqkVzVVX6U4MQPeuR2Z0pltX54qRTzVQP+dSI+DzSRReQ4HXioZTufrSK4PNRtggt74q1rqZVFodJpjA2qDHSp7gbhj0rK0SbgqTWrIc596d7o5noZ5ODTlPOe9NlHz01fXmk7s2izRtFzlscCpQcfXtQjCKxHqajibLijUd7l9yAiqDUtu22qRfcfpViJsmlfoJrQuh9z45xUjNioIxlgTUjkBsUGUWWIuB1p5bLcGq4Y08HikVckJOalVsCqyk5FTjIGBSYmWbYF3yBwKmkJLZParGnwgQ5bqadcxADFJqxm5akUQyOauQFVNVB8oxUsWTU3SE9TQL/ACcUkZ4qvvCjBNKkyjvSu2QTydM1W6MSamlkUJz1qpJMuDzSswRZWcDmljulZ6yTKWU4qBZ/LPWlew+Q6fz129aFnU1zf2/5etJHf4PX9apSD2TsdSCHPFSiIBSTWVpd0JDWwXDJWyehhJcrsUMfvCajlbGatNHgE4qhegrGcZ5qTSJl38oJJz0rnruTcx9q178kI3vWKULv+NF0dNPQhRSzZx3rStYsEE0kUAAz3qzkIuScAVlKV9C5S6IsFgkeO9Y0wJmyT371chlLOWboO1Qwp9oueOmea6KceVXNKUeXVku3yYUbGGbpVuzmUYzVa+kDzBBjagxSRHaQBVW0L3WpsyOrDisi7kzLtzx3q55oSP3NZEr5dm7Gm3ZCgtSfzeTjsKgzvJYmovMwhz3pI5MrjipNfQsN93HYVDuABY9e1RyS4BBqtJKSu09BSJSJGkBkA/GoJpMk1Gz1A8nWjctDnfamPWk3YTnvzTMgrlqjkk5wKGJscXPXPNMZwF96iL96jds5JosT6jmkHWopZcDPWmMwwMnioC5dsDoKFYlq5I/r61BI+Dx1pJZcEgdRVZmBySee1UvMLsl3Yamlsgmq7OSeM0xpeODjFFribJjLznmoXkx0FQvIe1RO+frVxWljNvuPZuD61E784BqNpO2eadCBu55NdFKk5u0Tnq1o01cntlUNufp1rSSSPaMAYrNMJIppEykgcivXpUI00eLWruo7skXg9akXOBzn1qPb7ZxTgc8Yr5k+nuP7DHJ96UNjjNIOmc03OM0NFJlhXx9aVGBU98VWDHqadE+CRnrTSuRUuXbOYxTKQcDvXRxyCQAg1yBbDDrWtpl3ltp4xTV0YyjdXNkx7uaikj2qMCrsADqCOhqR4A/FTezuRGVij5jFQOcAdKWJj1qzJbYXA71E0JVemaE76miaJEJbParVu3rVJSQAPWrMB59qY2zSV+lCndITimwKWU1Zt0VSc1DMr2FjBJPBqysXA45pMoq5yKVrhVAORQJu48xhakhUGqMt4p70i3ir3qGxpNm6tyEXb6VDPehnxmsSa/G0kGqgv1zktQxKk3qdA1wM5JqaK8VRXMSagp70ov1C/epJsp0XY6C4vfm61Gt7z1rnJdQAHBrPk1M5YhuKavcFQbOxudUBAG6s+fVAo61yj6gzgndVee8Y4w3FDT6m0MPY7KDVl2Hcao3OqAtwetcobpx3PNQvO+epoZtHDK9zp5NV2jG7miHUu+ea5Yyt3Jp63BHANRyluij0nRdVUYywrprXU424LV4lBqMsMvyk4rYtNclXqSK2WiscNTCybuew/bY2H3hVS5lWTpXndt4gY4BfJrWh1xT1b9aGzL2Eos1byLexx0qqtsAc1LDexyAc9auAKUytQ2x/CZ0uIxzWbc3QkcRr+NWdTlAYIp5zVJ4hGAx5JrSlT1ua0431ZJK+2IKpq1aOIIc/xGs5jyM1OXDgHPHpW8tdDdrSxYijMjHHc5NEzhTgfw0W0ypA7d+lUJZCSSTz9akFqy28+UBJqs0m4Y64qq8pI60qHZHz1NK9y1Gw6V/lAzxQr8cdKqs+5sUF+BnrUlsnd8nioQQzHsKjZ8KaieTAIz1oJsEknWoVOW60wseSaardTTfkO1kSyPgcdqgduATTXk3/AEqKV+w7UWEPLbnA/GmO/wDCKYW8sZJyTULPtUljzTIYsz5IVaiLiKM9c01XKsWPeqskhdielO2uhNxzEspJPWoXYngUkknH6GoWk4PIzTir7gK79R+tQtJjHSmu47VA7ZwR1q1HQhyJmfP0phfn2pu0d6NhyODzXbQwrnvsefXxahpEcUGOvOe9PjBHY49KQIeCQT7VZt1LOBmvUhTjBWR5M6kpvURHfIHQVaIT+LOak+zx455qT7IDzV69DNlUr3xTDnmpc5pjcfhXyZ9aiMN0FOOMUxhTeQaL9y9x5OTmkDYbPGaBz25oZcEGtETNaDy+fwpscpjbcuaiZsseaQHg+lJrqRE7HRb4Og3Ecda34yGG72rza1u2gcFT1610+maqGQfN+FTJGU6dtUdKAGPanSQhhVW1ukfHPNX9ykZJxWexnqjOkgPmACpo4QAD2onuIkOMjPes251RVfCkUXLTvsbYlWJTk496rNqCr0Nc5e6qTwhqnDdtJIoJ60XNI0r6s6efUyTjtVSXUiwxmqLsAvXrVZ2GCf60ky4Rii3JqTBupqL+1JG4BJAqqoDg46mlMCoASeaaXc2TiTvqDMuM1CbuXoKYqoDn0p6sgZjwDii1h8yXQeJ5PLBJxmklu3V8bgBVe4uQFAHaqD3G5801HQuK5jct5GlbBPFQ3JC5ANVrGfYTz7VM4Lvk07E2syHfwKJCTirCxZ59KawH41XIXzLoRbSWUUki/N7VNsZjmneWccjJFPkW4KRVPJ4pu35uKsmPHAoWP5sEUcvcfMRRwlmHvViSAqPap4I13ZqdwCcVKhchy1M+JHGOtWQZFwc81MqZbgdOtSSKMYGKfL1BsW21GVGGT0NdZY6gWsWck5x0rk4LcmTP6Vq23ypsBOPSmo9zGrGLRMJGeUMeankffgnFRsuzA9qaD7VreyJ06D3AZuOgpjOV4FIXAGPWoz1yai40yxHJ8hGaqzE/XNNaYqeKbvDMDmpuykragRgbjUbyE4FLPIMcYxVYPz1pXLWpM3GOc0yRuKY8mf8ACoHekwJS/GKikk+aoZZMCoGkPrg0r9hk5fJx2qGWXnaKhaTaKi387s81S3uJljfgcnp+tMD/ACliarebuJ9KSSTC4ppkssMdxz2FVpXLP2xQ8vG3PSqckwGcHrVKxk3qSTTHoOlVnkwD61FJLgnnI9KrvKeoq4q+gXJpJDyM1A0meTUTSZNSpC7AE9K2p0ubYxq1ow3ERWkPAqcWp65p0Ksp5GAKuI3y9BXoUsMo6yPKrYpy0iZ5jZT6irFvGpPzVbjjD4J4NSR2q7sgGuxO2hwPV6hHAHACrzT2tjGDgDNSRqYwSp5qQSAj5jzQmGxAh2HBxxzVlbn5RkVE+1zkYqu6srYDcVVg2KudvTrRnI5pvrxTS3p0r5U+rJCM9OtNC8YpobPSng5PANCRSALzkfWnMODmnrzjNPA4OKdu4nqZUp2uT2pA/NWb6LAJArPDddx5FaLVELQtKwI7c9KkilZTlSQKpB88dKkD1LRojdstUeMqHPArWuNdEcaqrckZrjlkxmnM5Ygk+1Q49Rezi2bMurSSPnOKi+0Fn+Y81m9+uacSfXmk43RfIuhdL7ix60iPsfIOCKrxk4OaXPUCly6jSNMXRKZJ6CozcnkcVURsLyfwqLcxf2quW4KKL0VyQ4J6UlzqDNJwOnaoIyN/IqcRA8460cvUNE9SEXTsCBnmgPK2etSKgU5xQzKB1p2uPmS2RG27AJORTVjPQ/rTydxxipYge3aq5dC1Jk9mnzgkYAqw0uHPPHpTU+UD1NRsp3cdexo5SL3epc83KbQeaagyen51BGhHWp4hhgaN9xNW2LRVUAAxTcgemKQ5c+lBU468012EmRt97NJkZAxmlA+fOKfHHl/motZlXHocDgVZjUvihIQOe1Tx4AJ9KdkQ5Id5QQU3yizDjIqaJg5q3BGuQKfL0JcrCWlvlcntUxUI/SpRII0wMVUmmAPWjYi7bJpG5+lQPLtyMVDJcZHBqEN/EalsqKLWeATTJ5qhkmGMA1Fu4yTzUXQ4rqwZ+cijzNo4qGaTC8Gq/m5AzSehqtSwz54oL4Q8VVklK9OKj831JxSGWGb1NRSSY5B6VC8npxUE0ny4zk0AOklBbr0qJ5MDrzUJfHPaq7Scn0p2BssNJnk5qN5ckgVAsmRxTC3PvTSJbRZ34PBqN5cD+tQ+Ye3SoJJMd+apIzbJXmwCM9arPKfXpUcr8n0quzFjgc1pGBnKViR5ckgHk8UxQ8jbVzQsDdSMmrVr8p561106DlqcVbFRjohkUBUgtyavxOAMY4p8aiTBwKV4Tuypxiu+EIwWh5dSo6j1JFjRu/WgwFRkA81FHlG9quxy7iNx4FWmZ2IFYrjPrVpJsKNvfvTmMRACgEmq8qbFwKpX6iaLu5SuSwqjcDn5TxVRrhkbPamveFxxgY4q4p9SGxxuHBxk4qVbhdvzZzVcFWHXn2pPIB5w351drbC0JD3qM8nk04kU0EE18mj65CL0HNSD9Kao9akGBxTa7juOQgdeKkVuck8dqg9x0pyk0D3JnAdMHmsa8iMbH0rXHbFRXEfmKQRz2qlKxDXYxQw/Gl3888UXMRjbIGBUKtkc1pa+wk+5YEnbNPDHI55qsGFODA+xqGjRFtHxkkmpA4zxVNXPrUgbjk+1JLoNF0HpjpUgYZAzVISc0/zCTnIoasNoul1I96YFxzmokkOfrUvmAUkle4LQkRcEmp1J45NVlfc2eM09JOAc1VwepYfpk1Fs7DrStICoz1FLG4BGelGwrkkcWDzzU6oMj1qFZRu4xUol59qd0K7JiBmpI1DdRVZZPepYpc9etF0K5aKjGR1p6gbcmqplHelExJAGKSaDUtEgDFKMZ5/SqokPc9aXzcH2pXQE4xnijzOeKg8w9qjL5OaE7FIvefxjNTJJlMZ4NZm/5utTxzADFLmBxLqy7TVhbs8c1mljjOaBJgZ7GmpWE0aguCTx1qJnJbk8VXjcZ60GTBzmhzuTbUmY4XNRu5x1prTgJVSSXcTk1m2OKJxLluaWaYAVSeX0qJ5eOTSS6mliy8pPU5pjS4HvVYy+hpjyjGc0ddQ2JmlyaY0uRweKqtIWOc9Ka0uB16Ux6Fh5gMjPFQtICeeKrNJk8moWkPPOaaSJuTvJknngVE78HFQtIfWo9/f17VSQnIlMnYGmtJ3ORUDSYJPaozLnHNact9jNyJzJgdTmoJJGHHembyzALz3qaGA7wXHetoQctjmq1lDcjSF5m4DHjNXbe128lelXrfy1G1RzipJVyuAcHNdtPDpas8yriZT0jsViseOgzUTQgHKjGKbMWTPU0i3BZcZrrSRxt3H+YyZ5wakS5XB3Gq5kUjA55qFkxkiqatsFzSUqwyDwaUtzgdPSsYTPG/B4q3HdDAotYXMXBKY88VH9p3n52qNpFcdQO9VpeeapRFzE7ESNhec96Ps+MHPNQxBycAVftwN2XFO5PUrLGY23cmpxKCATVvCSfdXFRPCd3RaaBlJic8cUgPenEZzSc4657c18tY+sJgeM07p3qJPu57U7cc8fjQMd3p4FMByM1KgGBijcbHKDwc05s54FKuOn8qCOf607CKl1CJBxwaxbmFkY4ro2GQf6VWngDjGOapNoTVzn1Y5wKkBqW6tSjEjP4VVzg89a0Wor2Jt34Uoc7ce9QbvfigPz70rFqXctB/yqVH4yKphueaep6DvSaRaZeD+hpwYnHNU99PWTGMcipae4F4Hing8j0qmJhjnrTllyPSp1EWi4J4NPUnGc/lVQNzkGpvMOAABkUwLCMeKm3e9URIM1KsmFqWDLhk460sb471R35I9qkV/fmi4WLnmfNUkb9jVEyelKZeKLgXmlGOtJ5nNUfMJHWl8zI5ofYaRfMnHBFIZRmqJl6elKsmSP1qU+gJFsuSeKlRx39aomTHTpT1lAxTGaHncYzj60eb61nmXPcCkE2OO9Im1zUMuD1pj3HqazzOT0NRtId3WkNIvtMSMdaj8zPQ1U8z3xR5nGc0rILWJ2k475qN5OTg1C0gI61Cz/ADdelNBcstL78immTjk/jVXzMn3qNpeBzV2C5ZMnHFRPKADzVd5vfNQvJng9KqMRXJ2lHuajZ8mq7yYHFMMvr3q1ElyJnfnrxTTJkfzquX3DABoGWGTWkabZhOso7jy5J4GRTlQk8jirFrFGDl/wFXQg2/KtdlPDN7nnVcWtolW1CBjuxVvejDaMVSkiIbOaSO58sEGu2FNJWSPPlNz1ZdO4P8oxinC42/fJ4qtFciQHJ5qKZizYGcVfKQpFySdX+Xp9KpyKOxHPSqzs4bHX0p8Unz/N2p2tqxdNAbcpwM+1RNPJnGSM1c3huAPxqOW2VwT39quyEiBXyeRzUxU7BgYqExlOccZqxC5Y4Y4FF1cRAWcZ6+tTQTAAAjn1qYiMnoSe1PNqSmRgU7JahcntsY3E471eRAeV5zWXDGY+uSKuwXG1cdKQEkiuhynSozIf4jz71OHVx8xx9KiaIE+tJuwnqVyDt9aa3GOKcen17Uw9Dzye1fM21PrEg/nQpwfWmAnrQDik0UTKcYzUqnB9qrK2KlVuM0AWlYd6M88VAH4p4bnjrSQWJAQfw6UnbmmB8HmlJ4yaEBHIisDmsy5tcZwOK1M5zTTzx+NUnbUVjnZImQnIqENg5Fb81qHyVrKmsyCcD3rVO6CzWxXDDpnk1Krc1XdWjOCOlIG5NO3Ual3LOcnjpTw2COc1WD4H+NPVulJroVcshiM9OKkjbkE1VVuPapEapaC5aL81Irc471U3A5oEnNRYdy7vyfYU4P0FUw/v1p4fJ+tDQXLW+nCTjiqu/A604P09aVuoFgPnml3cdeveq4bp6DpSlxzQh3uWFcY9TSmSqfnYo8zilygWt3U5/GgSYI54qsH4pC4Jz2otYdy4JPelWbmqYlODS7xyc0+Udy153PJpPM61UZ+OM+9G84HpRYLl0S8UrOQcngVTifMgBPU1Z1CQblVegFKxDkKXz34pDL8pFVPNwTt6mozKcU+UTZbaXPSojLwTVffzyetMd+O3rTUe4uYsCXn9MUxn496rGTnk8U1pD2rRRJc0TmQE9aiL/N1461GCWJABqSK3Zhkg1pGk5bIwnWUdxjPuz+gpoDdMkCtCG0CgF+BU6WyNjaK66eF6yOCrjOkSjFATjtV+G0Ur83U08QFSMVNHhW+YmuuMIxWhxSnKerZB9n8s8c84p/mlflJxzVhpQQQAKr3AXb1Gfar3M79xCyEDpn3qlcRltxUfSkkYqahknOMGrtYREpeM5PSpo7jHaozIpP8AtUCJmGcYBqmidywoVuSakWJW5Xn61V8pgM5qaF2Q4xmkmDJDEyEgelETbTzzViJN/wAzGnrbqeRzQxIiQ72AwKRoBjjH4UpiO/C9PrU8QWM/NRfuFisF2N0qdHO7np3qfaJGAGAM0SQE/dpiQ4SR5GBnNNlj+XIzUDq6c4zipIZexHBp27hchG5cljyKsreKBg4qYRRt0GfXNNNmB24oaQrXKm7n19KRjg80zd19qUH1PFfMWufWJBjHJNNOafnAppJB5HFHoUCH8eKkVuPao+lOTrT21QyYMcUoY/iaiBpwPFJgSbsevFJu7ZppORxTM+h+lSwJAxoBzTATTlp30GPHvwaCgcYYClUjGKXtjtRfsBRubIMMgVl3FmV+6K6Tt7VFLGrHkCmptCcUzlSjIfmBpd+CK3LizBHAyKzJrIq3ANbKSZLTRCkhp4kH+FQPE4OMZFNLYyCDjtTtfYm7RbEgpd4yBVVZD3HX0pS5HSlyjTLavzTg/XoPeqYk9T7U4Sc+xpcpXMXRJwKXzMe1Ut/SlEmfr70uW47lsynHNI0me9VTJkDrSbvf2o5QvZFkPxzRvP4Gqwfn3pQ9O3QfMWvMx060eZ71V3jPBpSccg8UuXqFyyJKXf2qmHPc80u8EdaOVC5kWvM+v4UM/PHNVfM460eZ2BwaaiHMWhJhhyac02WyTk4qrv4OTzTGl9fWjlIcrFlpPc00vzxVfczHgGpYraV8bQcHmqUGRKoluKZPemB+cAHPpVuPTnbIY1bt7BRyRW0aMmzlqYqETKVHbotTRWrtjIP41uxQR5GB045p7xheFA+ldEMNb4jjni3LYo29uq9QCavi3BXgDAqIgpzt59KlFzxtxXTGmlscrm3q2Na3G3IqNQUPy1YMyEY70jJuXK1WxO4sS7+XpJ0A5UVVZ3UEhqga8PTvTSFsJNIwf09qhEy5+c5zQ8gbJYj0qpIm5vlquXQm76liSRJOFx9arSRkDr1qt+8jJAp6SkHDZzVLyCzJEXawOPzq0kv8JH41Ajbj6VI8fHy80NagvMsjacLnk9KmW3zk4GaqpGyCrkTEBQTzU311HYBG8a5U0+KUoDkZzVmNlZduOTTmt+M8cdKTlcLD4UWVdxOM9qRrZc5UVCoMZIJqZJyAQKeoupAEaMkIOKsQNtI3gN9alRlK/McmpUiU9AaGxeopVHHIGKha2VjnFT+WVzxTFkCk+tC1BxsVSjRMBUyuSKsZV1J9f0phjA6Z/CmCRz4bntTg2Mc9eoqDPFO3ZHvXz59WTbqBjk5qMHnrTgQajbYRIOtKM46/jSLx/jTucUhic9M0ueOMU08HOaaTg5P60gJP0xSZ7d6iZ+570obnORTsPYmHp0p69RUYbjjrT16D0qfIZJntmnZ9eKYGHApd3OaL6iHZGeCab9KM0meMUDEJqMgH7wFPJ4NNyMYqrXKIGtwxOPwqrNY5NaH8zTc8jvnvQpNEtGLLZkdODUDW0g9a6JlBxwKQRI3YVopsycexzJjdeqkikBYHnINdI1mh7Y/CoJNPHI4pqoidUYQfnJPvijfz161pSWGOOMdKqy2u0HAzj0q009hObRAJDwM0uTgcikaLA5OKYARVcjauR7ZLclLYPzUb6iOccn8KWnyMHWXck3HPpQWyOabtJ/iIqQQ/WhU2xPERQzcO9Bb0FTC2YrnFTRW2CMjFWqMmZPFRRVAJBCg5p/lyE5xite3tlIBbFX4bWMg8D6Vaw7MZYzsYENo78E9aux6XgZPNaDKIn4Ax3o+04PJ6dq2jhkmc8sXJ7EC2KovI61dhjSNAQKYLhX4zillYbQQRn61vGnFdDCVSUtS3H5ZXtk03ZkkKRxWd5pWke7xgZOfaqsrmZYLGNjxULXJU1H9rU9T831qpNIW/iwD0p2C5fN0rEBjwetNeRG+6ayHZhk5pIpmXqee9FhXNMkhsg59qctwQeTxVWKTeMlhipSq7eKe+wyczgggY96ryRZyQcVE5ZRwM+9RmVt+GJ/GjbcQ10KnrSB23AA4qwrKw7A0hiJ5yM9hRqMRFVhluaY1uHOVWplhZQOKejNjgAGhSBoqtEwxjOKkhbYfmxmrOOOeppFg38gA0PYQsMu9j04qx5fI2nJqqbdlbI4qxDL5X385oeoth7bo8YFTJMTgMT9KElWXk0jorHgZNDWhVywhjfjH41HLEVJKEAVVdmT7pOfWm/amyd1EVcltdCYs0ZII6VbhucBR0FUBOr8dvWpFIb7pqrPdiTRtxyxugGar3EQ3HbWfvMZBqeOdm4JwKSVgY1ndDkmp47sbeQfwpC0Z46mmFFBwBxVWJbOfDY68U4NURB70meM5r5659bYsBuCaerZIqBXPXAqRG9DRbULFpD+lPzUKnpT84PtUsQrehqNj04p5fjgU1j1zSsNER680qtznimtj9aaTg+npQ/Mq5ZV+cD9TUoPrxVZDwcVKDnHHFSwJqdg8UwGpe3FTbqJidgOtBFLnmg5/ChDQxhz7U0/nT+/FM79OtVoVcb9cUhPHFBHX1+tAwKa7CYufX8qfkVH2wTS5y1CM2S5xn0phPB+tNLZHFNLU0iGNkYckiqU7jn1qxO+BjvWbcOcV0UomFWVkVbhjzjmqYlPSpZZMHABBpqKrgFsZrvjGyPNnK7HRyAkbsc1YUBulV/KGcipEyOg59auxDZMFYDIp6uQeaSNh3IzTwAzcY/CrjFGbkW4pNy8Y4qykYYcHk1n7SuOwqeKQqQeR7U0iWXPLdR3oFwye2KUXYKjOPeoZmRjnIFXG5LJjcB1O449KiYhssDx+tUZSwB2nIpiXTDgjnuabQty4SemaVJgMk8+1VklBPWncuPl4FNoLlg3Cu4GOelRTHP3eTVRwykkfpQkzAEYOaegrD3Vsg0hZunFPD78ZqeNA3aiwXK+cpg9fXNSxxhhzxUklt8uV4OagUsuOuKXTUY/ymVvl6U9C4IGOKmgfCjI5qcRh13ZAzU7bAr9SBGLYzjFEiKeFWnPEV+7VdpGXOOlPQTQjxbRnoTTBIY3wRkUq3HUMeKa3zgEY56UWHexehuFYAEfWpzGhGcjNZgUqQRxVhZWVgSP1qWikSvFtHHIpVYquOgqRZt5AAqV41IGOuKEIRZE8vnBOaUxB13DGPSoPKKnipEkdcA8D1p+hJAFkXODxTo7nYSCDmrgKBeRkmo5rYOCcCnuAwSB+SRxUckZdsgZpv2dl4BJ70pd40zt5/lVol3sVpIpFx2FPt7gocEZqYOCvzHLUgtw7ZxjNNq+rEXIZBIM8VIyhu4qkIWU9eKkSVo+GGalajJixQ9KBcEdad5quhJ4PrULYJ4ORVLyJ9SpNBjsKqOhH0rop4FbI6VmXEIGcGvmVLU+rjIzhkDpUqk8dKHUKcetMBwfXNaLXQssBs08NxioFPUjjinKe9K1xtE+7jjmkPPemZNKec+vrSa0uIa3rjim9ScClznFKB0qN2O9hUyBUynqKi6HAp44xTaY7ky84IqQHj+XtVZT096l6YqQsTKeKQ8nqcUwGlJwRStfQaQvrzTTz0pR0HFHbNEQGE8cUnU805hwT6UnbNO/UliNjPJpv8Rp3Ue1NPSqsTsJn2ppPeimSHjNUrESdiCdh3NUJiCCBVycfrWfP8pJBrtpRRwV53ZVnjJ5HWmKCo5NTbtxwaQ/dOO1dfKcLYRycYI4qyirj+tVdmVJNSIdoHerWiJuiXysscZ4pwDKOB0p8Tk8VahUMvIq0uxmyvFMP4h+dWoyHHGaZJEpPPJ9aiJMbfKapXYmWJUAXOefSoGZl56inoxOSaZI2c07CuQ+aWOMYp21CPU01kBx2pyrtwQeaq/RhbTQPIIyRnGKXeyjGegqeNyTg9OlPlgUoSe1JhsUWlzwfxpVUMQSaR4xn8KIxwD602+gJluGAHkdKuRxYwVBpLDkEEdK04QCvQYxWd1uNalVE3Y3ZNPaGMcYzmrBQAjFVpWK9PWpbbKcbEZi+XgUwgr14pVmYnHbNSSAN7Zos0ySNZ1C4wCfWoLiMNzkYpzx89aqy5x1q15EsheMluDULSsvA4A61ODhfrT1gV8k96G+w0u4kEgYc9quxDzMYGR71USJQfxq3HwDg9KltsaRKIiDlQaUSFOW5qzagMpzzUk0aEE4pJ3CxWScO3PANTFVbocmqMigNleKms3IcEjNPXqJa7FjynUEhT7U395j5sirImL5UgYpQAzYPQVSTE3qQ7gBjGT60eQWB3Y5pZ02sME00kqC2ckVSEyB7XYflGacCwGCO/OatI+/AIAqbyEwTQ7oS8hkXl7fmAJps6qwyABTJMKOAOKidjg04vuDSKlwGQEg5qCO4ZVweeasSOWO3tSi3U1dmiD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21473=[""].join("\n");
var outline_f20_62_21473=null;
var title_f20_62_21474="Erythema multiforme lip";
var content_f20_62_21474=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucosal erosions and crusts on the lips of a patient with erythema multiforme.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21474=[""].join("\n");
var outline_f20_62_21474=null;
var title_f20_62_21475="Pseudofolliculitis barbae - chin and neck";
var content_f20_62_21475=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudofolliculitis barbae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmented papules and small pustules are present on the mandible and neck.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21475=[""].join("\n");
var outline_f20_62_21475=null;
var title_f20_62_21476="EEG electrode placement";
var content_f20_62_21476=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 582px\">",
"   <div class=\"ttl\">",
"    International electrode placement system",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 562px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The location of electrodes for recording electroencephalograms from the scalp, nasopharyngeal, and external ear sites are shown. The leads placed on the zygomatic arch beneath the eye allow for monitoring of eye movements.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21476=[""].join("\n");
var outline_f20_62_21476=null;
var title_f20_62_21477="Chlorothiazide: Patient drug information";
var content_f20_62_21477=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Chlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/2/35878?source=see_link\">",
"     see \"Chlorothiazide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/27/20919?source=see_link\">",
"     see \"Chlorothiazide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F149881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Diuril&reg;;",
"     </li>",
"     <li>",
"      Sodium Diuril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F149882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diuril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691367",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to get rid of extra fluid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701774",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to chlorothiazide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703777",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. This drug may raise blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium levels like muscle pain or weakness, muscle cramps, or a heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699155",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not freeze liquid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11599 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.80.101-E63CECF6F9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21477=[""].join("\n");
var outline_f20_62_21477=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149881\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F149882\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021799\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021801\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021800\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021805\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021806\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021808\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021803\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021804\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021809\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021810\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/2/35878?source=related_link\">",
"      Chlorothiazide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/27/20919?source=related_link\">",
"      Chlorothiazide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_62_21478="Skin biopsy MCTD II";
var content_f20_62_21478=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62041&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Skin lesion in mixed connective tissue disease (MCTD)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of an interface dermatitis with prominent suprabasilar lymphocytosis and dyskeratosis in mixed connective tissue disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21478=[""].join("\n");
var outline_f20_62_21478=null;
var title_f20_62_21479="Anatomy of brainstem";
var content_f20_62_21479=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53866&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53866&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Anatomy of the brainstem (lateral view)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 532px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21479=[""].join("\n");
var outline_f20_62_21479=null;
var title_f20_62_21480="Evaluation of the HIV-infected patient with hepatobiliary complaints";
var content_f20_62_21480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the HIV-infected patient with hepatobiliary complaints",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21480/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21480/contributors\">",
"     C Mel Wilcox, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21480/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21480/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21480/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21480/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/62/21480/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The era of potent antiretroviral therapy (ART) has been associated with a marked decrease in morbidity and mortality in HIV-infected patients.",
"   </p>",
"   <p>",
"    However, those who present with advanced immunosuppression are at risk for a wide variety of opportunistic infections (OIs), such as Cryptosporidium, Isospora, Microsporidium, Mycobacterium avium complex (MAC), and cytomegalovirus (CMV) and hepatobiliary complications, such as acalculous cholecystitis and AIDS-related cholangiopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/1\">",
"     1",
"    </a>",
"    ]. Those patients who undergo therapy are also at risk for treatment-related adverse events, such as lactic acidosis, hepatic steatosis, and drug-induced hepatotoxicity. Finally, a significant proportion of patients are infected with hepatitis B",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    C virus, due to shared routes of transmission.",
"   </p>",
"   <p>",
"    This topic will discuss a guided approach to the evaluation of the HIV-infected patient with hepatobiliary complaints. More detailed information regarding viral hepatitis B and hepatitis C infections and AIDS cholangiopathy are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26069?source=see_link\">",
"     \"AIDS cholangiopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HEPATOBILIARY COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Chronic viral hepatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common cause of hepatomegaly in HIV-infected patients is chronic viral hepatitis with either hepatitis B virus (HBV)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hepatitis C virus (HCV) infections [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/2\">",
"     2",
"    </a>",
"    ]. End-stage liver disease is a major cause for inpatient admissions and mortality in the era of antiretroviral therapy (ART) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"     \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Depending on the risk group studied, it is estimated that approximately 30 to 80 percent of patients with HIV have concomitant hepatitis C and approximately 5 to 10 percent have chronic hepatitis B. There are few data on the seroprevalence of multiple hepatitides, such as hepatitis B and C combined; one study of 423 HIV-infected patients in Spain found that approximately 5 percent of patients had HBV, HCV, and delta virus infections [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/5\">",
"     5",
"    </a>",
"    ] The most common risk factor for acquisition of HCV is injection drug use, while HBV can be acquired both sexually and parenterally. However, there are emerging data on acute HCV infection among men who have sex with men (MSM) who report sex with trauma or in association with other genital ulcer disease [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common symptom in patients with chronic viral hepatitis is fatigue; however, most patients are often asymptomatic and unaware of their infection until they develop decompensated cirrhosis or hepatocellular carcinoma (HCC). As shown in a large retrospective study (n = 24,040), the incidence of compensated and decompensated cirrhosis and HCC has risen significantly since 1996 to 2009 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/8\">",
"     8",
"    </a>",
"    ]. Risk factors for advanced disease included HCV infection, HBV infection, Hispanic ethnicity, alcohol use and diabetes, while protective factors included treatment-induced HCV eradication and black race [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/8\">",
"     8",
"    </a>",
"    ]. Risk factors associated with the development of hepatocellular carcinoma included HBV and HCV and a low CD4 cell count. ART, which may slow the rate of fibrosis progression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/9\">",
"     9",
"    </a>",
"    ], is now recommended in all HIV-infected patients, regardless of CD4 cell count [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9786?source=see_link&amp;anchor=H26#H26\">",
"     \"When to initiate antiretroviral therapy in HIV-infected patients\", section on 'Treatment recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hepatitis E is an uncommon cause of abnormal aminotransferases in the HIV-infected patient [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/11\">",
"     11",
"    </a>",
"    ]; it has been rarely reported to cause persistent infection in patients with advanced immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/12\">",
"     12",
"    </a>",
"    ]. Hepatitis A does not cause chronic liver disease regardless of HIV status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Infiltrative liver disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients are at risk for AIDS and non-AIDS-related malignancies, which can metastasize to the hepatobiliary system [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/13\">",
"     13",
"    </a>",
"    ]. Immunosuppression from HIV infection appears to play an important role in the development of both Kaposi's sarcoma and non-Hodgkin lymphoma. However, the introduction of ART has been associated with substantial decreases in the incidence of both of these diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27206?source=see_link\">",
"     \"HIV infection and malignancy: Epidemiology and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As patients have survived longer with AIDS, the frequency of non-AIDS-defining malignancies (such as lung cancer with metastasis to the liver) has increased compared with the non-HIV-infected population; cancer deaths now account for an increasing fraction of overall deaths in HIV-infected individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=see_link\">",
"     \"HIV infection and malignancy: Management considerations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with AIDS are also at risk for infiltrative hepatic disease secondary to opportunistic infections [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Opportunistic infections'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Primary liver cancers related to hepatitis B or C infection are discussed above. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Chronic viral hepatitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Opportunistic infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some disseminated opportunistic infections have prominent hepatobiliary manifestations, such as mycobacterium avium complex (MAC).",
"   </p>",
"   <p>",
"    The risk of MAC in patients with HIV infection increases as the CD4 cell number declines below 100",
"    <span class=\"nowrap\">",
"     cells/mm3.",
"    </span>",
"    Constitutional symptoms include fever, night sweats, weight loss, and abdominal pain. Laboratory abnormalities frequently include anemia and elevated alkaline phosphatase. The diagnosis of MAC is made by isolation of the organism in culture usually of the blood or lymph node. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Histoplasmosis is the most common endemic fungal infection in HIV-infected patients with advanced immunosuppression. Common symptoms of histoplasmosis include fever, night sweats, weight loss, cough, nausea, and vomiting. Physical examination may demonstrate hepatosplenomegaly and adenopathy along with skin and mucosal lesions. Pancytopenia and elevated aminotransferases are commonly seen. Diagnostic tests for disseminated H. capsulatum infection include culture, serology, antigen testing, and direct microscopy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39924?source=see_link\">",
"     \"Epidemiology and clinical manifestations of histoplasmosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other less common infectious etiologies of hepatitis in immunosuppressed HIV-infected patients include: candida, tuberculosis, Pneumocystis, Bartonella henselae (causing peliosis hepatis), and visceral leishmaniasis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. (See appropriate topic subjects).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hepatic steatosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have shown that",
"    <span class=\"nowrap\">",
"     HIV/HCV-coinfected",
"    </span>",
"    patients are at increased risk for hepatic steatosis when compared with patients with HCV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/18\">",
"     18",
"    </a>",
"    ]. Hepatic steatosis is associated with viral factors (eg, HCV genotype 3 infection, uncontrolled HIV infection), host factors (such as visceral adiposity, insulin resistance, and hyperlipidemia), alcohol use, and chronic nucleoside analog exposure (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"     Stavudine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    are no longer used for treatment of HIV infection since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/63/31734?source=see_link\">",
"     abacavir",
"    </a>",
"    have a safer toxicity profile, particularly with regard to mitochondrial toxicity. One study that examined liver biopsies from 1993 to 2008 demonstrated that the strongest risk factors for hepatic steatosis were obesity and alcohol use, while cumulative ART was protective [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/21\">",
"     21",
"    </a>",
"    ]. An algorithm for assessing the risk factors for hepatic steatosis among HIV-infected patients has been proposed (",
"    <a class=\"graphic graphic_algorithm graphicRef83736 \" href=\"UTD.htm?14/36/14927\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with hepatic steatosis are asymptomatic; fatty liver is often an incidental finding on imaging or is first identified on ultrasound during evaluation for gastrointestinal complaints or abnormal aminotransferases. Steatosis is associated with higher stages of fibrosis in HIV-infected patients with underlying hepatitis C [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hepatic steatosis has also been associated with abnormal aminotransferases among HIV-infected patients without evidence of chronic hepatitis C infection; these patients most likely have non-alcoholic fatty liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/23\">",
"     23",
"    </a>",
"    ]. In the setting of significant necroinflammation, hepatic steatosis can lead to steatohepatitis and cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38105?source=see_link\">",
"     \"Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Drug-induced liver injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients may develop drug-induced liver injury from antiretroviral medications or from commonly used drugs, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    . Several studies have demonstrated that HIV-infected patients with chronic viral hepatitis and baseline elevations of aminotransferases are at increased risk of ART-induced hepatotoxicity than HIV-infected patients without hepatitis B or C infection [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Drug-induced liver injury may lead to right upper quadrant pain, nausea, fatigue, and poor appetite. In severe cases, it can also be associated with jaundice, which increases the risk of mortality; this is a clinical observations known as \"Hy's law\" [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occasionally, mild jaundice can be induced by certain antiretroviral medications due to an elevation of indirect bilirubin (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/36/25161?source=see_link\">",
"     indinavir",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/31/506?source=see_link\">",
"     atazanavir",
"    </a>",
"    ) caused by inhibition of UDP-glucuronosyl transferase (UGT). The elevation in indirect bilirubin is reversible and not associated with liver injury or elevations in other liver tests (eg, transaminases or alkaline phosphatase). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/32/40458?source=see_link\">",
"     \"HIV protease inhibitors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If an antiretroviral medication that is dually active against hepatitis B and HIV (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/7/38007?source=see_link\">",
"     lamivudine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    ) is discontinued for any reason, a patient with concomitant chronic hepatitis B may experience a severe flare of aminotransferases. This can be associated with significant morbidity, and even mortality, in a patient with pre-existing cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16185?source=see_link\">",
"     \"Treatment of hepatitis B in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15151203\">",
"    <span class=\"h2\">",
"     AIDS cholangiopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;AIDS cholangiopathy is a syndrome of biliary obstruction resulting from infection-associated strictures of the biliary tract. It is usually seen in patients with a CD4 count well below 100",
"    <span class=\"nowrap\">",
"     cells/mm3.",
"    </span>",
"    AIDS cholangiopathy occurred in as many as one-fourth of AIDS patients prior to the advent of potent ART; the current incidence with active treatment of human immunodeficiency virus (HIV) infection has clearly decreased but is not known. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26069?source=see_link\">",
"     \"AIDS cholangiopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The organism found most commonly is Cryptosporidium parvum; other pathogens that have been identified include Microsporidium, cytomegalovirus (CMV), Cyclospora cayetanensis, Isospora, and Giardia. However, in approximately 20 to 40 percent of cases, no etiology can be found.",
"   </p>",
"   <p>",
"    AIDS cholangiopathy should be suspected in the HIV-infected patient with advanced immunosuppression who presents with right upper quadrant abdominal pain, fever, and an elevated serum alkaline phosphatase [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/26\">",
"     26",
"    </a>",
"    ]. Frank jaundice is unusual. Diarrhea is a frequent concomitant complaint since the infectious agent often involves the small intestine as well. Imaging with ultrasound or a CT scan may demonstrate biliary tract dilation or thickening of the common bile duct wall.",
"   </p>",
"   <p>",
"    Right upper quadrant pain with or without jaundice may be a presenting complaint in papillary stenosis, acalculous cholecystitis,",
"    <span class=\"nowrap\">",
"     cholelithiasis/choledocholithiasis,",
"    </span>",
"    or drug-induced liver injury. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Drug-induced liver injury'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93353806\">",
"    <span class=\"h2\">",
"     Atazanavir-associated cholelithiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/31/506?source=see_link\">",
"     Atazanavir",
"    </a>",
"    appears to be associated with complicated cholelithiasis. In a series of 14 HIV-infected patients with cholelithiasis who were receiving an atazanavir-based antiretroviral regimen, eight had significant concentrations of atazanavir detected from biliary stones [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/27\">",
"     27",
"    </a>",
"    ]. Cholelithiasis-related symptoms occurred after a median duration of 42 months of receiving an atazanavir-based regimen (range 1 to 90 months). Cholelithiasis-related complications included cholecystitis (in 11 patients), cholangitis (in 1 patient), and acute pancreatitis (in 4 patients).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     HISTORY AND PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial efforts in the evaluation of the HIV infected patient with symptoms or signs consistent with hepatobiliary disease (eg, right upper quadrant pain, nausea, jaundice) should be directed at determining whether there is intrahepatic or extrahepatic disease. Knowledge of the patient's CD4 cell count will help guide the differential diagnosis. Simultaneous disease in both sites must also be considered.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of mild jaundice and constitutional symptoms (eg, fatigue, nausea), is more consistent with intrahepatic disease, such as acute viral hepatitis (eg, hepatitis A, hepatitis B, or hepatitis C infections)",
"     </li>",
"     <li>",
"      The subacute onset of fevers, chills, anorexia, and weight loss in a patient with advanced AIDS and hepatosplenomegaly may be related to disseminated infections, such as MAC, tuberculosis, Bartonella henselae, visceral leishmaniasis, histoplasmosis, or lymphoma. (See appropriate individual topics).",
"     </li>",
"     <li>",
"      In contrast, signs of jaundice accompanied by relatively acute abdominal pain suggest extrahepatic disease, such as a solid tumor or lymphadenopathy at the porta hepatis.",
"     </li>",
"     <li>",
"      Right upper quadrant pain with or without jaundice may be a presenting complaint in AIDS-related cholangiopathy, papillary stenosis, acalculous cholecystitis,",
"      <span class=\"nowrap\">",
"       cholelithiasis/choledocholithiasis,",
"      </span>",
"      or drug-induced liver injury.",
"     </li>",
"     <li>",
"      A history of abdominal bloating, nausea, weight loss and right upper quadrant pain may be associated with the lactic acidosis syndrome, which is more common in women than men and usually secondary to chronic nucleoside analogue use with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"       didanosine",
"      </a>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"       stavudine",
"      </a>",
"      . These agents are no longer recommended in the United States and Europe, but are commonly used in resource-limited settings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/40/30345?source=see_link\">",
"       \"Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/34/10794?source=see_link\">",
"       \"Adverse effects of antiretroviral therapy in developing countries\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A careful review of medications, both prescription and non-prescription, should be performed in patients with new symptoms or signs of hepatitis to address the possibility of drug toxicity. Travel history and TB skin testing status should be evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Liver function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver function tests traditionally refer to aminotransferases, which do not measure liver function at all. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are usually elevated in the setting of liver injury. Measures of synthetic liver function include prothrombin time and serum albumin (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34090?source=see_link\">",
"     \"Approach to the patient with abnormal liver biochemical and function tests\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Elevations of aminotransferases are common in patients with chronic viral hepatitis, lactic acidosis, choledocholithiasis, and drug-induced liver injury. In these clinical scenarios, ALT is usually greater than AST; however, this finding alone will not help differentiate the immediate cause of hepatobiliary disease. Marked elevations of aminotransferases should raise the possibility of acute viral hepatitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with chronic hepatitis C virus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When AST is greater than ALT, alcoholic liver injury should be considered; if there is no history of alcohol abuse, advanced liver disease is another diagnostic consideration. In the latter case, synthetic function may be impaired (as reflected by low serum albumin and prolonged prothrombin time). However, hypoalbuminemia can also be seen in patients with advanced AIDS and wasting.",
"   </p>",
"   <p>",
"    A cholestatic pattern or isolated elevations of one particular marker (eg, alkaline phosphatase or bilirubin) can be particularly helpful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A cholestatic picture may be seen with AIDS cholangiopathy; papillary stenosis combined with ductal sclerosis; or high-grade obstruction from other causes such as tumor or drug-induced liver injury (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/56/43912?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Marked elevation of alkaline phosphatase, in the absence of extrahepatic obstruction, is suggestive of MAC infection in the liver in patients with AIDS [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/28\">",
"       28",
"      </a>",
"      ]. Concomitant bone-marrow suppression is frequent and the degree of anemia can be severe [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A rising bilirubin in the setting of cirrhosis may signal the onset of decompensated liver disease. Alternatively, an elevated bilirubin can be related to certain antiretroviral medications, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/31/506?source=see_link\">",
"       atazanavir",
"      </a>",
"      (or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/36/25161?source=see_link\">",
"       indinavir",
"      </a>",
"      , which is uncommonly used today) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. It is helpful to fractionate the bilirubin in these cases, since a drug-induced effect results in elevation of the indirect portion, in contrast to the direct hyperbilirubinemia seen in liver failure.",
"     </li>",
"     <li>",
"      In the patient with elevated serum transaminases, viral hepatitis should be excluded. Appropriate testing for hepatitis B and C in the HIV-infected patient is discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"       \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Drug-induced causes of elevated aminotransferases include prescription, over-the-counter, and herbal remedies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;If an infectious cause is being considered in the immunosuppressed host, blood cultures for MAC and Bartonella henselae should be performed. CMV antigen testing is preferred to CMV cultures for more rapid diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin testing for tuberculosis should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4298?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <p class=\"headingAnchor\" id=\"H4802707\">",
"     <span class=\"h3\">",
"      Ultrasound",
"     </span>",
"     &nbsp;&mdash;&nbsp;A right upper quadrant ultrasound can be helpful in identifying ductal dilatation, gallbladder pathology, and focal hepatic lesions,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     abscesses. The presence of dilated ducts or other biliary abnormalities suggests an extrahepatic cause for jaundice, such as papillary stenosis in AIDS cholangiopathy. If an ultrasound demonstrates multiple lucencies within the liver in a patient with advanced immunosuppression, fever, anemia, and skin lesions, peliosis hepatis secondary to Bartonella infection should be considered.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4802714\">",
"     <span class=\"h3\">",
"      CT scanning",
"     </span>",
"     &nbsp;&mdash;&nbsp;CT scanning is useful for evaluating infiltrative disease, including hepatic steatosis. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/40/30345?source=see_link\">",
"      \"Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h3\">",
"      Hepatobiliary scintigraphy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Additional imaging procedures are sometimes indicated. In patients with acalculous cholecystitis, a right-upper quadrant ultrasound is usually non-specific, with findings consistent with gallbladder thickening or pericholecystic fluid, and absence of gallstones. Hepatobiliary scintigraphy (HIDA) is more useful in this situation since it will demonstrate a non-functioning gallbladder [",
"     <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/1\">",
"      1",
"     </a>",
"     ]. A contrast-enhanced abdominal computed tomography (CT) scan can provide additional information concerning the liver, pancreas, or presence of lymphadenopathy",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     mass lesions. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26069?source=see_link\">",
"      \"AIDS cholangiopathy\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link\">",
"      \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h2\">",
"      Endoscopic retrograde cholangiopancreatography",
"     </span>",
"     &nbsp;&mdash;&nbsp;If CT or ultrasound demonstrates biliary duct pathology, stricturing, or dilated ducts, an endoscopic retrograde cholangiopancreatography (ERCP) may be indicated. In patients with papillary stenosis, a narrowing of the terminal common bile duct with proximal dilatation and extrahepatic or intrahepatic bile duct stricturing may be seen; in AIDS cholangiopathy, the ducts may have a classic beaded pattern [",
"     <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/1\">",
"      1",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     ERCP permits diagnostic sampling of bile, which can be examined for neoplastic cells, protozoa, or cultured for viruses, as well as ductal biopsy. [",
"     <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/32\">",
"      32",
"     </a>",
"     ]. ERCP can be used for therapeutic interventions, such as sphincterotomy (in papillary stenosis) and removal of stones or stent strictures.",
"    </p>",
"    <p>",
"     Although magnetic resonance cholangiopancreatography (MRCP) may also be helpful for imaging [",
"     <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/33\">",
"      33",
"     </a>",
"     ], ERCP still offers the advantage of tissue sampling and potential sphincterotomy, if needed.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h2\">",
"      Laparoscopy with biopsy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Laparoscopy may be useful to identify any peritoneal pathology, as seen in tuberculosis or malignancy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h2\">",
"      Liver biopsy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Liver biopsy can be considered in patients with infiltrative processes, mitochondrial toxicity, chronic viral hepatitis, or neoplasm. This is generally a safe procedure in HIV-infected patients, provided coagulation parameters are normal or corrected [",
"     <a class=\"abstract\" href=\"UTD.htm?20/62/21480/abstract/34\">",
"      34",
"     </a>",
"     ]. The usefulness of liver biopsy in diagnosing drug-induced liver injury is limited to when eosinophils are present; otherwise many of the necroinflammatory changes that can be seen in drug-related hepatotoxicity can overlap with chronic viral hepatitis. Discontinuation of potential hepatotoxic medications with careful follow-up of aminotransferases over time is a useful strategy. A liver biopsy can be considered when aminotransferases remain abnormal.",
"    </p>",
"    <p>",
"     If a liver biopsy is done, appropriate culture and special stains of the specimen will increase the yield when infection is suspected. Cultures should include testing for routine bacterial, mycobacterial, and fungal pathogens. All appropriate clinical information, including the degree of immunosuppression, should be communicated to the pathologist since granuloma formation can be quite poor in patients with advanced AIDS and MAC infection.",
"    </p>",
"    <p>",
"     If mitochondrial toxicity is suspected, electron microscopy can confirm the presence of mitochondrial abnormalities (such as paracrystalline inclusions and swollen mitochondrial cristae).",
"    </p>",
"    <p>",
"     However, in many of these circumstances, the liver biopsy may not be needed. For example:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       In the setting of disseminated infection, such as MAC, the diagnosis is often made by examination of other sites, such as blood or bone marrow.",
"      </li>",
"      <li>",
"       Mitochondrial toxicity is often strongly suggested by the presence of elevated serum lactate in a patient with abdominal bloating, weight loss, nausea, and fatigue.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     In contrast, a liver biopsy may be helpful in the setting of chronic hepatitis B or hepatitis C to help stage the disease and to determine if treatment is necessary. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=see_link\">",
"      \"Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=see_link\">",
"      \"Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </span>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       HIV-infected patients with severe immunosuppression are at risk for AIDS cholangiopathy and opportunistic infections, such as Mycobacterium avium complex disease, which can cause significant hepatobiliary disease. Due to shared routes of infection, HIV-infected patients are also at risk for hepatitis B and hepatitis C virus infections, which are a major cause for morbidity and mortality, such as decompensated cirrhosis and hepatocellular carcinoma. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'Hepatobiliary complications'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Hepatic steatosis is associated with viral factors (eg, hepatitis C genotype 3 infection), host factors (such as visceral adiposity, insulin resistance, and hyperlipidemia) and chronic nucleoside analog use (ie,",
"       <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"        stavudine",
"       </a>",
"       and",
"       <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"        didanosine",
"       </a>",
"       ). In the setting of necroinflammation, hepatic steatosis can lead to liver fibrosis. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'Hepatobiliary complications'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       HIV-infected patients may develop drug-induced liver injury from antiretroviral medications or from commonly used medications, such as",
"       <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"        isoniazid",
"       </a>",
"       ,",
"       <a class=\"drug drug_general\" href=\"UTD.htm?16/12/16586?source=see_link\">",
"        fluconazole",
"       </a>",
"       , or",
"       <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"        trimethoprim-sulfamethoxazole",
"       </a>",
"       . Several studies have demonstrated that HIV-infected patients with chronic viral hepatitis and baseline elevations of aminotransferases are at increased risk of ART-induced hepatotoxicity than HIV-infected patients without hepatitis B or C infection. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'Hepatobiliary complications'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Initial efforts in the evaluation of the HIV-infected patient with symptoms or signs consistent with hepatobiliary disease (eg, right upper quadrant pain, nausea, jaundice) should be directed at determining whether there is intrahepatic or extrahepatic disease. Knowledge of the patient's CD4 cell count will help guide the differential diagnosis. (See",
"       <a class=\"local\" href=\"#H9\">",
"        'History and physical examination'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are usually elevated in the setting of liver injury (eg, drug-induced liver injury or viral hepatitis). Elevations of either alkaline phosphatase or bilirubin are suggestive of a cholestatic pattern or obstructive process (eg, tumor or lymphadenopathy at the porta hepatis). Measures of synthetic liver function include prothrombin time and serum albumin; abnormalities in these markers suggest advanced liver disease. (See",
"       <a class=\"local\" href=\"#H10\">",
"        'Diagnostic studies'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Imaging is particularly helpful if an obstructive process, opportunistic infection, or malignancy is suspected. If CT or ultrasound demonstrates biliary duct pathology, stricturing, or dilated ducts, an endoscopic retrograde cholangiopancreatography (ERCP) may be indicated for diagnostic evaluation and therapeutic intervention. (See",
"       <a class=\"local\" href=\"#H10\">",
"        'Diagnostic studies'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Liver biopsy can be considered in patients with infiltrative processes, mitochondrial toxicity, chronic viral hepatitis, or neoplasm. This is generally a safe procedure in HIV-infected patients, provided coagulation parameters are normal or corrected. (See",
"       <a class=\"local\" href=\"#H10\">",
"        'Diagnostic studies'",
"       </a>",
"       above.)",
"      </li>",
"     </ul>",
"    </p>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/1\">",
"      Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part II. AIDS Patient Care STDS 1998; 12:451.",
"     </a>",
"    </li>",
"    <li>",
"     DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents December 1, 2009. www.AIDSinfo.nih.gov (Accessed on October 14, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/3\">",
"      Weber R, Sabin CA, Friis-M&oslash;ller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166:1632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/4\">",
"      Lumbreras B, Jarr&iacute;n I, del Amo J, et al. Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. AIDS 2006; 20:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/5\">",
"      Arribas JR, Gonz&aacute;lez-Garc&iacute;a JJ, Lorenzo A, et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS 2005; 19:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/6\">",
"      Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 2007; 21:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/7\">",
"      G&ouml;tz HM, van Doornum G, Niesters HG, et al. A cluster of acute hepatitis C virus infection among men who have sex with men--results from contact tracing and public health implications. AIDS 2005; 19:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/8\">",
"      Ioannou GN, Bryson CL, Weiss NS, et al. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology 2013; 57:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/9\">",
"      Br&auml;u N, Salvatore M, R&iacute;os-Bedoya CF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006; 44:47.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.aidsinfo.nih.gov/guidelines/ (Accessed on May 14, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/11\">",
"      Madej&oacute;n A, Vispo E, Bottecchia M, et al. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009; 16:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/12\">",
"      Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/13\">",
"      Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/14\">",
"      Saab S, Rickman LS, Lyche KD. Ascites and the acquired immunodeficiency syndrome. Report of 54 cases. Medicine (Baltimore) 1996; 75:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/15\">",
"      Poblete RB, Rodriguez K, Foust RT, et al. Pneumocystis carinii hepatitis in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/16\">",
"      Poles MA, Dieterich DT, Schwarz ED, et al. Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV). J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/17\">",
"      Lebovics E, Thung SN, Schaffner F, Radensky PW. The liver in the acquired immunodeficiency syndrome: a clinical and histologic study. Hepatology 1985; 5:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/18\">",
"      Gaslightwala I, Bini EJ. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. J Hepatol 2006; 44:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/19\">",
"      McGovern BH, Ditelberg JS, Taylor LE, et al. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis 2006; 43:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/20\">",
"      Brown TT, Mehta SH, Sutcliffe C, et al. Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons. AIDS 2010; 24:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/21\">",
"      Woreta TA, Sutcliffe CG, Mehta SH, et al. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology 2011; 140:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/22\">",
"      McGovern BH. Hepatic steatosis in HIV/HCV-coinfected patients: time to reevaluate! Gastroenterology 2011; 140:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/23\">",
"      Sterling RK, Contos MJ, Smith PG, et al. Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2008; 47:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/24\">",
"      Soriano V, Puoti M, Garcia-Gasc&oacute; P, et al. Antiretroviral drugs and liver injury. AIDS 2008; 22:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/25\">",
"      Norris W, Paredes AH, Lewis JH. Drug-induced liver injury in 2007. Curr Opin Gastroenterol 2008; 24:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/26\">",
"      De Angelis C, Mangone M, Bianchi M, et al. An update on AIDS-related cholangiopathy. Minerva Gastroenterol Dietol 2009; 55:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/27\">",
"      Rakotondravelo S, Poinsignon Y, Borsa-Lebas F, et al. Complicated atazanavir-associated cholelithiasis: a report of 14 cases. Clin Infect Dis 2012; 55:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/28\">",
"      Schneiderman DJ, Arenson DM, Cello JP, et al. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 1987; 7:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/29\">",
"      Benson CA. Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994; 18 Suppl 3:S218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/30\">",
"      Busti AJ, Hall RG, Margolis DM. Atazanavir for the treatment of human immunodeficiency virus infection. Pharmacotherapy 2004; 24:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/31\">",
"      Zucker SD, Qin X, Rouster SD, et al. Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A 2001; 98:12671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/32\">",
"      Teare JP, Daly CA, Rodgers C, et al. Pancreatic abnormalities and AIDS related sclerosing cholangitis. Genitourin Med 1997; 73:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/33\">",
"      Bilgin M, Balci NC, Erdogan A, et al. Hepatobiliary and pancreatic MRI and MRCP findings in patients with HIV infection. AJR Am J Roentgenol 2008; 191:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21480/abstract/34\">",
"      Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part one. AIDS Patient Care STDS 1998; 12:347.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3729 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-0E3ADE63EF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21480=[""].join("\n");
var outline_f20_62_21480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HEPATOBILIARY COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Chronic viral hepatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Infiltrative liver disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Opportunistic infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hepatic steatosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Drug-induced liver injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15151203\">",
"      AIDS cholangiopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93353806\">",
"      Atazanavir-associated cholelithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HISTORY AND PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Liver function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Skin testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4802707\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4802714\">",
"      - CT scanning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Hepatobiliary scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Endoscopic retrograde cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Laparoscopy with biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Liver biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3729\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3729|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?14/36/14927\" title=\"algorithm 1\">",
"      Assessing risk factors for hepatic steatosis in HIV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/29/26069?source=related_link\">",
"      AIDS cholangiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/34/10794?source=related_link\">",
"      Adverse effects of antiretroviral therapy in developing countries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34090?source=related_link\">",
"      Approach to the patient with abnormal liver biochemical and function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/63/39924?source=related_link\">",
"      Epidemiology and clinical manifestations of histoplasmosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38105?source=related_link\">",
"      Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/55/7033?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of hepatitis B in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30218?source=related_link\">",
"      Epidemiology, natural history, and diagnosis of hepatitis C in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11848?source=related_link\">",
"      Evaluation of the HIV-infected patient with chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27206?source=related_link\">",
"      HIV infection and malignancy: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30202?source=related_link\">",
"      HIV infection and malignancy: Management considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/32/40458?source=related_link\">",
"      HIV protease inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/40/30345?source=related_link\">",
"      Mitochondrial toxicity of HIV nucleoside reverse transcriptase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=related_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16185?source=related_link\">",
"      Treatment of hepatitis B in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4298?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/35/9786?source=related_link\">",
"      When to initiate antiretroviral therapy in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_62_21481="Premature adrenarche";
var content_f20_62_21481=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Premature adrenarche",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Robert L Rosenfield, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Lynnette K Nieman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Mitchell Geffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21481/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/62/21481/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenarche is the term for the maturational increase in adrenal androgen production that becomes biochemically apparent as a rise in dehydroepiandrosterone sulfate (DHEA-S) at about six years of age in both girls and boys (",
"    <a class=\"graphic graphic_figure graphicRef79533 \" href=\"UTD.htm?18/5/18527\">",
"     figure 1",
"    </a>",
"    ). It represents a gradual change in the pattern of adrenal secretory response to corticotropin (adrenocorticotropic hormone, ACTH), characterized by a disproportionate rise of 17-hydroxypregnenolone and dehydroepiandrosterone (DHEA) relative to cortisol. This change primarily occurs in the zona reticularis of the adrenal cortex, the cells of which express a unique pattern of steroidogenic enzymes that includes expression of sulfotransferase 2A1 (SULT2A1), which catalyzes the formation of DHEA-S, the major adrenarchal steroid (",
"    <a class=\"graphic graphic_figure graphicRef58179 \" href=\"UTD.htm?8/10/8355\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23302?source=see_link\">",
"     \"Normal adrenarche\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The causes, diagnosis, and management of premature adrenarche will be reviewed here. It is useful, however, to begin with a review of definitions used to describe the various aspects of premature sexual development as they relate to adrenarche.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definitions used to describe normal and premature puberty and pubarche are as follows:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Puberty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Puberty is the stage of development during which secondary sexual characteristics appear and there is a transition from the sexually immature to the sexually mature stage. True puberty results from activation of the hypothalamic-pituitary-gonadal (HPG) axis. Testicular enlargement is the usual first sign of gonadal activation (gonadarche) in boys, and breast development (thelarche) is the first sign in girls, with sexual hair development ordinarily occurring later. The physiology and clinical stages of puberty are discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=see_link\">",
"     \"Normal puberty\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Premature puberty",
"    </span>",
"    &nbsp;&mdash;&nbsp;The exact age at which puberty is abnormally early (precocious) is not well defined. In general, signs of secondary sexual development occurring before the age of eight years in girls and the age of nine years in boys are considered premature and warrant careful evaluation. This practice is supported by data in girls, though breast budding is normal during the seventh year in Black and Mexican-American girls [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/1\">",
"     1",
"    </a>",
"    ], while good data are still lacking in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/2\">",
"     2",
"    </a>",
"    ]. Gonadotropin-dependent precocious puberty (also termed &ldquo;central,&rdquo; &ldquo;true,&rdquo; &ldquo;or &ldquo;complete&rdquo; precocity) results from activation of the normal HPG axis. Gonadotropin-independent precocious puberty (also termed &ldquo;peripheral&rdquo; precocious puberty) results from excess exposure to androgens or estrogens derived from the gonads, adrenal glands, exogenous sources, or ectopic production of human chorionic gonadotropin (hCG) by a tumor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=see_link\">",
"     \"Definition, etiology, and evaluation of precocious puberty\"",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pubarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pubarche is the term applied to the appearance of sexual hair (Tanner stage 3) (",
"    <a class=\"graphic graphic_table graphicRef55329 \" href=\"UTD.htm?8/1/8220\">",
"     table 1",
"    </a>",
"    ). Although this development requires adrenarchal levels of androgen, sexual hair ordinarily does not appear until shortly after clinical evidence of gonadarche (ie, breast development in girls and testicular enlargement in boys). In girls, sexual hair usually appears first on the labia majora, and the hair gradually spreads upwards onto the mons; in some girls, sexual hair growth begins in the axilla. Tanner stage 3 pubic hair appears in five percent or less of normal-weight American eight and nine year old girls and boys, respectively, according to the National Health and Nutrition Examination Survey III, irrespective of ethnicity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/1\">",
"     1",
"    </a>",
"    ]. While pre-sexual hair (Tanner stage 2) development precedes the onset of sexual hair, it is an unreliable sign of pubarche, because similar vellus hair development may be due to hypertrichosis. (See",
"    <a class=\"local\" href=\"#H2485518\">",
"     'Hypertrichosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Premature pubarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature pubarche refers to the isolated appearance of sexual hair (ie, unaccompanied by breast development) before the age of eight years in girls and nine years in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. It appears to be more common in girls, with the ratio of affected girls to boys four to one or more [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Premature pubic hair development is seen in approximately 15 percent of girls under eight years of age in pediatric office practice [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/6\">",
"     6",
"    </a>",
"    ]. Obesity is a common associated factor in girls [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/1,7\">",
"     1,7",
"    </a>",
"    ], but the association is less clear in boys [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/8\">",
"     8",
"    </a>",
"    ]. In some populations, there is no association between premature pubarche and obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Premature pubarche is unusual before the age of four to five years, but can develop earlier [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. Those children younger than two years of age have different clinical and laboratory features than those of older ones: they are generally not obese, and their plasma concentrations of DHEA-S and androstenedione are high for their age and sex but lower than those expected for Tanner stage 2. The premature pubarche in these infants is probably because of a persistent fetal zone of the adrenal gland, hypersensitivity of hair follicles, or both.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Premature adrenarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature adrenarche is an incomplete, benign, slowly progressive form of premature puberty that is an extreme variant of normal or nearly normal. The term is used to designate a very mild form of androgen excess, most often manifest as premature pubarche, that is characterized by a serum steroid pattern typical of adrenarche (",
"    <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3\">",
"     3",
"    </a>",
"    ] and is otherwise unexplained.",
"   </p>",
"   <p>",
"    Premature adrenarche is characterized by the following biochemical findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The serum concentration of dehydroepiandrosterone sulfate (DHEA-S) is the best marker for the presence of adrenarche. Adrenarche is traditionally indicated by a DHEA-S level greater than 40",
"      <span class=\"nowrap\">",
"       &micro;g/dL.",
"      </span>",
"      This value is above normal for one- to five-year-olds and above average for six- to eight-year-olds, while no greater than normal for early puberty (",
"      <a class=\"graphic graphic_figure graphicRef79533 \" href=\"UTD.htm?18/5/18527\">",
"       figure 1",
"      </a>",
"      ). It is accompanied by an above-average DHEA level; other androgen levels are normal or minimally elevated above the prepubertal range.",
"     </li>",
"     <li>",
"      Serum testosterone and androstenedione concentrations typically are in the upper end of the normal prepubertal range, but can be as high as 40 and 75",
"      <span class=\"nowrap\">",
"       ng/dL,",
"      </span>",
"      respectively (1.4 and 2.7",
"      <span class=\"nowrap\">",
"       nmol/L),",
"      </span>",
"      according to high-specificity radioimmunoassays (",
"      <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The serum steroid responses to ACTH parallel the DHEA-S changes, with rises of 17-hydroxypregnenolone and DHEA predominating (",
"      <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53342 \" href=\"UTD.htm?37/34/38447\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3,10\">",
"       3,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some children have premature adrenarche with normal prepubertal serum levels of DHEA-S and other androgens, and premature adrenarche is detectable only by provocative testing with ACTH. In such children, an adrenarchal response of serum DHEA",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      17-hydroxypregnenolone to ACTH administration indicates premature adrenarche [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/11\">",
"       11",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H21\">",
"       'ACTH stimulation test'",
"      </a>",
"      below). There are two possible explanations for these findings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The child has true premature adrenarche with coincidentally low sulfotransferase activity, thereby preventing an elevation in serum DHEA-S, due to mild sulfotransferase deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The child may have a type of exaggerated adrenarche in which adrenal 17-ketosteroid hyperresponsiveness to ACTH occurs in the absence of a high basal serum DHEA-S concentration [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/13\">",
"       13",
"      </a>",
"      ]. This may be related to the functional adrenal hyperandrogenism sometimes seen in adults with polycystic ovary syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=see_link\">",
"       \"Adrenal hyperandrogenism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link\">",
"       \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Premature adrenarche is characterized by the following clinical findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Premature adrenarche is often accompanied by an increase in axillary body odor, seborrhea, and a minor degree of microcomedonal acne; these may sometimes be the first signs [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/14\">",
"       14",
"      </a>",
"      ]. However, it is a benign normal or nearly normal variant that is not accompanied by any other signs of puberty, frank virilization, or an abnormal advance in bone age. The sexual hair development and bone age increase slowly, in proportion to linear growth. Since the pilosebaceous unit sensitivity to androgen is highly variable, pubarche may occur at androgen levels typical of a young child (\"idiopathic premature pubarche\") before frankly adrenarchal androgen levels are reached.",
"     </li>",
"     <li>",
"      Paralleling the trend of androgen levels, children who have premature adrenarche tend to have a growth rate and bone age that are above average but still within the normal range. However, they have been reported to have slightly increased bone mineral density that is independent of bone age and other lean body mass parameters [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Exaggerated adrenarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exaggerated adrenarche is a clinically extreme type of premature adrenarche [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3\">",
"     3",
"    </a>",
"    ]. This diagnosis is suspected in children with premature adrenarche who have clinical features that suggest an atypical degree of androgen excess (eg, slightly increased linear growth rate that leads to a gradual rise in height percentile and modestly advanced bone age) or insulin resistance (eg, central adiposity or acanthosis nigricans). This term has been variously applied when the baseline DHEA-S or androstenedione level is over the level typical for adrenarche or elevated for age, or when baseline plasma androgens or the response to ACTH of 17-hydroxypregnenolone is above that of early pubertal girls. While the bone age advancement associated with exaggerated adrenarche may be associated with a slightly advanced onset of true puberty in some populations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/16\">",
"     16",
"    </a>",
"    ], this is not necessarily the case [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/17\">",
"     17",
"    </a>",
"    ]. Height potential does not seem to be compromised unless there is a congenital or hereditary reason for short stature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of premature adrenarche is unclear. The traditional hypothesis is that it is an extreme variant of normal development (ie, \"normal adrenarche occurring early\"). Some cases are familial; however, no convincing genetic basis has been established [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/5\">",
"     5",
"    </a>",
"    ]. The proposed mechanism is that the process is caused by premature development of the adrenal zona reticularis (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23302?source=see_link\">",
"     \"Normal adrenarche\"",
"    </a>",
"    ). If this hypothesis is correct, premature adrenarche would have no long-term consequences. However, a number of observations suggest that premature adrenarche may be a pathologic entity:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Associations of the syndrome with temporal lobe lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/11\">",
"       11",
"      </a>",
"      ] and poliomyelitic scoliosis [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/18\">",
"       18",
"      </a>",
"      ] have led to speculation that adrenal androgen-stimulating factor (or zona reticularis growth factor) is controlled by neural pathways.",
"     </li>",
"     <li>",
"      Premature adrenarche is associated with obesity and metabolic syndrome, as well as insulin resistance that may be independent of obesity [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3,4,7\">",
"       3,4,7",
"      </a>",
"      ]. This suggests that premature adrenarche may be a risk factor for cardiovascular disease.",
"     </li>",
"     <li>",
"      Some studies suggest that low birth weight, whether or not appropriate for gestational age, predisposes to premature adrenarche [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3,19,20\">",
"       3,19,20",
"      </a>",
"      ]. Consistent with the &ldquo;thrifty phenotype hypothesis&rdquo; (also known as &ldquo;metabolic programming&rdquo;), some of these studies suggest this relationship of low birth weight to premature adrenarche is mediated by subsequent obesity, particularly when associated with rapid early childhood weight gain. However, the association of premature adrenarche with low birth weight is not consistent across populations [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3,17,21,22\">",
"       3,17,21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link&amp;anchor=H14#H14\">",
"       \"Definition; epidemiology; and etiology of obesity in children and adolescents\", section on 'Metabolic programming'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Girls seem to be at moderately increased risk for developing polycystic ovary syndrome (PCOS) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3\">",
"       3",
"      </a>",
"      ]. The risk seems to be greatest in the subgroup with exaggerated adrenarche. These observations suggest that premature adrenarche may be an early manifestation of the steroidogenic dysregulation that will cause persistent functional hyperandrogenism of the adrenal glands and ovaries. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/9/34970?source=see_link\">",
"       \"Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link\">",
"       \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Heterozygosity for congenital adrenal hyperplasia may be a risk factor for premature adrenarche [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition to the clinical studies cited above, animal experiments support the hypothesis of in utero programming of adrenocortical function. Prenatal androgenization of female rhesus monkeys has been reported to induce functional adrenal hyperandrogenism along with other features of PCOS [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS OF PREMATURE PUBARCHE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature pubarche is usually due to premature adrenarche. However, several other causes of premature pubarche must be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2485518\">",
"    <span class=\"h2\">",
"     Hypertrichosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature pubarche must be distinguished from hypertrichosis. Fine hair appearing in the genital area is often a manifestation of a generalized excess of body hair (hypertrichosis), rather than the initial stage (Tanner stage 2) of sexual hair development. Hypertrichosis is the term for the generalized excessive growth of vellus body hair that is prominent in nonsexual areas [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/26\">",
"     26",
"    </a>",
"    ]. It is most commonly familial or caused by metabolic disorders (eg, thyroid disturbances, anorexia nervosa, porphyria) or medications (Dilantin,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/24/34176?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ). Pubic hair in a young child that is similar in characteristics and degree to forearm hair is typically due to hypertrichosis, not adrenarche. It is not caused by excess androgen, although hyperandrogenemia may aggravate it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Idiopathic premature pubarche",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic premature pubarche is a term applied to children who have premature pubarche but no evidence of adrenarche (",
"    <a class=\"graphic graphic_figure graphicRef79533 \" href=\"UTD.htm?18/5/18527\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/27\">",
"     27",
"    </a>",
"    ]. In other words, bone age, DHEA-S, and other plasma androgens are normal for age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23302?source=see_link&amp;anchor=H4#H4\">",
"     \"Normal adrenarche\", section on 'Clinical manifestations of adrenarche'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Idiopathic premature pubarche presumably reflects increased sensitivity of the pilosebaceous unit to normal adrenarchal androgen concentrations. This may be due to increased androgen receptor gene activity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/28\">",
"     28",
"    </a>",
"    ]. This is analogous to idiopathic hirsutism in adults, in which increased sexual hair growth occurs in the absence of hyperandrogenemia. Indeed, our personal experience suggests idiopathic premature pubarche may be a risk factor for idiopathic hirsutism in some individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24007?source=see_link\">",
"     \"Pathogenesis and causes of hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2485538\">",
"    <span class=\"h2\">",
"     Gonadotropin-dependent precocious puberty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gonadotropin-dependent precocious puberty (also known as &ldquo;central,&rdquo; &ldquo;complete,&rdquo; or &ldquo;true&rdquo; precocious puberty) is another condition characterized by the premature appearance of pubic hair. However, it is typically preceded by the cardinal antecedent signs of precocious puberty (ie, testicular enlargement in boys and breast development in girls). True precocious puberty is accompanied by premature adrenarche in about half of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=see_link\">",
"     \"Definition, etiology, and evaluation of precocious puberty\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Familial isolated luteinizing hormone (LH) excess was reported to cause mild virilization with isolated premature pubarche in a 1.5-year-old boy and his four-year-old sister [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2485576\">",
"    <span class=\"h2\">",
"     Virilizing disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature pubic hair development may be the initial manifestation of a virilizing disorder. Other than true sexual precocity in boys, virilizing disorders are gonadotropin-independent. They are unusual, accounting for less than 5 percent of premature pubarche, but their progressive nature requires vigilance.",
"    <br/>",
"   </p>",
"   <p>",
"    Frankly virilizing disorders, such as classic congenital adrenal hyperplasia, are suggested by the rapid progression of sexual hair development, acne that requires drug treatment, a growth spurt, increasing musculature, lowering of the voice, and, in girls, clitoromegaly (accompanied by genital ambiguity when the virilization commences in early fetal life, as in classic congenital adrenal hyperplasia). Serum testosterone",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    DHEA-S concentrations are well above the normal adrenarchal range. A serum testosterone level above that of normal females should be considered frankly virilizing in a young child. This degree of androgen excess causes the bone age to progressively advance disproportionately to linear growth. Affected children typically present with a significantly advanced bone age (&gt;2.0 SD for age and &gt;20 percent above height age) unless the disorder is of very recent onset.",
"   </p>",
"   <p>",
"    Mildly virilizing disorders, however, closely mimic premature or exaggerated adrenarche. The inordinate progression in pubarche, growth, and bone age becomes apparent only slowly. Nonclassic congenital adrenal hyperplasia accounts for the vast majority of such cases and so is a major consideration in the work-up of premature adrenarche. Serum testosterone",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    DHEA-S concentrations are at or slightly above the normal adrenarchal range. Thus, for children with characteristics of exaggerated adrenarche (ie, with significantly elevated bone age or baseline androgen levels above the usual adrenarchal range), an ACTH test is usually indicated. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Evaluation of premature pubarche'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Virilizing congenital adrenal hyperplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital adrenal hyperplasia (CAH) is a term historically applied to disorders that arise from various genetic defects in the adrenal enzymes involved in corticosteroid biosynthesis.",
"   </p>",
"   <p>",
"    Classic virilizing CAH in its most common and severe form presents in infancy (&ldquo;salt-wasting&rdquo; 21-hydroxylase deficiency). Girls typically have genital ambiguity, but in boys premature pubarche in early childhood may be the first clear sign (&ldquo;simple virilizing&rdquo; form). Inadequate therapy of either form also causes premature pubarche.",
"   </p>",
"   <p>",
"    Nonclassic CAH results from mutations that cause mild hyperandrogenism rather than frank virilization; girls lack the genital ambiguity of classic CAH. Nonclassic CAH may first present with premature pubarche in mid-childhood. It can be caused by a variety of disorders of adrenal steroid synthesis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Deficiency of 21-hydroxylase (CYP21A2). This is the most common cause of nonclassic CAH. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=see_link\">",
"       \"Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Deficiency of 11&beta;-hydroxylase (CYP11B1). This disorder classically presents with hypertension and virilization (including genital ambiguity in girls), but occasionally presents from mid-childhood onward in its nonclassic form with mild hyperandrogenism; hypertension and hypokalemia are not necessarily present [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=see_link\">",
"       \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Deficiency of 3&beta;-hydroxysteroid dehydrogenase (HSD3B2). This disorder classically presents in infancy with genital ambiguity (in both sexes) and symptoms of cortisol and aldosterone deficiency, but occasionally presents later in its nonclassic form with mild symptoms including premature pubarche. The diagnosis of this disorder presents a diagnostic quandary because of its characteristic elevation of DHEA-S, which makes it difficult to distinguish from premature adrenarche. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=see_link&amp;anchor=H12#H12\">",
"       \"Uncommon causes of congenital adrenal hyperplasia\", section on '3-Beta-hydroxysteroid dehydrogenase deficiency'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H17\">",
"       'Evaluation of premature pubarche'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8595812\">",
"    <span class=\"h3\">",
"     Related congenital ACTH-dependent forms of adrenal hyperandrogenism",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Glucocorticoid resistance results from defects in glucocorticoid receptor signaling. It is a rare congenital form of ACTH-dependent adrenal hyperandrogenism that is caused by inadequate negative feedback by cortisol, with consequent excessive ACTH release [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/33\">",
"       33",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12408?source=see_link&amp;anchor=H12#H12\">",
"       \"Unusual causes of adrenal insufficiency\", section on 'Familial glucocorticoid resistance'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cortisone reductase deficiency results from a defect in the peripheral metabolism of cortisol. Increased ACTH production is necessary to compensate for the excessively rapid cortisol turnover caused by failure to regenerate cortisol from cortisone in peripheral tissues. This rare disorder is caused either by deficiency of 11&beta;-hydroxysteroid dehydrogenase type 1 (HSD11B1), which is functionally the major cortisone reductase [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/34\">",
"       34",
"      </a>",
"      ], or more commonly by deficiency of hexose-6-phosphate dehydrogenase (H6PDH), which is a cofactor for cortisone reductase (this form is known as &ldquo;apparent&rdquo; cortisone reductase deficiency) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=see_link&amp;anchor=H27#H27\">",
"       \"Uncommon causes of congenital adrenal hyperplasia\", section on 'Hexose-6-phosphate-dehydrogenase deficiency (apparent cortisone reductase deficiency)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Apparent DHEA sulfotransferase deficiency is due to a genetic defect in DHEA sulfation [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/36\">",
"       36",
"      </a>",
"      ]. Corticosteroid secretion is not affected. A mutation in the gene encoding the sulfate donor to SULT2A1 (3&rsquo;- phosphoadenosine-5'-phosphosulfate synthase 2, PAPSS2) caused pubarche and other clinical manifestations of androgen excess, as well as very low (undetectable) DHEA-S levels. These observations indicate the crucial role of DHEA sulfation as a gatekeeper to human androgen synthesis and demonstrate that the role of DHEA sulfation in adrenal function is to prevent unconjugated DHEA from becoming available for conversion to active androgens.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Cushing's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diverse forms of Cushing&rsquo;s syndrome due to adrenal hyperplasia are on rare occasions associated with childhood virilization. Some cases are due to hereditary forms of adrenocortical hyperplasia, and some are due to late-onset ACTH-dependent disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=see_link\">",
"     \"Adrenal hyperandrogenism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282918\">",
"    <span class=\"h3\">",
"     Virilizing tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adrenal or ovarian tumors are rare causes of virilization. The abnormal differentiation that underlies tumor formation typically leads to abnormal patterns of steroid secretion. A disproportionately elevated DHEA-S level is found in about half of virilizing adrenal tumors. Virilizing adrenal neoplasia are sometimes accompanied by cushingoid changes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=see_link\">",
"     \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=see_link\">",
"     \"Clinical presentation and evaluation of adrenocortical tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Exogenous androgen exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature pubarche can result from passive transfer of androgens in topical preparations used by caretakers [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/37\">",
"     37",
"    </a>",
"    ]. This is increasingly common, as topical androgens are used for replacement or enhancement of sexual function by adults of both sexes. Anabolic steroids, such as those used for therapeutic purposes like growth promotion, are well-known to have weak androgenic effects capable of causing premature pubarche and clitoromegaly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1545?source=see_link\">",
"     \"Testosterone treatment of male hypogonadism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EVALUATION OF PREMATURE PUBARCHE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of premature pubarche begins with a history, physical examination, and determination of bone age. Depending upon the results of this initial evaluation, other tests may be indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     History and physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial examination is directed toward determining whether the premature pubarche is an isolated phenomenon or part of one of the disorders described above. An accurate measurement of height, examination of breast and genital development, including inspection of the external genitalia in girls and palpation of the testes in boys, and recording of the stage and amount of sexual hair development are essential baseline data.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bone age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimation of bone age is the single most important diagnostic test. It is important that it be determined by a physician trained and experienced in its interpretation, such as a pediatric radiologist or pediatric endocrinologist. If the bone age is normal (ie, within 2 SD of average) in a child with a minimal amount of sexual hair and a history of slow hair growth, predicted adult height is ordinarily normal, and a serious cause for precocious pubarche is unlikely. A common confounder is a bone age that is significantly advanced for chronological age but not for height age, producing a predicted adult height that is normal for the family. This is most often observed when there is coexistent obesity, a pattern of early puberty in the family, or exaggerated adrenarche. In all cases, it is important to reexamine the patient and repeat the bone age in six months to rule out a virilizing disorder of recent onset. If the height prediction is stable, bone age can be reassessed at longer intervals thereafter to rule out an early virilizing disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Hormonal measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the bone age is abnormally advanced (yielding an unexpectedly low predicted adult height), we ordinarily undertake a modest further work-up by measuring only serum DHEA-S and total testosterone. Girls and boys with premature adrenarche typically have DHEA-S levels of 40 to 130",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    and a testosterone level that is no greater than the upper normal for an early pubertal girl, as described above (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Definitions'",
"    </a>",
"    above). We make a presumptive diagnosis of premature adrenarche if the serum DHEA-S and testosterone concentrations are within these ranges (",
"    <a class=\"graphic graphic_figure graphicRef79533 \" href=\"UTD.htm?18/5/18527\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"     table 2",
"    </a>",
"    ), and if predicted adult height is within the target range for the family.",
"   </p>",
"   <p>",
"    If the serum testosterone and DHEA-S concentrations are in excess of those typical of ordinary premature adrenarche, if there are any atypical features on the initial evaluation, or if these measures worsen upon follow-up, congenital adrenal hyperplasia (CAH) and other virilizing disorders should be excluded.",
"   </p>",
"   <p>",
"    The modern multi-channel platform assays available in many community hospitals are unreliable for assays of testosterone at the relatively low levels that are normal for young children. These tests should only be ordered if they will be measured in a specialty laboratory by accurate methodology, such as by liquid chromatography-tandem mass spectrometry, preferably in consultation with a pediatric endocrinologist [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/38\">",
"     38",
"    </a>",
"    ]. On the other hand, platform assays are generally reliable for DHEA-S assays.",
"   </p>",
"   <p>",
"    An early morning baseline 17-hydroxyprogesterone (17OHP) is a good screening test for nonclassic congenital adrenal hyperplasia, and should be performed in children with premature pubarche in whom CAH or other virilizing disorder is suspected because of their clinical picture (eg, serum testosterone and DHEA-S concentrations are in excess of those typical of ordinary premature adrenarche, advanced bone age) or ethnicity (eg, Ashkenazi Jews are at high risk for nonclassic 21-hydroxylase deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/39\">",
"     39",
"    </a>",
"    ]). In children, a 17OHP level of &gt;200",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (6",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    taken at 8:00 AM has 99 percent sensitivity and specificity for the diagnosis of nonclassic 21-hydroxylase deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/40-43\">",
"     40-43",
"    </a>",
"    ]. The early morning timing is critical because the 17OHP level falls rapidly during the course of the day. A 17OHP level of &gt;1500",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (45",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    is diagnostic. An",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/45/29397?source=see_link\">",
"     ACTH stimulation test",
"    </a>",
"    is recommended to confirm the diagnosis of CAH if the 17OHP level is intermediate (eg, between 200 and 1500",
"    <span class=\"nowrap\">",
"     ng/dL)",
"    </span>",
"    or if the clinical picture suggests virilization in spite of a normal 17OHP level.",
"   </p>",
"   <p>",
"    The baseline pattern of plasma steroid intermediates can be a helpful adjunct in the differential diagnosis of virilizing disorders. The ratio of 17-hydroxypregnolone to 17OHP levels is necessary to distinguish between 21-hydroxylase and 3&szlig;-HSD2 deficiency in children with premature pubarche when an elevated baseline DHEA-S level is associated with an elevated 17OHP level [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/44\">",
"     44",
"    </a>",
"    ]. DHEA-S levels &gt;700",
"    <span class=\"nowrap\">",
"     &micro;g/dL",
"    </span>",
"    are characteristic of 3&szlig;-HSD2 deficiency and are found in about half of adrenal virilizing tumors. Virilizing tumors typically form androgens inefficiently, so considerable elevations of 17OHP and androstenedione are typical [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     ACTH stimulation test",
"    </span>",
"    &nbsp;&mdash;&nbsp;An",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/45/29397?source=see_link\">",
"     ACTH stimulation test",
"    </a>",
"    is the definitive test to diagnose or exclude congenital adrenal hyperplasia. As noted above, we generally perform this test in children with premature pubarche in whom initial testing reveals an early morning 17OHP concentration between 200 and 1500",
"    <span class=\"nowrap\">",
"     ng/dL.",
"    </span>",
"    Individuals with serum 17-hydroxyprogesterone (17OHP) concentrations above 1500",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    do not require a confirmatory ACTH stimulation test.",
"   </p>",
"   <p>",
"    The ACTH test is performed using synthetic ACTH 1-24 (cosyntropin) infused over one minute intravenously. The standard test dose is 250 mcg (150 mcg per square meter). Blood is sampled before and 30 to 60 minutes after the administration of ACTH (",
"    <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most cost-effective steroid to measure is the serum 17-hydroxyprogesterone, because CAH due to 21-hydroxylase deficiency is by far the most common virilizing disorder of childhood. Normal values are shown in the table (",
"      <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"       table 2",
"      </a>",
"      ). After cosyntropin stimulation, a serum 17OHP peak response of more than 1000",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (30",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      is suggestive of 21-hydroxylase deficiency; a peak level of more than 1500",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (45",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      is definitive [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/40,42\">",
"       40,42",
"      </a>",
"      ]. Intermediate values are found in either a carrier state, 3&szlig;-hydroxysteroid dehydrogenase deficiency, 11&szlig;-hydroxylase deficiency, or the dysregulational form of functional adrenal hyperandrogenism [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/13,32\">",
"       13,32",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H2485576\">",
"       'Virilizing disorders'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=see_link\">",
"       \"Clinical features and diagnosis of polycystic ovary syndrome in adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Serum 17-hydroxypregnenolone and DHEA responses to ACTH should be tested in children with the clinical picture of exaggerated adrenarche or unusual elevation of DHEA-S. Elevated responses that are discovered in evaluating an elevated DHEA-S level present the most diagnostic confusion. Some researchers initially labeled the bulk of these cases as having nonclassic 3&szlig;-hydroxysteroid dehydrogenase deficiency, but it has become clear that this diagnosis is not tenable unless the post-ACTH serum 17-hydroxypregnenolone concentration is 5 SD or more above normal for pubic hair Tanner stage [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/44\">",
"       44",
"      </a>",
"      ]. In post-menarcheal girls, intermediate degrees of hyperresponsiveness suggest the PCOS-type of functional adrenal hyperandrogenism [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=see_link\">",
"       \"Adrenal hyperandrogenism\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Dexamethasone androgen-suppression test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the specific approach differs among endocrinologists, we favor the",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    androgen-suppression test (DAST) as the next diagnostic step if a virilizing disorder is suspected and the ACTH test rules out congenital adrenal hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/41\">",
"     41",
"    </a>",
"    ]. If a DAST and the preceding studies are normal, there is no endocrinologic basis to further consider the possibility of tumor.",
"   </p>",
"   <p>",
"    The DAST is performed by administering",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in a dose of 1.0",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    in three to four divided doses daily for four days and then measuring the serum cortisol, DHEA-S, and androgens on the morning of the fifth day after a final dexamethasone dose. In premature adrenarche, serum DHEA-S should fall by more than 75 percent, serum cortisol fall to under 1.0",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (28",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    and serum androgens fall to prepubertal concentrations. In patients with virilizing tumors, one or more androgen levels remains above these benchmarks in the presence of normal cortisol suppression. In endogenous Cushing's syndrome, none suppress normally.",
"   </p>",
"   <p>",
"    Four days of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    administration seems necessary to suppress the hyperandrogenism of congenital adrenal hyperplasia sufficiently for diagnostic purposes. This is in part related to blood levels of DHEA-S having a very long half-life (approximately two days [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]), and is in part probably related to persistent function of the hyperplastic adrenocortical cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2486738\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography is the initial radiographic study of choice to screen for the location of a pelvic, scrotal, or adrenal neoplasm [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. However, the ability of ultrasonography to detect small adrenal neoplasms is highly dependent on the expertise of the ultrasonographer. On rare occasions, ultrasonography has been insensitive in detecting an ovarian tumor in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/50\">",
"     50",
"    </a>",
"    ]. Computed tomography and magnetic resonance imaging permit better visualization and more detailed assessment of tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF PREMATURE ADRENARCHE",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the evaluation above leads to the diagnosis of premature adrenarche, no specific endocrine treatment is required, since this is a benign condition in children. Patients and their parents should be informed that the condition is ordinarily an extreme variation of normal due to inordinate sensitivity of the hair follicles to normal trace amounts of male hormone in children,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a normal incomplete form of puberty that is occurring early and is only occasionally followed by other pubertal abnormalities.",
"   </p>",
"   <p>",
"    Deodorants can be used, and pubic hairs may be shaved or clipped. Counseling about a diet and exercise program is indicated for obesity and metabolic syndrome, if present. In addition, the parents should be evaluated for type 2 diabetes if there is a family history of this disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=see_link\">",
"     \"Classification of diabetes mellitus and genetic diabetic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because the initial diagnosis may have been incorrect, these patients should be re-evaluated 6 to 12 months later for evidence of virilization.",
"   </p>",
"   <p>",
"    Girls with premature pubarche appear to carry about a 15 to 20 percent risk of developing PCOS. It seems likely that the risk is higher in those with exaggerated adrenarche, and relatively low in those with ordinary premature adrenarche (DHEA-S 40 to 130",
"    <span class=\"nowrap\">",
"     mcg/dL)",
"    </span>",
"    or in idiopathic premature pubarche (DHEA-S &lt;40",
"    <span class=\"nowrap\">",
"     mcg/dL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21481/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Premature adrenarche may occasionally be a harbinger of type 2 diabetes or metabolic syndrome in adulthood; this is particularly the case in girls who are coincidentally obese. Patients with premature adrenarche should be followed regularly after true puberty occurs. The parents should be told of these possibilities, but that there is no way of predicting if they will occur. They should also be told that these disorders are treatable, should they occur, and may be preventable or delayed by maintaining physical fitness and a healthy body weight.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/58/31650?source=see_link\">",
"       \"Patient information: Early puberty (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Premature pubarche is the isolated appearance of sexual hair before the age of eight years in girls and nine years in boys. It is more common in girls. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Premature pubarche'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Premature adrenarche is the most common cause of premature pubarche. It is the term applied to otherwise unexplained, slowly progressive, premature pubarche that is associated with a serum steroid pattern indicative of adrenarche, including a DHEA-S level over 40",
"      <span class=\"nowrap\">",
"       mcg/dL.",
"      </span>",
"      Typically, the DHEA-S and testosterone levels are no greater than normal for early female puberty (",
"      <a class=\"graphic graphic_table graphicRef75217 \" href=\"UTD.htm?42/59/43965\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Premature adrenarche'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other more serious causes of premature pubarche include complete precocious puberty and virilizing disorders, including nonclassic congenital adrenal hyperplasia, exogenous exposure to androgens, and rarely, virilizing tumors. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Differential diagnosis of premature pubarche'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children presenting with premature pubarche should be carefully examined for breast and genital development, the height and amount of pubic hair recorded for future comparison, and the bone age measured. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Evaluation of premature pubarche'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with an unusual amount of sexual hair, evidence of true pubertal development (breast development in girls, testicular enlargement in boys), or significantly advanced bone age should undergo further evaluation. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Hormonal measurements'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'ACTH stimulation test'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Dexamethasone androgen-suppression test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Premature adrenarche is generally benign but seems to be associated with moderately increased risks for polycystic ovary syndrome, insulin resistance, and metabolic syndrome in adulthood. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Precautions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24530496\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate would like to acknowledge Dr. Kenan Qin, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/1\">",
"      Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics 2009; 123:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/2\">",
"      Bordini B, Rosenfield RL. Normal pubertal development: part II: clinical aspects of puberty. Pediatr Rev 2011; 32:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/3\">",
"      Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/4\">",
"      Charkaluk ML, Trivin C, Brauner R. Premature pubarche as an indicator of how body weight influences the onset of adrenarche. Eur J Pediatr 2004; 163:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/5\">",
"      Williams RM, Ward CE, Hughes IA. Premature adrenarche. Arch Dis Child 2012; 97:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/6\">",
"      Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics 1997; 99:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/7\">",
"      Utriainen P, J&auml;&auml;skel&auml;inen J, Romppanen J, Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab 2007; 92:4282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/8\">",
"      Denburg MR, Silfen ME, Manibo AM, et al. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J Clin Endocrinol Metab 2002; 87:5604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/9\">",
"      Kaplowitz P, Soldin SJ. Steroid profiles in serum by liquid chromatography-tandem mass spectrometry in infants with genital hair. J Pediatr Endocrinol Metab 2007; 20:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/10\">",
"      Rich BH, Rosenfield RL, Lucky AW, et al. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab 1981; 52:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/11\">",
"      Rosenfield RL, Rich BH, Lucky AW. Adrenarche as a cause of benign pseudopuberty in boys. J Pediatr 1982; 101:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/12\">",
"      Idkowiak J, Lavery GG, Dhir V, et al. Premature adrenarche: novel lessons from early onset androgen excess. Eur J Endocrinol 2011; 165:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/13\">",
"      Rosenfield RL. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/14\">",
"      Utriainen P, Voutilainen R, J&auml;&auml;skel&auml;inen J. Continuum of phenotypes and sympathoadrenal function in premature adrenarche. Eur J Endocrinol 2009; 160:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/15\">",
"      Sopher AB, Thornton JC, Silfen ME, et al. Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls. J Clin Endocrinol Metab 2001; 86:5269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/16\">",
"      Ib&aacute;&ntilde;ez L, Jim&eacute;nez R, de Zegher F. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics 2006; 117:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/17\">",
"      Oron T, Lebenthal Y, de Vries L, et al. Interrelationship of extent of precocious adrenarche in appropriate for gestational age girls with clinical outcome. J Pediatr 2012; 160:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/18\">",
"      Rappaport R, Forest MG, Bayard F, et al. Plasma androgens and LH in scoliotic patients with premature pubarche. J Clin Endocrinol Metab 1974; 38:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/19\">",
"      Neville KA, Walker JL. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Arch Dis Child 2005; 90:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/20\">",
"      Ong KK, Potau N, Petry CJ, et al. Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004; 89:2647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/21\">",
"      Paterson WF, Ahmed SF, Bath L, et al. Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistry. Clin Endocrinol (Oxf) 2010; 72:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/22\">",
"      Ib&aacute;&ntilde;ez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998; 83:3558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/23\">",
"      Nayak S, Lee PA, Witchel SF. Variants of the type II 3beta-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. Mol Genet Metab 1998; 64:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/24\">",
"      Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med 1997; 62:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/25\">",
"      Zhou R, Bird IM, Dumesic DA, Abbott DH. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90:6630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/26\">",
"      Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/27\">",
"      Rosenfield RL. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited. Horm Res 1994; 41 Suppl 2:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/28\">",
"      Vottero A, Capelletti M, Giuliodori S, et al. Decreased androgen receptor gene methylation in premature pubarche: a novel pathogenetic mechanism? J Clin Endocrinol Metab 2006; 91:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/29\">",
"      Bordini B, Littlejohn E, Rosenfield RL. LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity. Int J Pediatr Endocrinol 2010; 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/30\">",
"      Rosenfeld RG, Reitz RE, King AB, Hintz RL. Familial precocious puberty associated with isolated elevation of luteinizing hormone. N Engl J Med 1980; 303:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/31\">",
"      Joehrer K, Geley S, Strasser-Wozak EM, et al. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Hum Mol Genet 1997; 6:1829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/32\">",
"      Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, et al. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/33\">",
"      Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 2008; 93:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/34\">",
"      Lawson AJ, Walker EA, Lavery GG, et al. Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1. Proc Natl Acad Sci U S A 2011; 108:4111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/35\">",
"      Lavery GG, Walker EA, Tiganescu A, et al. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. J Clin Endocrinol Metab 2008; 93:3827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/36\">",
"      Noordam C, Dhir V, McNelis JC, et al. Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 2009; 360:2310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/37\">",
"      Kunz GJ, Klein KO, Clemons RD, et al. Virilization of young children after topical androgen use by their parents. Pediatrics 2004; 114:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/38\">",
"      Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/39\">",
"      Speiser PW, Dupont B, Rubinstein P, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/40\">",
"      Armengaud JB, Charkaluk ML, Trivin C, et al. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab 2009; 94:2835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/41\">",
"      Rosenfield RL, Lucky AW. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess. Endocrinol Metab Clin North Am 1993; 22:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/42\">",
"      Bidet M, Bellann&eacute;-Chantelot C, Galand-Portier MB, et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009; 94:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/43\">",
"      Escobar-Morreale HF, Sanch&oacute;n R, San Mill&aacute;n JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008; 93:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/44\">",
"      Lutfallah C, Wang W, Mason JI, et al. Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 2002; 87:2611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/45\">",
"      Rosenfield RL, Cohen RM, Talerman A. Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. J Reprod Med 1987; 32:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/46\">",
"      Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974; 39:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/47\">",
"      Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L. 24-Hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 1975; 40:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/48\">",
"      Balassy C, Navarro OM, Daneman A. Adrenal masses in children. Radiol Clin North Am 2011; 49:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/49\">",
"      Shah RU, Lawrence C, Fickenscher KA, et al. Imaging of pediatric pelvic neoplasms. Radiol Clin North Am 2011; 49:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21481/abstract/50\">",
"      Pascale MM, Pugeat M, Roberts M, et al. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours. Clin Endocrinol (Oxf) 1994; 41:571.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5806 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-7E15F350EB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21481=[""].join("\n");
var outline_f20_62_21481=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Premature puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pubarche",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Premature pubarche",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Premature adrenarche",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Exaggerated adrenarche",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS OF PREMATURE PUBARCHE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2485518\">",
"      Hypertrichosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Idiopathic premature pubarche",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2485538\">",
"      Gonadotropin-dependent precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2485576\">",
"      Virilizing disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Virilizing congenital adrenal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8595812\">",
"      - Related congenital ACTH-dependent forms of adrenal hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282918\">",
"      - Virilizing tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Exogenous androgen exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EVALUATION OF PREMATURE PUBARCHE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      History and physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bone age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Hormonal measurements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ACTH stimulation test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Dexamethasone androgen-suppression test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2486738\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      MANAGEMENT OF PREMATURE ADRENARCHE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24530496\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5806\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5806|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/5/18527\" title=\"figure 1\">",
"      DHEAS pubic hair develop",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/10/8355\" title=\"figure 2\">",
"      Steroidogenesis by zone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/34/38447\" title=\"figure 3\">",
"      Hormonal changes during adrenarche",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5806|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/1/8220\" title=\"table 1\">",
"      Sexual maturity rating of secondary sexual characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/59/43965\" title=\"table 2\">",
"      Androgen range child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40071?source=related_link\">",
"      Adrenal hyperandrogenism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14874?source=related_link\">",
"      Classification of diabetes mellitus and genetic diabetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/13/39130?source=related_link\">",
"      Clinical features and diagnosis of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/33/12826?source=related_link\">",
"      Clinical presentation and evaluation of adrenocortical tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15878?source=related_link\">",
"      Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19546?source=related_link\">",
"      Definition, etiology, and evaluation of precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/9/34970?source=related_link\">",
"      Definition, pathogenesis, and etiology of polycystic ovary syndrome in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19560?source=related_link\">",
"      Genetics and clinical presentation of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/48/23302?source=related_link\">",
"      Normal adrenarche",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/25/1434?source=related_link\">",
"      Normal puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24007?source=related_link\">",
"      Pathogenesis and causes of hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/58/31650?source=related_link\">",
"      Patient information: Early puberty (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8778?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/32/1545?source=related_link\">",
"      Testosterone treatment of male hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35641?source=related_link\">",
"      Uncommon causes of congenital adrenal hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12408?source=related_link\">",
"      Unusual causes of adrenal insufficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_62_21482="Overview of the clinical utility of ultrasonography in thyroid disease";
var content_f20_62_21482=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of the clinical utility of ultrasonography in thyroid disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21482/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21482/contributors\">",
"     Manfred Blum, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21482/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21482/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/62/21482/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/62/21482/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/62/21482/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Current methods of ultrasonography permit \"real-time\" identification of structures as small as 2 mm in diameter, thereby allowing the visualization of very small tumors of the thyroid and parathyroid glands. These methods also permit estimates of overall and regional blood flow to the thyroid. However, the results of thyroid ultrasonography do not correlate well with histopathologic findings.",
"   </p>",
"   <p>",
"    Although the cost-effectiveness of ultrasonography in solving patient-specific clinical problems has not been formally tested, ultrasonography, used judiciously, helps to answer important clinical questions in specific patients. At present, ultrasonography is considered useful in the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To evaluate the anatomic features of thyroid nodules",
"     </li>",
"     <li>",
"      To assist in fine needle aspiration of thyroid nodules and cervical lymph nodes",
"     </li>",
"     <li>",
"      To monitor nodular thyroid disease",
"     </li>",
"     <li>",
"      To assist in the planning of thyroid cancer surgery",
"     </li>",
"     <li>",
"      To assist in the surveillance for recurrence in patients with thyroid cancer",
"     </li>",
"     <li>",
"      To assess for fetal goiter",
"     </li>",
"     <li>",
"      To screen for the presence of thyroid nodules in high risk groups (eg, history of childhood radiation exposure)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic review will discuss the clinical utility of thyroid ultrasonography. The technical aspects of thyroid ultrasound and the use of ultrasonography to aid in thyroid biopsy are considered elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2437?source=see_link\">",
"     \"Technical aspects of thyroid ultrasound\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31814?source=see_link\">",
"     \"Ultrasound-guided thyroid biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26549334\">",
"    <span class=\"h1\">",
"     THYROID NODULES",
"    </span>",
"    &nbsp;&mdash;&nbsp;High-resolution ultrasonography provides a detailed map of thyroid nodules and helps to characterize the nodules and adjacent structures in the neck. Thyroid ultrasound, in conjunction with fine needle aspiration (FNA) biopsy, plays an important role in the evaluation of a patient with a suspected thyroid nodule. It should be performed in all patients with a suspected thyroid nodule or nodular goiter on physical examination or with nodules incidentally noted on other imaging studies (carotid ultrasound, CT, MRI, or FDG-PET scan). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H2#H2\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Nodule identification and characterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solid nodules should be described by using normal thyroid tissue as a reference. They are called isoechoic if their texture closely resembles that of normal thyroid tissue, hyperechoic if more echogenic, and hypoechoic if less echogenic (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81788 \" href=\"UTD.htm?31/4/31809\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71418 \" href=\"UTD.htm?5/3/5170\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51480 \" href=\"UTD.htm?36/24/37263\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Hemorrhage within nodules alters the sonographic appearance. Clot may be hyperechoic and after liquefaction may be hypoechoic so that part of the nodule looks cystic; this is called a complex nodule (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55508 \" href=\"UTD.htm?42/51/43839\">",
"     image 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The presence of fluid in a nodule causes a relative increase in the transmission of the sound waves, resulting in increased echogenicity distal to the liquid, due to reflection of the waves from the posterior interface between the cystic and solid component. It may be difficult to distinguish between a hypoechoic solid nodule and a cystic nodule that contains debris.",
"   </p>",
"   <p>",
"    A cyst is ultrasonically characterized as thin-walled and spherical, without internal structure. It transmits ultrasound with little reflection and results in an increased echo pattern behind the structure. It is prudent to be conservative in the use of the word \"cyst.&rdquo; Pure cysts are rare and benign, but cystic degeneration of solid, benign or malignant nodules is common.",
"   </p>",
"   <p>",
"    Calcifications are brightly reflective echogenic densities that greatly attenuate the ultrasound beam. This blockade of the signal causes the phenomenon of \"shadowing,\" which renders the tissue deep to the calcification invisible (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81952 \" href=\"UTD.htm?32/60/33743\">",
"     image 5",
"    </a>",
"    ). By altering the acoustic pathway, the ultrasonographer can avoid this pitfall. Air and metallic artifacts also cause shadowing and can mimic calcifications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Criteria for identifying cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no ultrasonographic findings that are pathognomonic for thyroid cancer. Ultrasonic evidence of vascular invasion may be the most reliable predictor of malignancy but is observed uncommonly. The characteristics of nodules that have been evaluated for identifying cancers include the intensity of the echoes, the sharpness of the boundary of the nodule, the presence of a sonolucent \"halo,\" calcifications, internal structure, including vascularity and the shape (deeper or taller than wide in the transverse view) (",
"    <a class=\"graphic graphic_table graphicRef68199 \" href=\"UTD.htm?20/17/20763\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The predictive value of these characteristics varies widely. In a retrospective evaluation of 849 nodules that were diagnosed at surgery or biopsy in 831 patients, the presence of at least one malignant feature had a sensitivity and specificity of 83 and 74 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/3\">",
"     3",
"    </a>",
"    ]. The presence of multiple suspicious ultrasound features increases the likelihood for malignancy. In another series of 1244 nodules in 900 patients, nodules were stratified according to ultrasound characteristics that assessed cancer risk on a scale of 1 to 5, with nodules classified as 3.5 or greater evaluated as malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/4\">",
"     4",
"    </a>",
"    ]. Of 233 nodules that were ultrasonographically evaluated as malignant, 76.8 percent were also malignant by cytology (FNA). Of the 142 nodules that were categorized as malignant on ultrasound and were surgically resected, 138 were confirmed by pathology to be thyroid cancer (97 percent positive predictive value for diagnosed cancer). Of 710 nodules evaluated as benign (ultrasound score &le;2.5), 96.1 percent had benign cytology. Thus, although ultrasound cannot be used to definitively diagnose thyroid cancer or select patients for thyroid surgery, ultrasound findings can be used to select nodules for fine needle aspiration (FNA) biopsy, for example, in a patient with multiple nodules. Indications for FNA are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Intensity of the echoes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant thyroid nodules often have a hypoechoic appearance on ultrasound (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51480 \" href=\"UTD.htm?36/24/37263\">",
"     image 3",
"    </a>",
"    ). In a study of 202 patients with nodules, 62 percent of the cancers were hypoechoic, and few were hyperechoic [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/5\">",
"     5",
"    </a>",
"    ]. In another series of 132 consecutive ultrasound-guided fine needle aspiration biopsies, none of the 14 cancers were hyperechoic [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/6\">",
"     6",
"    </a>",
"    ]. However, many benign nodules are also less echogenic than surrounding normal thyroid tissue. The sensitivity and specificity of a hypoechoic appearance is approximately 53 and 73 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Sharpness of border",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sharpness of the border of a nodule probably has little diagnostic value, although cancers that have invaded surrounding tissue may have a poorly defined, irregular border. Furthermore, an ill-defined edge of a nodule may be a marker of aggressive characteristics of papillary thyroid cancer. In one series of 155 cases, poor definition of a nodule's edge was observed in 21.5 percent of patients, all of whom showed worse disease-free survival than those with a well-defined edge [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/7\">",
"     7",
"    </a>",
"    ]. Extrathyroidal invasion of a papillary cancer can be predicted preoperatively (with 75 percent accuracy) when 50 percent or more of the tumor abuts the thyroid capsule [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Halo",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some nodules are partly or completely surrounded by a sonolucent ring or halo. A halo only indicates that there is an interface between the thyroid tissue and the nodule that is less echogenic than either the nodule or the gland. The partition could be capsule or compressed or atrophic thyroid tissue, local inflammation, or edema. When seen with color flow Doppler imaging, the halo is often vascular and may represent capsular vessels (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54263 \" href=\"UTD.htm?0/62/992\">",
"     image 6",
"    </a>",
"    ). An incomplete or absent halo has been reported as a feature of malignancy but has neither high sensitivity nor specificity (64 and 61 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Calcifications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcifications are often present in both benign and malignant nodules and are therefore only partially predictive of histopathology. In one report, the prevalence of cancer was significantly higher when there were calcium flecks in a nodule (29 percent) than in nodules without calcium (14 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/9\">",
"     9",
"    </a>",
"    ]. Furthermore, some information about a nodule (or lymph node) can be inferred from the nature of the calcification:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Punctate calcifications in the range of 1 mm are uncommonly seen and suggest the presence of microscopic psammoma bodies in papillary carcinomas (",
"      <a class=\"graphic graphic_picture graphicRef60315 \" href=\"UTD.htm?10/0/10242\">",
"       picture 1",
"      </a>",
"      ). \"Twinkling\" on B-flow imaging may be a very sensitive way to detect microcalcifications [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Using 10 to 13 MHz transducers, apparent microcalcifications may be detected within nodules. These bright spots have been reported to correlate with thyroid cancer in one-third of the cases. At histologic examination, only some of the bright spots prove to be calcified psammoma bodies. The rest may represent inspissated colloid, as mentioned below. Rarely, microcalcifications in the absence of a mass have been associated with papillary thyroid cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Peripheral or eggshell-like calcification is indicative of chronicity, suggesting a benign nodule. However, some cancers, probably those that are chronic and have undergone degenerative change, may demonstrate peripheral calcification and therefore diagnostic aspiration biopsy may be appropriate [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Coarse, scattered calcifications may be seen in benign or malignant nodules into which there was a hemorrhage (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55508 \" href=\"UTD.htm?42/51/43839\">",
"       image 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Large areas of calcification may be seen in medullary cancers of the thyroid.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Internal structure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The uniformity of the internal structure of a nodule is not a useful indicator for diagnosis of cancer; cancers may be either ultrasonographically solid or complex. The complex patterns in both benign nodules and cancers may result from cystic or hemorrhagic degeneration. Similarly, cystic degeneration may be seen in cancerous or benign regional lymph nodes.",
"   </p>",
"   <p>",
"    There are some ultrasound findings that are useful predictors of benign nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/14\">",
"     14",
"    </a>",
"    ]. The most common is a layered appearance of the echo pattern described as spongiform or honeycomb, which has been defined as an aggregation of microcystic spaces involving at least 50 percent of the nodule (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61030 \" href=\"UTD.htm?0/4/76\">",
"     image 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/3\">",
"     3",
"    </a>",
"    ]. This finding has been observed with colloid nodules that are almost invariably benign. A bright spot with a fading plume tail, like a comet, has also been described with small deposits of colloid (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68699 \" href=\"UTD.htm?42/62/44000\">",
"     image 8",
"    </a>",
"    ) and must be differentiated from &ldquo;psammoma body&rdquo; microcalcifications described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Shape of a nodule",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been reported that cancers more frequently than benign nodules have a tall and narrow shape that may provide a diagnostic clue. In one study, an anteroposterior and transverse diameter ratio",
"    <span class=\"nowrap\">",
"     (A/T)",
"    </span>",
"    greater than 1 was more likely than central blood flow, microcalcifications, or irregular borders to identify cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/15\">",
"     15",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     A/T",
"    </span>",
"    in combination with any other suspicious ultrasonographic characteristic missed fewer cancers than hypoechogenicity combined with any other suspicious characteristic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Color Doppler flow patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;An internal flow pattern in a hypofunctioning (\"cold\") nodule or lymph node should raise one's suspicion of malignancy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82381 \" href=\"UTD.htm?8/27/8627\">",
"     image 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53482 \" href=\"UTD.htm?20/30/20975\">",
"     image 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. However, at its present stage of development, color Doppler flow cannot reliably distinguish benign from malignant pathology. In one study of consecutive patients with nonpalpable thyroid nodules (8 to 15 mm), 31 of 402 thyroid nodules were thyroid malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/16\">",
"     16",
"    </a>",
"    ]. At ultrasound, an intranodular vascular pattern was present in 74 percent of malignant nodules. In another study of 203 patients with thyroid nodules who were treated surgically, the addition of color flow Doppler imaging to conventional sonography slightly increased the screening sensitivity and accuracy (from 72 to 83 percent) in identifying the 36 malignant thyroid nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Nonpalpable nodules (\"incidentalomas\")",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incidentalomas are nonpalpable thyroid nodules that are detected during other imaging procedures. Nonpalpable nodules have approximately the same risk of malignancy as palpable nodules (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61668 \" href=\"UTD.htm?21/44/22209\">",
"     image 11",
"    </a>",
"    ). Thus, all incidentalomas cannot be dismissed as harmless. Ultrasound should be performed in all patients with nodules incidentally noted on other imaging studies (carotid ultrasound, CT, MRI, or FDG-PET scan). This topic is reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H17#H17\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Thyroid incidentalomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22439454\">",
"    <span class=\"h2\">",
"     Autonomous thyroid nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autonomous thyroid nodules probably have a long evolution, often cause hyperthyroidism in mid or later life, and when they are over several centimeters in size may undergo hemorrhagic and cystic degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/18\">",
"     18",
"    </a>",
"    ]. Ultrasonography can detect and quantify the size of the cystic area that appears on a scintiscan as a \"cold\" area within the \"hot\" nodule, assuaging clinical concern that the \"cold\" zone might be a cancer. Alternatively, when the \"cold\" area is solid tissue, sonography can facilitate percutaneous biopsy to obtain a cytological diagnosis. \"Hot\" nodules can sometimes be differentiated from \"cold\" nodules with Doppler scanning because of their more prominent vascular patterns and significantly higher peak systolic velocity values [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4206486\">",
"    <span class=\"h2\">",
"     Monitoring thyroid nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is useful to monitor cytologically benign thyroid nodules and nodules that initially do not meet indications for fine needle aspiration biopsy. Small changes in nodule size on serial ultrasonography do not require a repeat aspiration. However, reassessment is warranted when there is substantial growth. The criteria for repeat aspiration are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Benign nodules'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Monitoring of small nodules that are not biopsied'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One must be especially cautious when interpreting reported changes in the volume of nodules based upon ultrasonic volume assessments because it is difficult to reproduce identical two-dimensional image planes for follow-up studies. The accuracy of thyroid volume assessment of thyroid volume and improved intra-observer variability and repeatability appears to be improved with three-dimensional echography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2437?source=see_link&amp;anchor=H26548600#H26548600\">",
"     \"Technical aspects of thyroid ultrasound\", section on 'Estimation of thyroid gland volume'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1481349\">",
"    <span class=\"h2\">",
"     Screening for nodules in high risk groups",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation exposure of the thyroid during childhood is associated with an increased risk of benign and malignant thyroid nodules. Radiation exposure includes therapeutic external radiation for the treatment of cancer, historical use of external radiation to treat a wide variety of nonmalignant conditions, and exposure to nuclear fallout (from testing, accidents, or in Japanese survivors of atomic bombing). The use of screening thyroid ultrasound to detect nodules in radiation-exposed patients is controversial and should be guided by individual risk factors, including dose of radiation to the thyroid, young age of exposure, and the presence of another, potentially radiation-related tumor. This topic is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1818?source=see_link&amp;anchor=H7#H7\">",
"     \"Radiation-induced thyroid cancer\", section on 'Ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22439513\">",
"    <span class=\"h2\">",
"     Ultrasonography versus CT and MRI for thyroid nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generally ultrasonography rather than computed tomography is performed to evaluate thyroid nodules because of superior resolution, lack of exposure to ionizing irradiation, lower cost, and avoidance of iodinated contrast medium, which may influence thyroid function and management. When additional imaging is required for clinical reasons, magnetic resonance imaging may be preferred to CT because iodinated dye is not required [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     THYROID CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography plays an important role in the assessment of lymph node status in patients with thyroid nodules or newly diagnosed thyroid cancer and in the detection of recurrent disease in treated thyroid cancer patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Thyroid ultrasonography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link\">",
"     \"Overview of the management of differentiated thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Lymphadenopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography is important to confirm or detect cervical lymphadenopathy in a patient with a thyroid nodule or newly diagnosed thyroid cancer. Identification of suspicious lymph nodes in a patient with a thyroid nodule increases the likelihood of malignancy. In some cases, FNA cytology is obtained from the abnormal cervical lymph node rather than the nodule. For patients requiring thyroidectomy for biopsy-proven papillary thyroid cancer, preoperative neck ultrasound is used to identify suspicious lymph nodes prior to thyroidectomy as metastatic disease is often not clinically apparent to the surgeon intraoperatively. Preoperative cervical ultrasound can detect clinically nonpalpable, metastatic nodes in up to 30 percent of patients with papillary thyroid cancer, which can result in an altered surgical approach in as many as 40 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Ultrasonography is also essential to detect recurrence after thyroidectomy for thyroid cancer. Cervical lymph nodes are the most common site of recurrent papillary thyroid cancer. (See",
"    <a class=\"local\" href=\"#H22439917\">",
"     'Thyroid cancer follow-up'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Optimal recognition and diagnosis of adenopathy requires a high-resolution ultrasound system equipped with a high-energy linear probe, a 12 to 14 MHz transducer, B-Mode and Doppler capability, and a dedicated, specifically skilled operator. Benign lymph nodes tend to be thin and oval in shape, and have an echogenic hilum (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73138 \" href=\"UTD.htm?2/8/2178\">",
"     image 12",
"    </a>",
"    ), whereas malignant ones may have microcalcifications or cystic regions, are \"plump\" or rounded, lack a defined hilum, and may be intensely vascular (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53482 \" href=\"UTD.htm?20/30/20975\">",
"     image 10",
"    </a>",
"    ). Color and spectral Doppler demonstrate peripheral rather than central vascularity but do not reliably distinguish benign and malignant nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are sonographic features of adenopathy that have a reasonably high specificity for malignancy but lesser sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. This was illustrated in a study of 56 lymph nodes (28 benign and 28 malignant) from patients who had a thyroidectomy for cancer and treatment with I-131 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/26\">",
"     26",
"    </a>",
"    ]. Of eight sonographic characteristics that were examined for sensitivity and specificity, cystic appearance (100 percent specific but only 11 percent sensitive), bright hyperechoic spots (100 percent specific, 46 percent sensitive), loss of a fatty hilum, and peripheral vascularization were determined to be major ultrasound criteria of lymph node malignancy, while round shape, hypoechogenicity, or the loss of hyperechoic hilum were minor criteria. In contrast, a nodal short axis less than 5mm is highly likely to signify a benign lymph node.",
"   </p>",
"   <p>",
"    In elderly, diabetic, or obese patients, fatty involution of lymph nodes (called lipoplastic lymphadenopathy) may enlarge nodes and mimic a palpable thyroid metastasis, which may confuse ultrasonic diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/30\">",
"     30",
"    </a>",
"    ]. In children and adolescents, inflammatory lymph nodes are common, whereas malignant lymph nodes are uncommon, so nodes must be conservatively interpreted in this age group even when a thyroid nodule is present.",
"   </p>",
"   <p>",
"    Ultrasound-guided aspiration biopsy of enlarged cervical lymph nodes for cytological and immunocytological analysis can differentiate metastases from thyroid cancer and inflammatory lymphadenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31814?source=see_link\">",
"     \"Ultrasound-guided thyroid biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22439917\">",
"    <span class=\"h2\">",
"     Thyroid cancer follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography is the most frequently used imaging procedure for following patients with thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. It can detect recurrent cancer in the thyroid bed after total thyroidectomy or lobectomy, in the contralateral lobe, or in lymph nodes before they have grown sufficiently large to become palpable (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61668 \" href=\"UTD.htm?21/44/22209\">",
"     image 11",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/33\">",
"     33",
"    </a>",
"    ]. The procedure can be performed without discontinuing thyroxine therapy, thereby avoiding the inconvenience and risks of hypothyroidism, and without administering recombinant thyrotropin, either of which are needed for radionuclide imaging. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of the management of differentiated thyroid cancer\", section on 'Long-term follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During follow-up of patients with differentiated thyroid cancer, ultrasonography may be the most important predictors of the presence of metastatic disease. There is broad agreement that there are no significant differences in size between benign and malignant nodes in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/1,34\">",
"     1,34",
"    </a>",
"    ]. However, it has been reported that large size and central location of abnormal cervical lymph nodes assessed by ultrasound should be viewed with great suspicion. In a study of 42 patients who had biopsy-proven, recurrent differentiated thyroid cancer involving lymph nodes, a detailed sonographic neck examination was done on the day of surgery to remove the nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/35\">",
"     35",
"    </a>",
"    ]. One hundred and twenty-seven lesions were identified, plotted on a standard diagram of the neck, and given unique numbers to help track them during surgical intervention and histopathologic examinations. In univariate analysis, size, absent echogenic hilum, cystic changes, calcifications, and central location (medial to the sternomastoid muscle) of cervical lymph nodes were significantly associated with the presence of metastatic involvement. However, in multivariate analysis, only central location (odds ratio, 4.07; 95% confidence interval [CI] 1.64-10.10) and size (odds ratio, 5.14; 95% CI 1.64-16.06) remained significant. The receiver operating characteristic curve for the size of lymph nodes showed a large area under the curve of 0.77 (95% CI 0.68-0.85), and a size of 7.5 mm showed the highest sensitivity and specificity. Other sonographic criteria that suggest malignancy are discussed above (see",
"    <a class=\"local\" href=\"#H26\">",
"     'Lymphadenopathy'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Ultrasound examination enhances the sensitivity for recurrent thyroid cancer that is achieved by the tumor marker thyroglobulin. Among 340 consecutive patients with differentiated thyroid cancer who had been treated with near-total thyroidectomy, 131-I thyroid ablation, and TSH suppressive doses of l-thyroxine, rhTSH-stimulated thyroglobulin alone had a diagnostic sensitivity of 85 percent for detecting active disease and a negative predictive value of 98.2 percent. After adding the results of neck ultrasound, the sensitivity increased to 96.3 percent, and the negative predictive value to 99.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/36\">",
"     36",
"    </a>",
"    ]. In addition, ultrasonography of the neck may identify lymph node metastases from differentiated thyroid cancer even in patients with low or undetectable serum thyroglobulin levels and negative (131)I-whole body scintiscan performed after rhTSH stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/37\">",
"     37",
"    </a>",
"    ]. Furthermore, in a five-year observational study of 80 consecutive cases of papillary thyroid microcarcinoma, ultrasonography was highly sensitive in detecting nodal metastases in patients who had a near-total thyroidectomy and no I-131 therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sonography during the initial several months after surgery for thyroid cancer may give misleading results. During this time there may be abundant non-cancerous, enlarged lymph nodes and edematous or inflammatory postoperative changes that appear as heterogeneous and frequently sono-dense focal structures. These findings should not be confused with tumor and can be avoided by delaying the examination for three or more months.",
"   </p>",
"   <p>",
"    There are other sources of sonographic false positive evidence of recurrence. For example, suture granuloma that also mimicked cancer on 2-[fluorine-18] fluoro-2-deoxy-D-glucose positron emission tomography, but diagnosis of a suture granuloma was confirmed by a US-guided fine needle aspiration biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/39\">",
"     39",
"    </a>",
"    ]. The appearance of suture granuloma versus papillary cancer on ultrasound demonstrates central or paracentral clustering of the internal echogenic foci, and a paired appearance of echogenic foci that usually exceeds a diameter of 1 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1675562\">",
"    <span class=\"h2\">",
"     Routine screening for thyroid cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine screening of a population of individuals at low risk for thyroid cancer does not appear to be cost-effective. In one study, the detection rate for thyroid cancer was 2.6 percent for all subjects among 1401 women who were scheduled to undergo either a breast examination or a follow-up examination for breast cancer and who had thyroid ultrasonography [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, ultrasonic testing for the long-term risk of developing thyroid cancer has been useful in a population with a higher than average risk of cancer, eg, individuals exposed to radiation. In a prospective study of ultrasound examination in 2637 atomic-bomb survivors during an average follow-up of 13.3 years, six thyroid cancer cases were found among 68 subjects who had a solid thyroid nodule (7.3 percent), one case among 121 subjects who had a thyroid cyst (0.8 percent), and seven cases among 2434 thyroid nodule-free controls (0.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/42\">",
"     42",
"    </a>",
"    ]. Importantly, sex, age, TSH level, thyroglobulin level, radiation dose, nodule volume, and increase in nodule volume did not predict cancer development in the solid nodule group. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1818?source=see_link&amp;anchor=H7#H7\">",
"     \"Radiation-induced thyroid cancer\", section on 'Ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     GOITER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid enlargement, like thyroid nodules, is detected much more often by ultrasonography than physical examination. In an individual patient with a palpable diffuse goiter, ultrasonography may add several types of information.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It may identify distinctive, nonpalpable thyroid nodules within a nodular or diffuse goiter. Nodules with suspicious ultrasound features should be considered for biopsy because the prevalence of cancer in an individual nodule in a goiter is independent of the number of sonographically identified nodules [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H12#H12\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Multiple nodules'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It may be useful in evaluating a region of a goiter with unusual characteristics on palpation, such as hard consistency or tenderness, findings suggestive of possible coexisting adenoma, cancer, or lymphoma (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53093 \" href=\"UTD.htm?42/63/44016\">",
"       image 13",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/20\">",
"       20",
"      </a>",
"      ]. Screening of goiters for ultrasonic characteristics, such as enhanced posterior echoes, has been reported to contributing to early diagnosis of lymphoma, facilitating early initiation of therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a situation where a medical treatment may be associated with goiter, ultrasonography is superior to palpation in detecting enlargement of the thyroid. For instance, in a cross-sectional study of patients undergoing long-term treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      for bipolar, major depressive, and schizoaffective disease, total thyroid volume was significantly greater (23.7 mL versus 13.6 mL) in the lithium-treated group (96) than among controls (96 gender- and age-matched control subjects). Ultrasonography detected enlargement significantly more often than palpation [",
"      <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/46\">",
"       46",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42453?source=see_link\">",
"       \"Lithium and the thyroid\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The ultrasonic texture of a goiter and Doppler dynamics may yield information about diagnosis, function, and possibly even prognosis and medical management (see",
"      <a class=\"local\" href=\"#H29\">",
"       'Autoimmune thyroid disease'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4206983\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Autoimmune thyroid disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid glands in patients with chronic autoimmune thyroiditis (Hashimoto's disease) tend to be diffusely enlarged and have low echogenicity (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74696 \" href=\"UTD.htm?29/46/30435\">",
"     image 14",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Diffusely low echogenicity may also be seen in patients with Graves' hyperthyroidism (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79956 \" href=\"UTD.htm?23/36/24130\">",
"     image 15",
"    </a>",
"    ) and in patients with thyroiditis [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. In an investigation of 485 patients with diffuse thyroid hypoechogenicity compared with 100 patients with normal echogenicity, the positive and negative predictive values of hypoechogenicity as an indicator of autoimmune thyroid disease were 88 and 95 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Color flow Doppler imaging may offer additional clinical information [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. Among 55 patients with hyperthyroidism (Graves' disease or toxic adenoma), 24 with Hashimoto&rsquo;s thyroiditis, and 39 euthyroid controls, color flow Doppler examination differentiated untreated Graves' disease (high blood flow) from Hashimoto's thyroiditis (low blood flow), whereas conventional gray scale findings were similar [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/19\">",
"     19",
"    </a>",
"    ]. In a similar study of 114 patients with hyperthyroidism (56 Graves&rsquo; disease, 28 painless thyroiditis, 30 subacute thyroiditis), color flow Doppler could distinguish Graves&rsquo;s disease (high blood flow) from thyroiditis (normal blood flow), and total blood flow values significantly correlated with radioactive iodine uptake [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although these ultrasound findings are interesting, they are not clinically useful in the diagnosis of Graves&rsquo; disease or Hashimoto&rsquo;s thyroiditis in comparison to checking thyroid function tests, thyroid peroxidase antibodies (to diagnose Hashimoto&rsquo;s thyroiditis), or a radioiodine uptake and scan (to distinguish Graves&rsquo; from painless thyroiditis). In circumstances where radioiodine studies are contraindicated (pregnancy, breastfeeding) and Graves&rsquo; disease and thyroiditis cannot be differentiated by clinical findings, ultrasound with Doppler imaging may be clinically useful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=see_link\">",
"     \"Diagnosis of and screening for hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/15/248?source=see_link&amp;anchor=H8#H8\">",
"     \"Postpartum thyroiditis\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=see_link&amp;anchor=H25975118#H25975118\">",
"     \"Diagnosis of hyperthyroidism\", section on 'Radioiodine uptake'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=see_link&amp;anchor=H19#H19\">",
"     \"Diagnosis of hyperthyroidism\", section on 'Determining the etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although a micronodular pattern on ultrasound is often noted in the thyroid glands of patients with Hashimoto&rsquo;s thyroiditis, discrete nodules may also be present (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77505 \" href=\"UTD.htm?11/22/11631\">",
"     image 16",
"    </a>",
"    ). The sonographic features of nodular Hashimoto&rsquo;s thyroiditis are variable, although nodules are more often solid and often hypoechoic [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/56\">",
"     56",
"    </a>",
"    ]. On Doppler analysis, nodules may be hyper, hypo, or isovascular. In an analysis of 78 patients with 82 nodules within glands with diffuse Hashimoto&rsquo;s thyroiditis, 84 percent were benign and 16 percent were malignant (12 papillary carcinoma and one lymphoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/57\">",
"     57",
"    </a>",
"    ]. The ultrasound characteristics of malignant and benign nodules within diffuse Hashimoto&rsquo;s thyroiditis were similar to the characteristics of nodules in the general population. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Criteria for identifying cancer'",
"    </a>",
"    above.) Thus, the decision to perform FNA biopsy in a patient with Hashimoto&rsquo;s thyroiditis is based upon the same criteria as those used in the general population with thyroid nodules. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1676193\">",
"    <span class=\"h2\">",
"     Amiodarone induced thyrotoxicosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler flow sonography has been reported to differentiate the two types of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    -induced hyperthyroidism. In several studies, patients with hyperthyroidism who had underlying thyroid disease, such as nodular goiter, had moderate to high vascular flow (amiodarone-induced thyrotoxicosis Type I), while patients with thyrotoxicosis due to drug-related thyroiditis who had no apparent underlying thyroid disease showed no vascular flow (amiodarone-induced thyrotoxicosis Type II) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/58-61\">",
"     58-61",
"    </a>",
"    ]. Since only patients in the low flow group respond to glucocorticoid therapy, Doppler sonography may be used to direct steroid therapy in these patients. However, in one study that examined the data retrospectively from 24 patients who had been treated for amiodarone-induced thyrotoxicosis, the responsiveness to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     prednisolone",
"    </a>",
"    correlated poorly with the absence of enhanced blood flow in the thyroid glands, but enhanced flow appeared to correlate well with a lack of response to prednisolone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/62\">",
"     62",
"    </a>",
"    ]. There is no consensus about the correlation of Interleukin 6 (IL-6) levels, which shows a relationship to the inflammatory type of thyrotoxicosis, with the ultrasonic Doppler appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. This topic is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/30/25065?source=see_link&amp;anchor=H22#H22\">",
"     \"Amiodarone and thyroid dysfunction\", section on 'Differentiating the two types'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22440291\">",
"    <span class=\"h2\">",
"     Thyroid lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid lymphoma has a hypoechogenic appearance that is difficult to differentiate from chronic thyroiditis. Three patterns have been reported according to internal echoes within the suspected lesion, the border of the lesion, and the intensity of the echoes behind the lesion (due to enhanced transmission of the signal through uniform tissue that minimally reflects ultrasound). Nodular lymphoma reportedly has a very uniform and hypoechoic pattern that may be sufficiently hypoechoic to be pseudo-cystic. The border between lymphoma and non-lymphomatous tissue is well defined and the borderline may be \"broccoli-like\" or \"coastline-like\" irregular. In this report, the diffuse type of lymphoma had an indistinct border between lymphoma and non-lymphomatous thyroid gland and otherwise looked like goiter but the internal echoes were of exceedingly low intensity. The mixed type lymphoma showed multiple, patchy hypoechoic lesions, each with enhanced posterior echoes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/8/35974?source=see_link\">",
"     \"Thyroid lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22440199\">",
"    <span class=\"h2\">",
"     Subacute granulomatous thyroiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with subacute granulomatous thyroiditis, uniform or patchy hypoechogenicity without hypervascularity is seen. The gray-scale image returns to a normal pattern with resolution of the illness, and the Doppler study may show mild hypervascularity [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/64-68\">",
"     64-68",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1399?source=see_link\">",
"     \"Subacute thyroiditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Nonthyroid and ectopic thyroid cervical lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography can distinguish and sometimes identify disorders in the neck that are not thyroid in origin. Examples include parathyroid adenomas or cysts, subcutaneous lesions, vascular abnormalities, or branchial cleft cysts. It can also be useful in diagnosing and postoperatively evaluating patients with thyroid cancer of a thyroglossal duct [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/69\">",
"     69",
"    </a>",
"    ]. Interestingly, an esophageal tumor has been misidentified as a thyroid mass based on sonography [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients who are about to have parathyroid surgery, thyroid ultrasonography is useful and may be cost-effective to evaluate the thyroid gland for lesions that may need surgical intervention during parathyroidectomy. Thyroid nodules are also a potential source of a false positive sestamibi study for the preoperative localization of parathyroid adenomas. In a retrospective study of 1200 consecutive patients who were treated surgically for primary hyperparathyroidism with bilateral neck exploration, routine preoperative neck ultrasound identified coexisting thyroid disease in 43 percent (150 of 350 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/71\">",
"     71",
"    </a>",
"    ]. Thyroid cancer was found in 4.6 percent of the patients and was treated with total thyroidectomy at the time of the parathyroid surgery, avoiding the need for a second operation. Preoperative fine needle biopsy of sonographically detected thyroid nodules was performed in 20 percent, which was reportedly cost-effective in limiting concomitant thyroid surgery to fewer patients (6 percent;",
"    <span class=\"nowrap\">",
"     21/350).",
"    </span>",
"    Nearly half of thyroid pathology was colloid",
"    <span class=\"nowrap\">",
"     nodules/goiters,",
"    </span>",
"    followed by follicular adenomas, papillary cancer, thyroiditis, and intrathyroidal parathyroid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Tuberculous thyroiditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a single case report, the characteristics of tuberculous thyroiditis included heterogeneous, hypoechoic lesions with ill-defined margins in both lobes of the thyroid and several small, oval lymph nodes, each with an intact fatty hilum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/72\">",
"     72",
"    </a>",
"    ]. Fine needle aspiration cytology revealed a small number of epithelioid histiocytes in a necrotic background, which was suggestive of tuberculosis. Sonography after three months of antituberculosis chemotherapy showed that the thyroid lesions had resolved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Intraoperative thyroid ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;When differentiated thyroid cancer does not trap radioiodine, surgical resection is considered by some an appropriate option for treatment. In one study of 13 patients with recurrent, scan-negative papillary thyroid cancer, intraoperative ultrasonography helped localize tumor in seven of the 13 patients (including all patients who had previously undergone external beam radiotherapy). Most importantly, it identified small tumor nodules that were invasive or adherent to the airway [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been reported that intra-operative ultrasound that was actually performed by the surgeon influenced the surgery in 57 percent",
"    <span class=\"nowrap\">",
"     (41/72)",
"    </span>",
"    of patients by identifying nonpalpable adenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/74\">",
"     74",
"    </a>",
"    ]. Although excision of nonpalpable nodules that are in proximity to a vital structure could be palliative if the cancer is removed before it invades, one wonders if resection of nonpalpable or even larger deposits of differentiated thyroid cancer will benefit outcome since even bilateral radical neck dissection is not associated with enhanced results when compared with thyroidectomy alone. Nevertheless, there may be a role for intra-operative ultrasonography to look for and remove nonpalpable nodes after a thyroidectomy for cancer has been completed.",
"   </p>",
"   <p>",
"    In a wider sense, other surgical techniques and concepts may change as a result of ultrasonic energy, just as medical practices have evolved because of sonography. Sonic energy can be used to destroy thyroid tissue and also to activate mechanical equipment. As an example of the latter, ultrasonically activated shears for thyroidectomy have reportedly shortened operative time, improved cosmetic results, and reduced the patient's pain, without greater expense or higher complication rates than conventional methods [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Ultrasound to evaluate pelvic thyroid tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trans-vaginal and trans-abdominal ultrasonography have been used to assess the fetal thyroid and its diseases, as will be discussed below. In addition, pelvic sonography identified a 16-cm mass in the right adnexa that was a cystic teratoma with struma ovarii, containing a 5-mm focus of papillary cancer within the thyroid tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     ULTRASONOGRAPHY OF THE THYROID IN THE FETUS AND NEONATE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22440146\">",
"    <span class=\"h2\">",
"     Fetal thyroid gland",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography has become useful to assess the fetal thyroid gland, diagnose fetal goiter or thyroid dysfunction, and to facilitate therapy. Thus, it can reduce obstetric complications and contribute to neonatal health. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16186?source=see_link\">",
"     \"Overview of thyroid disease in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study, trans-uterine sonography was performed in 200 fetuses between 16 and 37 weeks of pregnancy to acquire gestational age-dependent and age-independent normative data on fetal thyroid size [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In mothers with Graves' disease, ultrasonography of the fetal thyroid gland by an experienced ultrasonographer is an excellent diagnostic tool that can facilitate assessment of fetal thyroid function [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/78\">",
"     78",
"    </a>",
"    ]. Used in conjunction with clinical features, such as fetal tachycardia, intrauterine growth retardation, and occasionally cord blood sampling, findings of fetal goiter may lead to the diagnosis of fetal thyrotoxicosis. Conversely, fetal goiter without clinical manifestations of fetal thyrotoxicosis may suggest overtreatment of the mother with antithyroid drugs and result in a dose reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasonography can also be used to identify and facilitate treatment of fetal goitrous hypothyroidism. In one case report, a diagnosis of fetal goitrous hypothyroidism associated with high-output cardiac failure was made at 32 weeks of gestation using maternal ultrasound examination, amniocentesis, and cordocentesis. The fetus was treated by injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    sodium into the amniotic fluid at 33 weeks of gestation and the goiter decreased in size, the cardiac failure improved and fetal TSH was reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/80\">",
"     80",
"    </a>",
"    ]. In a second case report, routine ultrasound examination of a mother revealed a 29 week fetus with a goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/81\">",
"     81",
"    </a>",
"    ]. Fetal blood sampling showed a high TSH indicative of fetal hypothyroidism. Treatment was given between 31 and 36 weeks with intraamniotic injections of triiodothyronine and subsequently with thyroxine. Thereafter, the fetal goiter became smaller, neck flexion increased, and polyhydramnios resolved. Following birth, neonatal serum TSH was within the normal range [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22440153\">",
"    <span class=\"h2\">",
"     Neonates and infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography has been applied to assess the thyroid in neonates and infants. Normative data was collected in a study of 100 (49 male) healthy term Scottish neonates to ascertain the length, breadth, and depth of each thyroid lobe, and calculated the volume of each lobe using the formula for a prolate ellipsoid. There was no difference in mean volume between the right and left lobes, but there was considerable variation between the two lobes in individual infants. A wider geographic sample with attention to ambient iodine intake will be required before these data can be applied globally [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another useful method for assessing the size of the thyroid in infants and small children is to determine the ratio of the maximum width of both thyroid lobes to the width of the trachea [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been suggested that sonography might be used as the first imaging tool in neonates and infants with congenital hypothyroidism, but that scintigraphy should be used to distinguish agenesis from ectopia. In one study, ultrasonography identified 66 instances where the thyroid gland was not located in the usual anatomical position and one case of hemiagenesis. The diagnoses were confirmed by scintigraphy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGIC USE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid anatomy and size in iodine-deficient or radiation-exposed populations can be evaluated by ultrasonography. While inter-observer agreement on estimates of thyroid volume has been good in epidemiologic studies, agreement on echogenicity has been poor [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children, when thyroid volumes are to be compared with reference values, assessment based upon age is reportedly the most reliable method, providing there is normal somatic development [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/86\">",
"     86",
"    </a>",
"    ]. Furthermore, standards for thyroid volume and Doppler data that are specific to a geographic region, iodine status, gender, and pubertal stage may be more appropriate than a single age-specific international reference [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/87,88\">",
"     87,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Systematic screening with ultrasound has been reported as useful for early detection of thyroid cancer in the population of Belarus who were exposed to radiation due to the Chernobyl accident [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other examples of epidemiologic applications of thyroid sonography include detection of thyroid cancers in populations with endemic goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/90\">",
"     90",
"    </a>",
"    ], and the demonstration that the prevalence of thyroid cancer has not increased in the population exposed to the accidental release of I-131 in Hanford, Washington during 1944 to 1957 [",
"    <a class=\"abstract\" href=\"UTD.htm?20/62/21482/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22440161\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is the preferred imaging modality for evaluation of the thyroid.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasound should be performed in all patients with a suspected thyroid nodule or nodular goiter on physical examination or with nodules incidentally noted on other imaging studies (carotid ultrasound, CT, MRI, or FDG-PET scan). The characteristics of nodules that have been evaluated for identifying cancers include the intensity of the echoes, the sharpness of the boundary of the nodule, the presence of a sonolucent \"halo,\" calcifications, internal structure, including vascularity, and the shape (taller than wide) (",
"      <a class=\"graphic graphic_table graphicRef68199 \" href=\"UTD.htm?20/17/20763\">",
"       table 1",
"      </a>",
"      ). The cancer-predictive value of these characteristics varies widely; those with the highest clinical utility include microcalcifications, increased internal vascularity, taller than wide shape, indistinct margins (especially when they are focal), and hypoechogenicity. Although ultrasound cannot be used to definitively diagnose thyroid cancer or select patients for thyroid surgery, ultrasound findings offer important clues and can be used to select nodules for fine needle aspiration (FNA) biopsy. (See",
"      <a class=\"local\" href=\"#H26549334\">",
"       'Thyroid nodules'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H10#H10\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Fine needle aspiration biopsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ultrasonography plays an important role in the assessment of lymph node status in patients with thyroid nodules or newly diagnosed thyroid cancer and in the detection of recurrent disease in treated thyroid cancer patients. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Thyroid cancer'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H5#H5\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Thyroid ultrasonography'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link\">",
"       \"Overview of the management of differentiated thyroid cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In an individual patient with a palpable diffuse goiter, ultrasonography may add several types of information, including the identification of distinctive, nonpalpable thyroid nodules within a nodular or diffuse goiter, which may require FNA. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Goiter'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasonography can be employed as a real-time guide to direct the path of a biopsy needle into a thyroid nodule or lymphadenopathy, thus enhancing the diagnostic value of the procedure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31814?source=see_link\">",
"       \"Ultrasound-guided thyroid biopsy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ultrasonography can be used to assess the fetal, neonatal, or infant thyroid gland. (See",
"      <a class=\"local\" href=\"#H41\">",
"       'Ultrasonography of the thyroid in the fetus and neonate'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/1\">",
"      Cappelli C, Castellano M, Pirola I, et al. The predictive value of ultrasound findings in the management of thyroid nodules. QJM 2007; 100:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/2\">",
"      Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid 2009; 19:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/3\">",
"      Moon WJ, Jung SL, Lee JH, et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology 2008; 247:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/4\">",
"      Ito Y, Amino N, Yokozawa T, et al. Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid 2007; 17:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/5\">",
"      Solbiati L, Volterrani L, Rizzatto G, et al. The thyroid gland with low uptake lesions: evaluation by ultrasound. Radiology 1985; 155:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/6\">",
"      Cochand-Priollet B, Guillausseau PJ, Chagnon S, et al. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings. Am J Med 1994; 97:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/7\">",
"      Ito Y, Kobayashi K, Tomoda C, et al. Ill-defined edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarcinoma. World J Surg 2005; 29:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/8\">",
"      Park JS, Son KR, Na DG, et al. Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system. AJR Am J Roentgenol 2009; 192:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/9\">",
"      Kakkos SK, Scopa CD, Chalmoukis AK, et al. Relative risk of cancer in sonographically detected thyroid nodules with calcifications. J Clin Ultrasound 2000; 28:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/10\">",
"      Brunese L, Romeo A, Iorio S, et al. A new marker for diagnosis of thyroid papillary cancer: B-flow twinkling sign. J Ultrasound Med 2008; 27:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/11\">",
"      Jakobsen JA. Ultrasound contrast agents: clinical applications. Eur Radiol 2001; 11:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/12\">",
"      Kwak JY, Kim EK, Son EJ, et al. Papillary thyroid carcinoma manifested solely as microcalcifications on sonography. AJR Am J Roentgenol 2007; 189:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/13\">",
"      Yoon DY, Lee JW, Chang SK, Choi CS, Yun EJ, Seo YL, Kim KH, Hwang HS. Peripheral calcification in thyroid nodules: ultrasonographic features and prediction of malignancy. J Ultrasound Med. 2007; 26:1349-55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/14\">",
"      Bonavita JA, Mayo J, Babb J, et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol 2009; 193:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/15\">",
"      Cappelli C, Pirola I, Cumetti D, et al. Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology? Clin Endocrinol (Oxf) 2005; 63:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/16\">",
"      Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002; 87:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/17\">",
"      Appetecchia M, Solivetti FM. The association of colour flow Doppler sonography and conventional ultrasonography improves the diagnosis of thyroid carcinoma. Horm Res 2006; 66:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/18\">",
"      Blum M, Shenkman L, Hollander CS. The autonomous nodule of the thyroid: correlation of patient age, nodule size and functional status. Am J Med Sci 1975; 269:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/19\">",
"      Erdo��an MF, Anil C, Cesur M, et al. Color flow Doppler sonography for the etiologic diagnosis of hyperthyroidism. Thyroid 2007; 17:223.",
"     </a>",
"    </li>",
"    <li>",
"     Blum M. Evaluation of thyroid function: Sonography, computed tomography and magnetic resonance imaging. In: Principles and Practices of Endocrinology and Metabolism, Becker KL, Bilezikian JP, Bremner WJ, Hung W (Eds), Lippincott Williams and Wilkins, Philadelphia 1990. p.289.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/21\">",
"      Shimamoto K, Satake H, Sawaki A, et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998; 29:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/22\">",
"      Stulak JM, Grant CS, Farley DR, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 2006; 141:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/23\">",
"      Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003; 134:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/24\">",
"      Chang DB, Yuan A, Yu CJ, et al. Differentiation of benign and malignant cervical lymph nodes with color Doppler sonography. AJR Am J Roentgenol 1994; 162:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/25\">",
"      Choi MY, Lee JW, Jang KJ. Distinction between benign and malignant causes of cervical, axillary, and inguinal lymphadenopathy: value of Doppler spectral waveform analysis. AJR Am J Roentgenol 1995; 165:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/26\">",
"      Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007; 92:3590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/27\">",
"      Kessler A, Rappaport Y, Blank A, et al. Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma. J Clin Ultrasound 2003; 31:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/28\">",
"      Seven H, Gurkan A, Cinar U, et al. Incidence of occult thyroid carcinoma metastases in lateral cervical cysts. Am J Otolaryngol 2004; 25:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/29\">",
"      Wunderbaldinger P, Harisinghani MG, Hahn PF, et al. Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol 2002; 178:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/30\">",
"      Giovagnorio F, Drudi FM, Fanelli G, et al. Fatty changes as a misleading factor in the evaluation with ultrasound of superficial lymph nodes. Ultrasound Med Biol 2005; 31:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/31\">",
"      Pisani T, Vecchione A, Sinopoli NT, et al. Cytological and immunocytochemical analysis of laterocervical lymph nodes in patients with previous thyroid carcinoma. Anticancer Res 1999; 19:3527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/32\">",
"      Simeone JF, Daniels GH, Hall DA, et al. Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 1987; 148:45.",
"     </a>",
"    </li>",
"    <li>",
"     Arora, P, Blum, M. Utility of ultrasonography in post surgical management of patients with thyroid carcinoma. American Thyroid Association: Seventy-fourth Meeting, Washington, DC 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/34\">",
"      Ahuja AT, Ying M, Yuen HY, Metreweli C. Power Doppler sonography of metastatic nodes from papillary carcinoma of the thyroid. Clin Radiol 2001; 56:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/35\">",
"      Alzahrani AS, Alsuhaibani H, Salam SA, et al. Diagnostic accuracy of high-resolution neck ultrasonography in the follow-up of differentiated thyroid cancer: a prospective study. Endocr Pract 2005; 11:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/36\">",
"      Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88:3668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/37\">",
"      Torlontano M, Crocetti U, D'Aloiso L, et al. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol 2003; 148:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/38\">",
"      Torlontano M, Crocetti U, Augello G, et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 2006; 91:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/39\">",
"      Chung YE, Kim EK, Kim MJ, et al. Suture granuloma mimicking recurrent thyroid carcinoma on ultrasonography. Yonsei Med J 2006; 47:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/40\">",
"      Kim JH, Lee JH, Shong YK, et al. Ultrasound features of suture granulomas in the thyroid bed after thyroidectomy for papillary thyroid carcinoma with an emphasis on their differentiation from locally recurrent thyroid carcinomas. Ultrasound Med Biol 2009; 35:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/41\">",
"      Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination. Surg Today 2001; 31:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/42\">",
"      Imaizumi M, Usa T, Tominaga T, et al. Long-term prognosis of thyroid nodule cases compared with nodule-free controls in atomic bomb survivors. J Clin Endocrinol Metab 2005; 90:5009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/43\">",
"      Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000; 133:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/44\">",
"      Tollin SR, Mery GM, Jelveh N, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 2000; 10:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/45\">",
"      Ota H, Ito Y, Matsuzuka F, et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid. Thyroid 2006; 16:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/46\">",
"      Bauer M, Blumentritt H, Finke R, et al. Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders. J Affect Disord 2007; 104:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/47\">",
"      Marcocci C, Vitti P, Cetani F, et al. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 1991; 72:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/48\">",
"      Hayashi N, Tamaki N, Konishi J, et al. Sonography of Hashimoto's thyroiditis. J Clin Ultrasound 1986; 14:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/49\">",
"      Gutekunst R, Hafermann W, Mansky T, Scriba PC. Ultrasonography related to clinical and laboratory findings in lymphocytic thyroiditis. Acta Endocrinol (Copenh) 1989; 121:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/50\">",
"      Pedersen OM, Aardal NP, Larssen TB, et al. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 2000; 10:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/51\">",
"      Shahbazian HB, Sarvghadi F, Azizi F. Ultrasonographic characteristics and follow-up in post-partum thyroiditis. J Endocrinol Invest 2005; 28:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/52\">",
"      Ralls PW, Mayekawa DS, Lee KP, et al. Color-flow Doppler sonography in Graves disease: \"thyroid inferno\". AJR Am J Roentgenol 1988; 150:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/53\">",
"      Hodgson KJ, Lazarus JH, Wheeler MH, et al. Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg 1988; 12:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/54\">",
"      Fobbe F, Finke R, Reichenstein E, et al. Appearance of thyroid diseases using colour-coded duplex sonography. Eur J Radiol 1989; 9:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/55\">",
"      Ota H, Amino N, Morita S, et al. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease. Clin Endocrinol (Oxf) 2007; 67:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/56\">",
"      Anderson L, Middleton WD, Teefey SA, et al. Hashimoto thyroiditis: Part 1, sonographic analysis of the nodular form of Hashimoto thyroiditis. AJR Am J Roentgenol 2010; 195:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/57\">",
"      Anderson L, Middleton WD, Teefey SA, et al. Hashimoto thyroiditis: Part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis. AJR Am J Roentgenol 2010; 195:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/58\">",
"      Eaton SE, Euinton HA, Newman CM, et al. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 2002; 56:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/59\">",
"      Bogazzi F, Bartalena L, Brogioni S, et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid 1997; 7:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/60\">",
"      Macedo TA, Chammas MC, Jorge PT, et al. Differentiation between the two types of amiodarone-associated thyrotoxicosis using duplex and amplitude Doppler sonography. Acta Radiol 2007; 48:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/61\">",
"      Loy M, Perra E, Melis A, et al. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis. Acta Radiol 2007; 48:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/62\">",
"      Wong R, Cheung W, Stockigt JR, Topliss DJ. Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response. Intern Med J 2003; 33:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/63\">",
"      Ota H, Ito Y, Matsuzuka F, et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid. Thyroid 2006; 16:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/64\">",
"      Blum M, Passalaqua AM, Sackler JP, Pudlowski R. Thyroid echography of subacute thyroiditis. Radiology 1977; 125:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/65\">",
"      Hiromatsu Y, Ishibashi M, Miyake I, et al. Color Doppler ultrasonography in patients with subacute thyroiditis. Thyroid 1999; 9:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/66\">",
"      Kunz A, Blank W, Braun B. De Quervain's subacute thyroiditis -- colour Doppler sonography findings. Ultraschall Med 2005; 26:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/67\">",
"      Park SY, Kim EK, Kim MJ, et al. Ultrasonographic characteristics of subacute granulomatous thyroiditis. Korean J Radiol 2006; 7:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/68\">",
"      Lu CP, Chang TC, Wang CY, Hsiao YL. Serial changes in ultrasound-guided fine needle aspiration cytology in subacute thyroiditis. Acta Cytol 1997; 41:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/69\">",
"      Miccoli P, Minuto MN, Galleri D, et al. Extent of surgery in thyroglossal duct carcinoma: reflections on a series of eighteen cases. Thyroid 2004; 14:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/70\">",
"      Sierra M, Sebag F, De Micco C, et al. [Abrikossoff tumor of the proximal esophagus misdiagnosed as a thyroid nodule]. Ann Chir 2006; 131:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/71\">",
"      Milas M, Mensah A, Alghoul M, et al. The impact of office neck ultrasonography on reducing unnecessary thyroid surgery in patients undergoing parathyroidectomy. Thyroid 2005; 15:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/72\">",
"      Chung SY, Oh KK, Chang HS. Sonographic findings of tuberculous thyroiditis in a patient with Beh&ccedil;et's syndrome. J Clin Ultrasound 2002; 30:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/73\">",
"      Karwowski JK, Jeffrey RB, McDougall IR, Weigel RJ. Intraoperative ultrasonography improves identification of recurrent thyroid cancer. Surgery 2002; 132:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/74\">",
"      Solorzano CC, Carneiro DM, Ramirez M, et al. Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 2004; 70:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/75\">",
"      Casadei R, Perenze B, Vescini F, et al. Usefulness of the ultrasonically activated shears in total thyroidectomy. Chir Ital 2004; 56:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/76\">",
"      Makani S, Kim W, Gaba AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 2004; 94:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/77\">",
"      Ranzini AC, Ananth CV, Smulian JC, et al. Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med 2001; 20:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/78\">",
"      Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005; 90:6093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/79\">",
"      Cohen O, Pinhas-Hamiel O, Sivan E, et al. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Prenat Diagn 2003; 23:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/80\">",
"      Morine M, Takeda T, Minekawa R, et al. Antenatal diagnosis and treatment of a case of fetal goitrous hypothyroidism associated with high-output cardiac failure. Ultrasound Obstet Gynecol 2002; 19:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/81\">",
"      Agrawal P, Ogilvy-Stuart A, Lees C. Intrauterine diagnosis and management of congenital goitrous hypothyroidism. Ultrasound Obstet Gynecol 2002; 19:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/82\">",
"      Perry RJ, Hollman AS, Wood AM, Donaldson MD. Ultrasound of the thyroid gland in the newborn: normative data. Arch Dis Child Fetal Neonatal Ed 2002; 87:F209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/83\">",
"      Yasumoto M, Inoue H, Ohashi I, et al. Simple new technique for sonographic measurement of the thyroid in neonates and small children. J Clin Ultrasound 2004; 32:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/84\">",
"      Kreisner E, Camargo-Neto E, Maia CR, Gross JL. Accuracy of ultrasonography to establish the diagnosis and aetiology of permanent primary congenital hypothyroidism. Clin Endocrinol (Oxf) 2003; 59:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/85\">",
"      Knudsen N, Bols B, B&uuml;low I, et al. Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 1999; 9:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/86\">",
"      Semiz S, Senol U, G&uuml;m&uuml;��l&uuml; S, et al. Correlation between age, body size and thyroid volume in an endemic area. J Endocrinol Invest 2001; 24:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/87\">",
"      Kaloumenou I, Alevizaki M, Ladopoulos C, et al. Thyroid volume and echostructure in schoolchildren living in an iodine-replete area: relation to age, pubertal stage, and body mass index. Thyroid 2007; 17:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/88\">",
"      Yazici B, Simsek E, Erdogmus B, et al. Evaluation of the thyroid blood flow with Doppler ultrasonography in healthy school-aged children. Eur J Radiol 2007; 63:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/89\">",
"      Drozd V, Polyanskaya O, Ostapenko V, et al. Systematic ultrasound screening as a significant tool for early detection of thyroid carcinoma in Belarus. J Pediatr Endocrinol Metab 2002; 15:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/90\">",
"      Gurleyik E, Coskun O, Aslaner A. Clinical importance of solitary solid nodule of the thyroid in endemic goiter region. Indian J Med Sci 2005; 59:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/62/21482/abstract/91\">",
"      Kopecky KJ, Onstad L, Hamilton TE, Davis S. Thyroid ultrasound abnormalities in persons exposed during childhood to 131I from the Hanford nuclear site. Thyroid 2005; 15:604.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7859 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-218.189.88.190-7920B88E07-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21482=[""].join("\n");
var outline_f20_62_21482=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22440161\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26549334\">",
"      THYROID NODULES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Nodule identification and characterization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Criteria for identifying cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Intensity of the echoes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Sharpness of border",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Halo",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Calcifications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Internal structure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Shape of a nodule",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Color Doppler flow patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Nonpalpable nodules (\"incidentalomas\")",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22439454\">",
"      Autonomous thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4206486\">",
"      Monitoring thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1481349\">",
"      Screening for nodules in high risk groups",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22439513\">",
"      Ultrasonography versus CT and MRI for thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      THYROID CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Lymphadenopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22439917\">",
"      Thyroid cancer follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1675562\">",
"      Routine screening for thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      GOITER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4206983\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Autoimmune thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1676193\">",
"      Amiodarone induced thyrotoxicosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22440291\">",
"      Thyroid lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22440199\">",
"      Subacute granulomatous thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Nonthyroid and ectopic thyroid cervical lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Tuberculous thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Intraoperative thyroid ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Ultrasound to evaluate pelvic thyroid tissue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      ULTRASONOGRAPHY OF THE THYROID IN THE FETUS AND NEONATE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22440146\">",
"      Fetal thyroid gland",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22440153\">",
"      Neonates and infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      EPIDEMIOLOGIC USE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22440161\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7859\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7859|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/4/31809\" title=\"diagnostic image 1\">",
"      Isoechoic nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/3/5170\" title=\"diagnostic image 2\">",
"      Hyperechoic nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/24/37263\" title=\"diagnostic image 3\">",
"      Hypoechoic nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/51/43839\" title=\"diagnostic image 4\">",
"      Complex thyroid nodule Echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/60/33743\" title=\"diagnostic image 5\">",
"      Thyroid calcification Echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/62/992\" title=\"diagnostic image 6\">",
"      Thyroid nodule with halo Echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/4/76\" title=\"diagnostic image 7\">",
"      Thyroid nodule with spongiform appearance on ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/62/44000\" title=\"diagnostic image 8\">",
"      Thyroid nodule with degeneration and bright spot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/27/8627\" title=\"diagnostic image 9\">",
"      Hypoechoic hypervascular nodule Doppler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/30/20975\" title=\"diagnostic image 10\">",
"      Thyroid ultrasound enlarged lymph node metastatic thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/44/22209\" title=\"diagnostic image 11\">",
"      Thyroid ultrasound papillary thyroid carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/8/2178\" title=\"diagnostic image 12\">",
"      Elliptical lymph nodes on thyroid ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/63/44016\" title=\"diagnostic image 13\">",
"      Thyroid ultrasound of a multinodular goiter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/46/30435\" title=\"diagnostic image 14\">",
"      Hashimotos thyroiditis Doppler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/36/24130\" title=\"diagnostic image 15\">",
"      Thyroid ultrasound from a patient with Graves disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/22/11631\" title=\"diagnostic image 16\">",
"      Hashimotos goiter Echo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7859|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/0/10242\" title=\"picture 1\">",
"      Hypoechoic nodule with microcalcifications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7859|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/17/20763\" title=\"table 1\">",
"      Ultrasound features associated with thyroid cancer risk",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/30/25065?source=related_link\">",
"      Amiodarone and thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42453?source=related_link\">",
"      Lithium and the thyroid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=related_link\">",
"      Overview of the management of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16186?source=related_link\">",
"      Overview of thyroid disease in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/15/248?source=related_link\">",
"      Postpartum thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/49/1818?source=related_link\">",
"      Radiation-induced thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1399?source=related_link\">",
"      Subacute thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2437?source=related_link\">",
"      Technical aspects of thyroid ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/8/35974?source=related_link\">",
"      Thyroid lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31814?source=related_link\">",
"      Ultrasound-guided thyroid biopsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_62_21483="Staging of pressure ulcers";
var content_f20_62_21483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62903&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Staging of pressure ulcers*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Stage",
"      </td>",
"      <td class=\"subtitle1\">",
"       Description",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       I",
"      </td>",
"      <td>",
"       Skin intact but with non-blanchable redness for &gt;1 hour after relief of pressure.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       II",
"      </td>",
"      <td>",
"       Blister or other break in the dermis with partial thickness loss of dermis, with or without infection.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       III",
"      </td>",
"      <td>",
"       Full thickness tissue loss. Subcutaneous fat may be visible; destruction extends into muscle with or without infection. Undermining and tunneling may be present.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IV",
"      </td>",
"      <td>",
"       Full thickness skin loss with involvement of bone, tendon, or joint, with or without infection. Often includes undermining and tunneling.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Unstageable",
"      </td>",
"      <td>",
"       Full thickness tissue loss in which the base of the ulcer is covered by slough and/or eschar in the wound bed.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Suspected deep tissue injury",
"      </td>",
"      <td>",
"       Purple or maroon localized area of discolored intact skin or blood-filled blister due to damage of underlying tissue from pressure and/or shear.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * From the National Pressure Ulcer Advisory Panel.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21483=[""].join("\n");
var outline_f20_62_21483=null;
var title_f20_62_21484="CKD factors that affect hemostasis";
var content_f20_62_21484=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F80195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F80195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chronic kidney disease factors that affect hemostasis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Factors predisposing to bleeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelet abnormalities including subnormal dense granule content",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction in intracellular ADP and serotonin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Impaired release of the platelet &alpha;-granule protein and &beta;-thromboglobulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enhanced intracellular cAMP and abnormal mobilization of platelet Ca2+",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal platelet arachidonic acid metabolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Defective cyclo-oxygenase activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormality of the activation-dependent binding activity of GPIIb/IIIa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased formation of vascular PGI2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Altered von Willebrand factor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Indirectly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Presence of uremic toxins, especially parathyroid hormone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anemia/altered blood rheology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythropoietin deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Specific drug treatment (eg, nonsteroidal anti-inflammatory drugs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Procoagulant factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The high prevalence of systemic inflammation, atherosclerosis and diffuse endothelial damage may provide a substrate for hypercoagulability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dysfunctional activated protein C metabolism, possibly through multiple mechanisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The fibrinolytic system is also dysfunctional because of both elevated plasminogen activator inhibitor-1 to tissue-type plasminogen activator ratios and inhibition of plasmin by increased levels of lipoprotein(a)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Defects in the expression of glycoprotein GPIb (the receptor for von Willebrand factor)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ADP: adenosine di-phosphate; cAMP: cyclic adenosine di-phosphate; CKD: chronic kidney disease; GP: glycoprotein; PG: prostaglandin.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Reinecke H, Brand E, Mesters R, et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2009; 20:705. Copyright &copy; 2009 American Society of Nephrology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21484=[""].join("\n");
var outline_f20_62_21484=null;
var title_f20_62_21485="Approach neo thrombocytopenia";
var content_f20_62_21485=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Approach to the thrombocytopenic newborn infant",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Sick infant",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Neonatal history",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Is there a history of perinatal asphyxia?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Does the child have meconium aspiration syndrome or respiratory distress syndrome?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Is there evidence of infection?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Necrotizing enterocolitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Sepsis/disseminated intravascular coagulation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Does the child look abnormal?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Toxoplasmosis, rubella, cytomegalovirus, herpes simplex",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Chromosome abnormality",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Is the child small for gestational age?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Could the child have a thrombus? Were there indwelling catheters?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Did the child have an intracranial hemorrhage?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Maternal history",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Prenatal or perinatal infection",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Preeclampsia, hemolytic anemia, elevated liver enzymes, low platelet count",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Abnormal placenta",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Neonatal examination",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Head circumference, weight percentile",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Congenital anomalies: radial rays, thumbs, dysmorphic features",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hepatosplenomegaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Blueberry muffin rash",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hemangioma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Neonatal laboratory values",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Abnormalities in the white blood cell count or hematocrit",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Hyperbilirubinemia or liver function test abnormalitites",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Evidence of coagulopathy or DIC",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Well infant",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Maternal history",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            History of immune thrombocytopenic purpura or systemic lupus erythematosus?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Previous infant with thrombocytopenia or family history of thrombocytopenic neonate?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Infections during pregnancy?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"indent1\">",
"            Drug use during pregnancy?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Maternal platelet count",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Decreased, suggests autoimmune",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Normal, may be autoimmune or alloimmune process",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle2_single\">",
"            Neonatal examination",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2_start\">",
"            Does the child look abnormal?",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist2\">",
"            Thrombocytopenia with absent radii Fanconi anemia",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: George D, Bussel JB. Neonatal thrombocytopenia. Semin Thromb Hemost 1995; 21:276. Copyright &copy; 1995 Theime.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21485=[""].join("\n");
var outline_f20_62_21485=null;
var title_f20_62_21486="TW alternans and late potentials predict arrhythmias";
var content_f20_62_21486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Repolarization alternans (RPA) and late potentials (LP) predict arrhythmic events following myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 356px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 102 patients with a prior myocardial infarction (MI) followed for 13 months, the combination of repolarization alternans (RPA) and late potentials (LP) on a signal averaged ECG had a specificity and negative predictive value for an arrhythmic event of 91 and 92 percent, respectively. However, the positive predictive value was only 50 percent. The very low event rate in the group \"RPA negative and LP positive\" may be due to the small number of patients in this subset (n=5).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Ikeda T, Sakata T, Takami M, et al, J Am Coll Cardiol 2000; 35:722.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21486=[""].join("\n");
var outline_f20_62_21486=null;
var title_f20_62_21487="Dose points HDR brachyther";
var content_f20_62_21487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Brachytherapy dose points for inoperable endometrial cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 243px; height: 479px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dose points used for high dose rate (HDR) intracavitary brachytherapy for medically inoperable endometrial cancer. S and W represent myometrial points.",
"    <div class=\"footnotes\">",
"     * Length determined by ultrasound and/or MRI; distance to point Wn often corresponds to width of applicator cylinders.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bethany Anderson, MD and Josh Anderson.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_62_21487=[""].join("\n");
var outline_f20_62_21487=null;
